
<html lang="en"     class="pb-page"  data-request-id="b39e02be-d8b0-4b23-869d-e8f7eef6bdc7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm400349k;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2013.56.issue-10;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Kinase Scaffold Repurposing for Neglected Disease Drug Discovery: Discovery of an Efficacious, Lapatanib-Derived Lead Compound for Trypanosomiasis" /></meta><meta name="dc.Creator" content="Gautam  Patel" /></meta><meta name="dc.Creator" content="Caitlin E.  Karver" /></meta><meta name="dc.Creator" content="Ranjan  Behera" /></meta><meta name="dc.Creator" content="Paul J.  Guyett" /></meta><meta name="dc.Creator" content="Catherine  Sullenberger" /></meta><meta name="dc.Creator" content="Peter  Edwards" /></meta><meta name="dc.Creator" content="Norma E.  Roncal" /></meta><meta name="dc.Creator" content="Kojo  Mensa-Wilmot" /></meta><meta name="dc.Creator" content="Michael P.  Pollastri" /></meta><meta name="dc.Description" content="Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the protozoan parasite Trypanosoma brucei. Because drugs in use against HAT are toxic and require intravenous dosing, n..." /></meta><meta name="Description" content="Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the protozoan parasite Trypanosoma brucei. Because drugs in use against HAT are toxic and require intravenous dosing, n..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 3, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400349k" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400349k" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400349k" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400349k" /></link>
        
    
    

<title>Kinase Scaffold Repurposing for Neglected Disease Drug Discovery: Discovery of an Efficacious, Lapatanib-Derived Lead Compound for Trypanosomiasis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400349k" /></meta><meta property="og:title" content="Kinase Scaffold Repurposing for Neglected Disease Drug Discovery: Discovery of an Efficacious, Lapatanib-Derived Lead Compound for Trypanosomiasis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0020.jpeg" /></meta><meta property="og:description" content="Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the protozoan parasite Trypanosoma brucei. Because drugs in use against HAT are toxic and require intravenous dosing, new drugs are needed. Initiating lead discovery campaigns by using chemical scaffolds from drugs approved for other indications can speed up drug discovery for neglected diseases. We demonstrated recently that the 4-anilinoquinazolines lapatinib (GW572016, 1) and canertinib (CI-1033) kill T. brucei with low micromolar EC50 values. We now report promising activity of analogues of 1, which provided an excellent starting point for optimization of the chemotype. Our compound optimization that has led to synthesis of several potent 4-anilinoquinazolines, including NEU617, 23a, a highly potent, orally bioavailable inhibitor of trypanosome replication. At the cellular level, 23a blocks duplication of the kinetoplast and arrests cytokinesis, making it a new chemical tool for studying regulation of the trypanosome cell cycle." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400349k"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400349k">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400349k&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400349k&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400349k&amp;href=/doi/10.1021/jm400349k" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 3820-3832</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301689x" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301793a" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Kinase Scaffold Repurposing for Neglected Disease Drug Discovery: Discovery of an Efficacious, Lapatanib-Derived Lead Compound for Trypanosomiasis</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gautam++Patel">Gautam Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caitlin+E.++Karver">Caitlin E. Karver</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ranjan++Behera">Ranjan Behera</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+J.++Guyett">Paul J. Guyett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Sullenberger">Catherine Sullenberger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Edwards">Peter Edwards</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Norma+E.++Roncal">Norma E. Roncal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kojo++Mensa-Wilmot">Kojo Mensa-Wilmot</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+P.++Pollastri">Michael P. Pollastri</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry and Chemical Biology and Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Cellular Biology, University of Georgia, Athens, Georgia 30602, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div><div class="corresp-info"><strong>*</strong>For M.P.P., medicinal chemistry: phone, 617-373-2703; E-mail, <a href="/cdn-cgi/l/email-protection#0a67247a6566666b797e78634a646f7f246f6e7f"><span class="__cf_email__" data-cfemail="ea87c49a8586868b999e9883aa848f9fc48f8e9f">[email protected]</span></a>. For K.M.-W., biology: 706-542-3355; E-mail, <a href="/cdn-cgi/l/email-protection#630e060d1002140a0f231604024d060716"><span class="__cf_email__" data-cfemail="9af7fff4e9fbedf3f6daeffdfbb4fffeef">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400349k&amp;href=/doi/10.1021%2Fjm400349k" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 3820–3832</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 18, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 November 2012</li><li><span class="item_label"><b>Published</b> online</span>3 May 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 May 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400349k" title="DOI URL">https://doi.org/10.1021/jm400349k</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3820%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGautam%2BPatel%252C%2BCaitlin%2BE.%2BKarver%252C%2BRanjan%2BBehera%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D10%26contentID%3Djm400349k%26title%3DKinase%2BScaffold%2BRepurposing%2Bfor%2BNeglected%2BDisease%2BDrug%2BDiscovery%253A%2BDiscovery%2Bof%2Ban%2BEfficacious%252C%2BLapatanib-Derived%2BLead%2BCompound%2Bfor%2BTrypanosomiasis%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3832%26publicationDate%3DMay%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400349k"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2989</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">51</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400349k" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Kinase Scaffold Repurposing for Neglected Disease Drug Discovery: Discovery of an Efficacious, Lapatanib-Derived Lead Compound for Trypanosomiasis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Gautam&quot;,&quot;last_name&quot;:&quot;Patel&quot;},{&quot;first_name&quot;:&quot;Caitlin&quot;,&quot;last_name&quot;:&quot;E. Karver&quot;},{&quot;first_name&quot;:&quot;Ranjan&quot;,&quot;last_name&quot;:&quot;Behera&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;J. Guyett&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Sullenberger&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Edwards&quot;},{&quot;first_name&quot;:&quot;Norma&quot;,&quot;last_name&quot;:&quot;E. Roncal&quot;},{&quot;first_name&quot;:&quot;Kojo&quot;,&quot;last_name&quot;:&quot;Mensa-Wilmot&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;P. Pollastri&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;3820-3832&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400349k&quot;},&quot;abstract&quot;:&quot;Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the protozoan parasite Trypanosoma brucei. Because drugs in use against HAT are toxic and require intravenous dosing, new drugs are needed. Initiating lead discovery campaigns by using chemical scaffolds from drugs approved for other indications can speed up drug discovery for neglected diseases. We demonstrated recently that the 4-anilinoquinazolines lapatinib (GW572016, 1) and canertinib (CI-1033) kill T. brucei with low micromolar EC50 values. We now report promising activity of analogues of 1, which provided an excellent starting point for optimization of the chemotype. Our compound optimization that has led to synthesis of several potent 4-anilinoquinazolines, including NEU617, 23a, a highly potent, orally bioavailable inhibitor of trypanosome replication. At the cellular level, 23a blocks duplication of the kinetoplast and arrests cytokinesis, making it a new chemical tool for studying regulation of the trypanosome cell cycle.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400349k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400349k" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400349k&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400349k" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400349k&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400349k" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400349k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400349k&amp;href=/doi/10.1021/jm400349k" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400349k" /></input><a href="/doi/pdf/10.1021/jm400349k" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400349k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400349k%26sid%3Dliteratum%253Aachs%26pmid%3D23597080%26genre%3Darticle%26aulast%3DPatel%26date%3D2013%26atitle%3DKinase%2BScaffold%2BRepurposing%2Bfor%2BNeglected%2BDisease%2BDrug%2BDiscovery%253A%2BDiscovery%2Bof%2Ban%2BEfficacious%252C%2BLapatanib-Derived%2BLead%2BCompound%2Bfor%2BTrypanosomiasis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D10%26spage%3D3820%26epage%3D3832%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jmcmar.2013.56.issue-10/production/jmcmar.2013.56.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the protozoan parasite <i>Trypanosoma brucei</i>. Because drugs in use against HAT are toxic and require intravenous dosing, new drugs are needed. Initiating lead discovery campaigns by using chemical scaffolds from drugs approved for other indications can speed up drug discovery for neglected diseases. We demonstrated recently that the 4-anilinoquinazolines lapatinib (GW572016, <b>1</b>) and canertinib (CI-1033) kill <i>T. brucei</i> with low micromolar EC<sub>50</sub> values. We now report promising activity of analogues of <b>1</b>, which provided an excellent starting point for optimization of the chemotype. Our compound optimization that has led to synthesis of several potent 4-anilinoquinazolines, including NEU617, <b>23a</b>, a highly potent, orally bioavailable inhibitor of trypanosome replication. At the cellular level, <b>23a</b> blocks duplication of the kinetoplast and arrests cytokinesis, making it a new chemical tool for studying regulation of the trypanosome cell cycle.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neglected tropical diseases (NTDs) represent a significant global health burden, particularly in developing regions of the world. Estimates of as many as one in six in the world population (over 1 billion people) are infected by one or more NTDs, with one in three people at risk.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These diseases are “neglected” because so few research dollars are invested in treating or preventing them, in comparison to those conditions primarily affecting the developed world. As a result, pragmatic and cost-effective approaches for identification of drug leads are needed in order to spawn the discovery of new drugs.</div><div class="NLM_p">One such approach is to “repurpose” classes of proven molecular targets with essential homologues in the pathogens that cause these NTDs.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> For example, <i>Trypanosoma brucei</i> (which causes human African trypanosomiasis (HAT), <i>Trypanosoma cruzi</i> (Chagas’ disease), <i>Leishmania</i> spp. (causative agents for leishmaniases), and <i>Plasmodium</i> spp. (malaria) all express kinases and phosphodiesterases (PDEs) that are involved in aspects of cellular signaling.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Indeed, kinases and PDEs represent proven drug target classes in humans for a variety of indications and, as such, a large amount of data related to medicinal chemistry, toxicology, and structural biology are available that can potentially inform new optimization programs against parasites. Furthermore, the clinical and preclinical chemical matter itself can sometimes represent a starting point for new antiparasitic approaches, an approach demonstrated by us<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> and by others.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a></div><div class="NLM_p">Following parasite transmission via an infected tsetse fly, a trypanosome bloodstream infection gives rise to flu-like symptoms that eventually subside. At this point, the parasites invade the central nervous system (CNS), where they establish an infection that leads to sleep disruption, coma, and eventually death. Current drugs have less than optimal toxicity profiles, and the dosing regimens can be inconvenient, long, and costly. There is therefore a stated need for new HAT therapeutics that are orally administered, with minimal toxicity, and which are effective against both bloodstream and CNS forms of the disease. To that end, “hit” and “lead” criteria for HAT and other NTDs are clearly described.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">Kinase inhibitors have come to the fore as one of the principal enzyme target classes in drug discovery for a wide variety of indications, including cancer,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> inflammation,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> diabetes,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> and CNS diseases.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In particular, a number of tyrosine kinase inhibitors have been approved for clinical use.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> This list includes lapatinib (GW572016, Tykerb, <b>1</b>), an EGFR inhibitor that gained FDA approval in 2007.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p"><i>T. brucei</i> expresses over 180 protein kinases,<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> some of which (such as glycogen synthase kinase-3,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> phosphoinositol-3-kinases/TOR,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and Aurora kinase 1<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a>) have been targeted in drug discovery efforts already. There is unequivocal chemical data for protein Tyr phosphorylation in the parasite.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> However, trypanosomes do not express receptor tyrosine kinases (RTKs),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and it is widely held that Tyr-phosphorylation must therefore be performed by dual-specificity enzymes (e.g., wee1) that act on Ser/Thr as well as Tyr residues.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Intriguingly, on the basis of bioinformatics analysis, enzymes with “EGFR-like” kinase domains are present in the parasite.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Further, inhibitors of human EGFR/HER2 (i.e., canertinib,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><b>1</b>,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and AEE788<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>) kill <i>T. brucei</i> with EC<sub>50</sub> in the low micromolar range.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Transferrin is a growth factor that <i>T. brucei</i> acquires from its vertebrate host by receptor-mediated endocytosis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> We discovered that receptor-mediated endocytosis of Tf in the African trypanosome is stimulated by diacylglycerol (DAG).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In most eukaryotes, effects of DAG on signaling pathways are amplified by the Ser/Thr kinase protein kinase C, which binds to the lipid with its C1-domain. In trypanosomes, DAG signaling pathways have not been studied. To understand the pathway linking DAG and Tf endocytosis in the trypanosome, we tested the effect of inhibitors of Ser/Thr protein kinases (e.g., protein kinase C) or Tyr kinases on DAG-stimulated endocytosis of Tf. Unexpectedly, DAG-stimulated endocytosis of Tf was not blocked by a Ser/Thr protein kinase inhibitor, nor does the genome of <i>T. brucei</i> encode for a classic PKC. Instead, the pathway was inhibited by a Tyr kinase inhibitor Tyrphostin A47, a tyrosine mimic.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In a related study, we found that <b>1</b>, similar to Tyrphostin A47, inhibited endocytosis of transferrin.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">These data suggested to us that tyrosine kinase inhibitor drugs approved for treatment of nonparasite human diseases were worth testing as antitrypanosomal agents. We have evaluated the trypanocidal properties of a panel of EGFR inhibitors provided by GlaxoSmithKline (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), and we describe the subsequent design and synthesis of novel analogues for a structure–activity relationship study of a 6-phenyl 4-anilinoquinazoline scaffold, culminating in <b>23a</b>, a highly selective and potent inhibitor of trypanosome replication in vitro.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Initial Screening Data of Analogues of Lapatinib <b>1</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0008.gif" alt="" id="GRAPHIC-d413e358-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">All EC<sub>50</sub> values are ±7%.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Concentration giving 50% inhibition of growth of <i>T brucei brucei</i> Lister 427 cells.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></p></div></div><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We obtained nine quinazoline-based EGFR inhibitors (<b>1</b>–<b>9</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>)<a onclick="showRef(event, 'ref18 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref18 ref32 ref33 ref34">(18, 32-34)</a> from GlaxoSmithKline and screened them against cultures of <i>T brucei brucei</i> Lister 427. The inhibitors demonstrated a 4-fold range in potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) within the limited scope in variation of the R<sup>1</sup> “tail” region of the scaffold. We noted the EC<sub>50</sub> of <b>1</b> (1.54 μM) to be 4-fold more potent against <i>T. brucei</i> as compared to a HepG2 hepatocarcinoma cell line.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> For comparison, we have also included in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> the published activities of three front-line HAT treatments (eflornithine, melarsoprol, and pentamidine) and of SCYX-7158, currently in clinical trials.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The goal of our subsequent optimization efforts have dwelt on improvement of the potency of this chemotype for inhibition of <i>T. brucei</i> replication and increasing the selectivity ratio over HepG2 cells.</div><div class="NLM_p">Noting the effect of subtle tail-group changes on parasite growth inhibition, we first focused our attention on broader exploration of replacements for the furan-derived tail. This was achieved by a broad diversity scan utilizing Suzuki chemistry methodology using boronic acids or esters to enumerate a virtual library of analogues of <b>1</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The structures in this 197-membered virtual library were clustered based on a maximum dissimilarity algorithm, and cluster centers were selected for synthesis (PipelinePilot, Scitegic, Inc.).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Analogues <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) formamide, 170 °C, 4 h, 70%; (b) thionyl chloride, DMF, 80 °C, 12 h, 85%; (c) 3-chloro-4-((3-fluorobenzyl)oxy)aniline, 2-propanol, 80 °C, 12 h, 85%; (d) Ar-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, DME, EtOH, 80 °C, 12 h.</p></p></figure><div class="NLM_p">In anticipation of the parallel synthesis, we prepared the iodoquinazoline <b>14</b> by the route shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Treatment of the commercially available anthranilic acid <b>11</b> with formamide proceeded in 70% yield, followed by chlorination with thionyl chloride to provide the chloroquinazoline <b>13</b> in 85% yield. This template was reacted with the requisite aniline (<b>17</b>, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), which was prepared by a sequence of alkylation of the nitrophenol <b>15</b> with 3-fluorobenzyl bromide followed by nitro group reduction.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> With the required template <b>14</b> in hand, we prepared 10 analogues (<b>10a</b>–<b>j</b>) from the selected boronates using standard Suzuki reaction conditions. The structures and biological activities for these compounds are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. From this series of analogues, we identified NEU369 (<b>10a</b>), which was approximately equipotent to <b>1</b> against <i>T brucei</i> cells. Further testing of this compound and its analogues showed that, unlike <b>1</b>, it did not inhibit HepG2 cell growth (EC<sub>50</sub> > 15 μM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Requisite Aniline Intermediates <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) alkyl halide, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, 50 °C, 12 h; (b) Zn, NH<sub>4</sub>Cl, MeOH, H<sub>2</sub>O, 25–50 °C, 6 h.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>T. brucei</i> Growth Inhibition Data of Diverse Analogues <b>10a</b>–<b>10j</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0009.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0010.gif" alt="" id="GRAPHIC-d413e560-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">All EC<sub>50</sub> values are ±7%.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Concentration giving 50% inhibition of growth of <i>T brucei brucei</i> Lister 427 cells</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>T. brucei</i> Growth Inhibition Data for Headgroup Variations of <b>10a</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0011.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0012.gif" alt="" id="GRAPHIC-d413e589-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">All EC<sub>50</sub> values are ±7%.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Concentration giving 50% inhibition of growth of <i>T brucei brucei</i> Lister 427 cells</p></div></div><div></div></div><div class="NLM_p">Keeping the newly identified tail group present in <b>10a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), we turned our attention to exploration of the aniline headgroup region of the molecule. Preparation of the requisite chloroquinazoline <b>19</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) was achieved by treatment of <b>12</b> with the required boronic acid using Suzuki conditions, followed by chlorination with thionyl chloride. This intermediate was reacted with a range of anilines (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) to provide analogues <b>20</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Headgroup Expansion Set <b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (4-(morpholinosulfonyl)phenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, DME, EtOH, 80 °C, 30 h, 85%; (b) thionyl chloride, DMF, 80 °C, 36 h, 66%; (c) Ar-NH<sub>2</sub>, 2-propanol, 80 °C, 12 h.</p></p></figure><div class="NLM_p">This library was designed to explore the role of halogen substitutions on the terminal benzyl substituent (R<sup>1</sup>) headgroup, testing positional isomers of fluoro substitutions and other potential halogen replacements such as methoxy and trifluoromethyl groups. These modifications produced insignificant changes in activity of the compounds against <i>T. brucei</i>. We prepared a few analogues to assess functional group tolerance at the R<sup>2</sup> position of the headgroup, replacing the chlorine atom of <b>1</b> with hydrogen and methoxy groups; these changes also resulted in very modest alterations in antitrypanosomal activity. Interestingly, truncation of the molecule (<b>20a</b>) gave potency approximately equal to <b>10a</b>, translating to a similar ligand efficiency value (LE of <b>10a</b> = 0.14; <b>20a</b> = 0.18).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">For the next round of analogues, we turned our attention back to further refinement of the tail group region of <b>1</b>, performing focused modifications of the 6-aryl position of the quinazoline ring that were designed to evaluate steric requirements as well as the required adornment of polarity in this region of the inhibitor. These compounds (<b>10k</b>–<b>w</b>) were accessed from the corresponding boronic acids using the route shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The larger sulfonamide side chains showed some modest preference for <i>meta</i>-substitution (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, entries 1–6), although the methyl sulfones (entries 11–12) showed preference for <i>para</i>-substituents. Comparing the sulfonamide substituents, morpholine was preferred over the other heterocycles tested.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. <i>T. brucei</i> and HepG2 Growth Inhibition Data for Focused Analogues of <b>10a</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0013.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0014.gif" alt="" id="GRAPHIC-d413e723-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">All EC<sub>50</sub> values are ±7%.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Concentration giving 50% inhibition of growth of <i>T brucei brucei</i> Lister 427 cells.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Not determined.</p></div></div><div></div></div><div class="NLM_p">A more focused evaluation of linker and regiochemistry is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Compounds were synthesized from <b>14</b> by reaction with the appropriate boronate ester <b>22</b>. In the case of the morpholinosulfonamides (entries 1–8), <i>meta</i>-substitution is consistently better than <i>para</i>; the most potent analogue, NEU617 (<b>23a</b>), is directly linked to the aromatic ring (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). For piperidinosulfonamides (entries 9–16), the meta preference is less consistent, and none of these analogues show as potent growth inhibition as <b>23a</b>. When the tail contains a morpholine (entries 1–8), the linker has little impact on potency (except for <b>23a</b>, a clear outlier); all <i>meta</i>-substituted analogues are otherwise approximately equipotent. In cases where the morpholine moiety is at the <i>para</i>-position, there is little difference resulting from linker variation.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Growth Inhibitory Potency of Regiochemical and Linker Analogues of <b>10</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0015.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0016.gif" alt="" id="GRAPHIC-d413e789-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">All EC<sub>50</sub> values are ±7%.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Concentration giving 50% inhibition of growth of <i>T brucei brucei</i> Lister 427 cells.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">Not determined.</p></div></div><div></div></div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Analogues <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) bis(pinacolato)diboron, PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub>, KOAc, 1,4-dioxane, 80 °C, 12 h, 33–72%; (b) <b>14</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, DME, EtOH, 80 °C, 12 h.</p></p></figure><div class="NLM_p">With piperidine-substitution (entries 9–16), it appears that a modest preference exists for the <i>meta</i>-substituted amide, with a 6.7-fold loss of activity when moved to the <i>para</i> position (compare entries 13 and 14), although the importance of positional substitution is otherwise less for other examples, within ∼2-fold in activity.</div><div class="NLM_p">Lastly, we sequentially removed the headgroup substituents of <b>23a</b>. Removal of one (<b>23m</b>) or both (<b>23n</b>) halogens afforded an approximately 5-fold reduction in potency, and further truncation (<b>23o</b>) significantly reduced antiparasitic activity while restoring HepG2 potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Headgroup Truncation Analogues of <b>23a</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0017.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0018.gif" alt="" id="GRAPHIC-d413e886-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">All EC<sub>50</sub> values are ±7%.</p></div><div class="footnote" id="t6fn2"><sup>Table b</sup><p class="last">Concentration giving 50% inhibition of growth of <i>T brucei brucei</i> Lister 427 cells.</p></div></div><div></div></div><div class="NLM_p">Noting its potency against <i>T. brucei</i> and selectivity over HepG2 cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), we advanced <b>23a</b> into a mouse oral pharmacokinetic study. Mice were administered a single oral dose (40 mg/kg) of <b>23a</b>, and plasma and brain tissue drug levels were measured over 24 h (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure S1 and Table S6">Supporting Information Figure S1 and Table S6</a>). Although the CNS fraction was low (5%), the plasma levels were in excess of the EC<sub>50</sub> for >12 h. We determined that <b>23a</b> was 99.6% plasma protein bound. However, because trypanosomes are noted for their ability to endocytose host plasma proteins,<a onclick="showRef(event, 'ref29 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref29 ref37 ref38">(29, 37, 38)</a> we believed that the oral exposure and in vitro potency warranted in vivo efficacy evaluation.</div><div class="NLM_p">In a test of efficacy in a mouse model of HAT, mice were infected with <i>T. brucei brucei</i> CA427 (10<sup>4</sup> cells) and after 24 h were administered a 40 mg/kg dose of <b>23a</b> once per day. No parasites were detected in the blood of the infected mice for 3 days, whereas control mice had trypanosomes in their blood on day 2 postinfection. However drug-related toxicity was observed with <b>23a</b> in a multiday regimen at the 40 mg/kg dose. These data point to a need to improve the pharmacokinetic properties of <b>23a</b> so that it can be more effective in the mouse model of HAT.</div><div class="NLM_p">Nonetheless, inspired by these initial results, we adjusted the dosing regimen, opting to administer <b>23a</b> at 10 mg/kg twice per day (total dose of 20 mg/kg/day), either orally or intraperitoneally (ip). The results are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A. We noted three effects: First, ip treatment with <b>23a</b> delayed detection of trypanosomes in the blood of infected mice by 24 h. Whereas all control mice had trypanosomes in their blood on day 3, mice treated with <b>23a</b> all had parasites in their blood 24 h later, suggestive of either a significant reduction in replication rate (trypanosomes divide every 6 h) or of parasite killing during this initial phase of infection. Second, on day 8 when all untreated mice had died, the mice dosed ip with <b>23a</b> were all alive (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B). In the oral administration experiment, mice died in the same time frame as control mice, suggesting insufficient drug exposure at this dosage. Third, ip administration of <b>23a</b> led to better control of infection, leading to a doubling of mouse survival life span from 5 days in the control group to 9 days in <b>23a</b>-treated mice.</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Assessment of <b>23a</b> in a mouse model of human African trypanosomiasis. Parasitemia was measured each day in untreated (U, red) and treated (T, blue) mice (20 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although <b>23a</b> is structurally similar to <b>1</b>, the biological effects of the two compounds are different. Whereas <b>1</b> inhibited endocytosis of transferrin in the trypanosome<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> in a manner similar to what we previously observed with tyrphostin,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><b>23a</b> had no effect on receptor-mediated endocytosis of transferrin. Instead, <b>23a</b> affected the cell cycle in ways not observed with <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of <b>23a</b> on the cell cycle of the trypanosome. (A) <b>23a</b>-treated or control trypanosomes were analyzed by flow cytometry (10000 events analyzed; see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). Propidium iodide (PI) fluorescence is plotted against cell populations. (B) Quantitation of DNA content per cell (calculated with FloJo software). (C) Microscopic analysis of <b>23a</b>-treated or untreated trypanosomes after staining with DNA-binding dye DAPI. N, nucleus; K, kinetoplast; DIC, differential interference contrast image. (D) Quantitation of organelle (nucleus (N) or kinetoplast (K)) distribution after <b>23a</b> treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Trypanosomes possess two DNA-containing organelles (nucleus and kinetoplast (mitochondrial nucleoid)). The kinetoplast and nucleus can be tracked by microscopy during the cell cycle, which begins with trypanosomes harboring one nucleus (1N) and one kinetoplast (1K) (i.e., 1K1N cells).<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> A kinetoplast that is replicating its (DNA) (i.e., kDNA) and increasing the organelle’s mass is observed as an elongated kinetoplast (1Ke). Fission (segregation) of 1Ke kinetoplasts into two daughter kinetoplasts (2K) inside the same cell is coincident with the nuclear S-phase and produces 2K1N trypanosomes. Mitosis then occurs, yielding trypanosomes containing two kinetoplasts and two nuclei (2K2N). Following cell division, each daughter trypanosome has a 1K1N configuration of the organelles.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p last">After a 7 h incubation with <b>23a</b>, the chromosomal DNA profile of <i>T. brucei</i> was altered (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A); the fraction of cells with 2C–4C equivalents of DNA was reduced from 40 to 25%, whereas the proportion of cells with 4C DNA increased from 25% to 40% (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). Single cell microscopy studies were performed to determine whether the changes in DNA per cell caused by <b>23a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B) were reflected in alterations in the number of DNA-containing organelles per cell (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). Quantitation of the data obtained in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C revealed that <b>23a</b> reduced the number of cells containing one nucleus (i.e., 1K1N, 1Ke1N) but selectively increased the fraction of a group of cells that are not normally detected in the absence of the drug: cells containing two nuclei and one kinetoplast (1K2N) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D). This data is consistent with the increase in trypanosomes with 4C equivalent of DNA (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). Thus, <b>23a</b> blocks duplication of the kinetoplast and arrests cytokinesis without inhibiting division of the trypanosome nucleus.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51646" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51646" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While some efforts to find new antitrypanosomal lead compounds involve screening of large compound libraries against cell cultures,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> these can be complemented with lead discovery programs that target important physiological pathways in the parasite. Further, because many of these pathways employ enzymes of functional similarity to drug targets in humans, a privileged set of starting compounds already exist that can represent useful starting points for lead discovery without massive drug screening initiatives.</div><div class="NLM_p">In this report, we have described the discovery of potent trypanocidal compounds that are based on established human EGFR inhibitor chemotypes. By starting with such “privileged” lead compounds, we have accelerated our antitrypanosomal lead discovery program by circumventing a need to run high-throughput screens. Indeed, in only a few optimization cycles we have identified a potent chemotype as a lead series for trypanosomiasis. Although compound <b>23a</b> has high calculated lipophilicity and molecular weight, its oral bioavailability lent the compound to further assessment in a mouse model of HAT, where we observed modest effects in controlling parasitemia, with concomitant life extension of infected mice. Because the pharmacokinetic experiments suggest acceptable plasma levels in mice following oral dosing, we hypothesize that the high plasma protein binding (99.6%) observed for <b>23a</b> is the cause of the lower-than-expected effect on in vivo parasite loads.</div><div class="NLM_p">Trypanosome physiology analysis indicates that <b>23a</b> acts via a mechanism different from <b>1</b> and tyrphostin A47. Work is in progress to identify the molecular targets of our lead compound series. Nonetheless, we note that utilization of cell replication assays has led to promising outcomes that are worthy of future lead optimization studies.</div><div class="NLM_p">Besides working to reduce plasma protein binding, further optimization of <b>23a</b> is needed to improve predicted central nervous system exposure. A recent report by Wager et al. described an analysis that correlated compound properties to CNS exposure using data for both experimental and marketed drugs<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and devised a scoring paradigm for prediction of CNS exposure.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> This protocol, termed multiparameter optimization, or MPO, allows prediction of likely CNS exposure for a given compound based on how closely it meets desired property ranges for MW, cLogP, Log <i>D</i>, p<i>K</i><sub>a</sub>, and TPSA with a maximal MPO score of 6.0, and compounds >4.0 predicted to be CNS-penetrant. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, compound <b>23a</b> has significant shortcomings in terms of properties that have been shown relevant to CNS activity, particularly due to high calculated lipophilicity (cLogP, cLogD = 7.1) and molecular weight (541 Da). Future efforts will be focused on reduction of molecular size and lipophilicity to improve the likelihood of CNS penetration, a pivotal requirement for any new therapeutic for HAT.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Desirable Ranges for CNS Penetration and the MPO Scoring for <b>23a</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0019.gif" alt="" id="GRAPHIC-d413e1131-autogenerated" /></img><div></div></div><div class="NLM_p last">In summary, we have identified a potent trypanosomal growth inhibitor (<b>23a</b>) based on the 6-furanyl 4-anilinoquinazoline scaffold of <b>1</b>. The lead displays good selectivity over HepG2 cells, is orally bioavailable, and is modestly efficacious in a mouse model of HAT, such that it meets “Lead Criteria” as defined by The Special Programme for Research and Training in Tropical Diseases (TDR).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Further optimization of this scaffold for increased effectiveness in the mouse model will be reported in due course. Our ability to (i) identify trypanosome replication inhibitors based on basic biology principles using established kinase drug chemotypes and (ii) perform rapid hit-to-lead medicinal chemistry supports our approach of reoptimizing existing drug scaffolds for antitrypanosome lead discovery.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemical Synthesis</h3><div class="NLM_p last">Unless otherwise noted, reagents were obtained from Sigma-Aldrich, Inc. (St. Louis, MO) or Frontier Scientific Services, Inc. (Newark, DE) and used as received. Boronic acids and aniline reagents were purchased unless the synthesis is specifically described below. Reaction solvents were purified by passage through alumina columns on a purification system manufactured by Innovative Technology (Newburyport, MA). NMR spectra were obtained with Varian NMR systems operating at 400 or 500 MHz for <sup>1</sup>H acquisitions as noted. LCMS analysis was performed using a Waters Alliance reverse-phase HPLC, with single-wavelength UV–visible detector and LCT Premier time-of-flight mass spectrometer (electrospray ionization). All newly synthesized compounds that were submitted for biological testing were deemed >95% pure by LCMS analysis (UV and ESI-MS detection) prior to submission for biological testing. Preparative LCMS was performed on a Waters FractionLynx system with a Waters MicroMass ZQ mass spectrometer (electrospray ionization) and a single-wavelength UV–visible detector, using acetonitrile/water gradients with 0.1% formic acid. Fractions were collected on the basis of triggering using UV and mass detection. Yields reported for products obtained by preparative HPLC represent the amount of pure material isolated; impure fractions were not repurified. Screening data of selected boronates has been made freely available as a shared data set at <a href="http://www.collaborativedrugdiscovery.com" class="extLink">www.collaborativedrugdiscovery.com</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 4-Chloro-6-iodoquinazoline Hydrochloride (<b>13</b>).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></h3><div class="NLM_p last">Yield: 85%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.39 (d, <i>J</i> = 1.95 Hz, 1H), 8.29 (s, 1H), 8.13 (dd, <i>J</i> = 1.95, 8.30 Hz, 1H), 7.49 (d, <i>J</i> = 8.30 Hz, 1H). MS: <i>m</i>/<i>z</i> = 290.83 (M + H)<sup>+</sup>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-iodoquinazolin-4-amine Hydrochloride (<b>14</b>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></h3><div class="NLM_p">Yield: 84%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.21 (br s, 1H), 9.16 (s, 1H), 8.92 (s, 1H), 8.34 (d, <i>J</i> = 8.79 Hz, 1H), 7.93 (d, <i>J</i> = 2.44 Hz, 1H), 7.64–7.68 (m, 2H), 7.46–7.51 (m, 1H), 7.30–7.37 (m, 2H), 7.20 (dt, <i>J</i> = 2.44, 8.79 Hz, 1H), 5.30 (s, 2H). MS: <i>m</i>/<i>z</i> = 505.85 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Libraries of <b>10</b> were synthesized by Suzuki coupling of <b>14</b> with respective boronic acid/esters following general procedure A. Into glass vials was combined <i>N</i>-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-iodoquinazolin-4-amine (<b>14</b>, 100 μM), boronic acids/esters (120 μmol), and tetrakis(triphenylphosphine)palladium(0) (7 μmol). To the reaction mixture was added 1,2-dimethoxyethane (2 mL), ethanol (1.33 mL), and a 2 M aqueous solution of sodium carbonate (0.301 mL, 600 μM). The vials were capped and shaken at 80 °C for 18 h. The progress of the reaction was followed by LC-MS. Reaction mixture was evaporated to dryness. Crude products were purified using flash column chromatography or by dissolving in DMSO and purifying by reverse phase HPLC using a gradient of 30–100% acetonitrile in water containing 0.1% formic acid.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine (<b>10a</b>)</h3><div class="NLM_p last">Yield: 48.1%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.00 (s, 1H), 8.92 (d, <i>J</i> = 1.46 Hz, 1H), 8.64 (s, 1H), 8.28 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.17 (d, <i>J</i> = 8.79 Hz, 2H), 8.04 (d, <i>J</i> = 2.44 Hz, 1H), 7.92 (d, <i>J</i> = 8.79 Hz, 3H), 7.76 (dd, <i>J</i> = 2.45, 8.80 Hz, 1H), 7.46–7.50 (m, 1H), 7.30–7.36 (m, 3H), 7.19–7.23 (m, 1H), 5.28 (s, 2H), 3.66–3.68 (m, 4H), 2.93–2.95 (m, 4H). MS: <i>m</i>/<i>z</i> = 605.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-methylnaphthalen-1-yl)quinazolin-4-amine (<b>10b</b>)</h3><div class="NLM_p last">Yielded 1 mg (2.6%) as a yellow film. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.82 (s, 1H), 8.65 (s, 2H), 8.15 (d, <i>J</i> = 8.8 Hz, 1H), 8.03 (d, <i>J</i> = 2.2 Hz, 1H), 7.87–7.96 (m, 2H), 7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.71–7.76 (m, 1H), 7.63 (t, <i>J</i> = 8.0 Hz, 1H), 7.49–7.57 (m, 2H), 7.42–7.49 (m, 2H), 7.31 (t, <i>J</i> = 6.0 Hz, 2H), 7.25 (d, <i>J</i> = 8.8 Hz, 1H), 7.17 (t, <i>J</i> = 7.3 Hz, 1H), 5.24 (s, 2H), 2.74 (s, 3H). MS: <i>m</i>/<i>z</i> = 520.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 4-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)-<i>N</i>-ethyl-2-fluorobenzamide (<b>10c</b>)</h3><div class="NLM_p last">Yielded 1 mg (2.4%) as a yellow film. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.98 (s, 1H), 8.87 (s, 1H), 8.58–8.61 (s, 1H), 8.35–8.42 (m, 1H), 8.26–8.34 (m, 1H), 8.01 (s, 1H), 7.87 (d, <i>J</i> = 4.4 Hz, 1H), 7.84 (m, 2H), 7.79 (d, <i>J</i> = 8.1 Hz, 1H), 7.70–7.76 (m, 1H), 7.47 (q, <i>J</i> = 7.3 Hz, 1H), 7.32 (dd, <i>J</i><sub>A</sub> = 13.2 Hz, <i>J</i><sub>B</sub> = 7.3 Hz, 3H), 7.18 (t, <i>J</i> = 8.8 Hz, 1H), 5.27 (s, 2H), 3.29 (q, <i>J</i> = 8.0 Hz, 2H), 1.14 (t, <i>J</i> = 7.0 Hz, 3H). MS: <i>m</i>/<i>z</i> = 545.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl)quinazolin-4-amine (<b>10d</b>)</h3><div class="NLM_p last">Obtained 1 mg (2.5% yield) as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.09–10.04 (brs, 1H), 8.88 (s, 1H), 8.61 (s, 1H), 8.42 (s, 1H), 8.37 (s, 1H), 8.26 (d, <i>J</i> = 8.8 Hz, 1H), 8.11 (d, <i>J</i> = 8.1 Hz, 1H), 8.0 (m, 2H), 7.89 (d, <i>J</i> = 8.8 Hz, 1H), 7.72–7.81 (m, 2H), 7.43–7.51 (m, 1H), 7.28–7.36 (m, 2H), 7.14–7.22 (m, 1H) 5.26 (s, 2H), 2.65 (s, 3H). MS: <i>m</i>/<i>z</i> = 538.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 3-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)-<i>N</i>-cyclopropylbenzamide (<b>10e</b>)</h3><div class="NLM_p last">Yielded 0.8 mg (2.0%) as a yellow film. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.00 (s, 1H), 8.83 (s, 1H), 8.63 (d, <i>J</i> = 3.7 Hz, 1H), 8.59 (s, 1H), 8.35 (s, 1H), 8.26 (d, <i>J</i> = 5.1 Hz, 1H), 8.22 (s, 1H), 7.97–8.05 (m, 1H), 7.87 (t, <i>J</i> = 8.1 Hz, 2H), 7.74 (dd, <i>J</i><sub>A</sub> = 8.8 Hz, <i>J</i><sub>B</sub> = 2.0 Hz, 1H), 7.63 (t, <i>J</i> = 7.7 Hz, 1H), 7.43–7.52 (m, 1H), 7.25–7.35 (m, 2H), 7.17 (t, <i>J</i> = 8.0 Hz, 1H), 5.27 (s, 2H), 2.85–2.92 (m, 1H), 0.69–0.76 (m, 2H), 0.58–0.65 (m, 2H). MS: <i>m</i>/<i>z</i> = 539.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(quinolin-5-yl)quinazolin-4-amine (<b>10f</b>)</h3><div class="NLM_p last">Yielded 3.2 mg (8.4%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.81 (s, 1H), 8.98 (d, <i>J</i> = 2.9 Hz, 1H), 8.70 (s, 1H), 8.68 (s, 1H), 8.21–8.27 (m, 1H), 8.14 (d, <i>J</i> = 8.1 Hz, 1H), 8.03 (d, <i>J</i> = 2.2 Hz, 1H), 7.95–8.00 (m, 1H), 7.88–7.95 (m, 2H),7.68–7.96 (m, 2H), 7.53–7.59 (dd, <i>J</i><sub>A</sub> = 8.4 Hz, <i>J</i><sub>B</sub> = 4.0 Hz, 1H), 7.46 (q, <i>J</i> = 8.0 Hz, 1H), 7.22–7.33 (m, 3H), 7.17 (t, <i>J</i> = 8.8 Hz, 1H), 5.23 (s, 2H). MS: <i>m</i>/<i>z</i> = 507.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(2-phenoxyphenyl)quinazolin-4-amine (<b>10g</b>)</h3><div class="NLM_p last">Yielded 1.4 mg (2.4%) as an orange oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.85 (s, 1H), 8.65 (s, 1H), 8.58 (s, 1H), 8.01–8.06 (m, 2H), 7.72–7.78 (m, 2H), 7.67 (d, <i>J</i> = 6.6 Hz, 1H), 7.42–7.51 (m, 2H), 7.24–7.39 (m, 6H), 7.19 (t, <i>J</i> = 7.3 Hz, 1H), 7.00–7.09 (m, 2H), 6.94 (d, <i>J</i> = 8.1 Hz, 2H), 5.27 (s, 2H). MS: <i>m</i>/<i>z</i> = 548.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 6-(Benzo[b]thiopen-2-yl)-<i>N</i>-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)quinazolin-4-amine (<b>10h</b>)</h3><div class="NLM_p last">Obtained 5.4 mg (14% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.75 (s, 1H), 8.15 (t, <i>J</i> = 8.8 Hz, 1H), 8.03 (m, 1H), 7.96 (d, <i>J</i> = 8.8 Hz, 1H), 7.87 (d, <i>J</i> = 2.1 Hz, 2H), 7.82 (d, <i>J</i> = 7.3 Hz, 1H), 7.68 (s, 1H), 7.51–7.59 (m, 1H), 7.49 (s, 1H), 7.32–7.44 (m, 3H), 7.19–7.25 (m, 1H), 6.91–7.09 (m, 2H), 5.27 (s, 2H). MS: <i>m</i>/<i>z</i> = 512.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 4-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)phenol (<b>10i</b>)</h3><div class="NLM_p last">Yielded 1 mg (2.4%) as a yellow film. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.09 (s, 1H), 8.98 (s, 1H), 8.63 (s, 2H), 8.45 (s, 1H), 8.42 (s, 1H), 8.05 (s, 1H), 7.96 (d, <i>J</i> = 8.8 Hz, 1H), 7.82 (d, <i>J</i> = 9.5 Hz, 1H), 7.43–7.51 (m, 2H), 7.27–7.36 (m, 2H), 7.14–7.22 (m, 1H), 6.66–6.72 (m, 2H), 5.27 (s, 2H). MS: <i>m</i>/<i>z</i> = 472.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>10j</b>)</h3><div class="NLM_p last">Yielded 2.6 mg (7.1%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.76–9.82 (brs, 1H), 8.47–8.59 (m, 2H), 8.30 (s, 1H), 8.04 (m, 2H), 7.81–7.88 (m, 1H), 7,71–7.80 (m. 2H), 7.59–7.67 (m, 1H), 7.43–7.50 (m, 1H), 7.31–7.36 (m, 1H), (m, 7.23–7.31 (m, 2H), 7.18 (t, <i>J</i> = 8.4 Hz, 1H), 5.26 (s, 2H). MS: <i>m</i>/<i>z</i> = 490.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(3-(morpholinosulfonyl)phenyl)quinazolin-4-amine (<b>10k</b>)</h3><div class="NLM_p last">Yield: 30.4%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.01 (s, 1H), 8.85 (d, <i>J</i> = 1.95 Hz, 1H), 8.63 (s, 1H), 8.24–8.27 (m, 2H), 8.12 (t, <i>J</i> = 1.71 Hz, 1H), 8.03 (d, <i>J</i> = 2.93 Hz, 1H), 7.86–7.92 (m, 2H), 7.80–7.85 (m, 1H), 7.73 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.46–7.52 (m, 1H), 7.30–7.35 (m, 3H), 7.17–7.22 (m, 1H), 5.28 (s, 2H), 3.66 (t, <i>J</i> = 4.90 Hz, 4H), 2.95 (t, <i>J</i> = 4.40 Hz, 4H). MS: <i>m</i>/<i>z</i> = 605.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(piperidin-1-ylsulfonyl)phenyl)quinazolin-4-amine (<b>10l</b>)</h3><div class="NLM_p last">Yield: 14.6%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.00 (s, 1H), 8.91 (d, <i>J</i> = 1.46 Hz, 1H), 8.64 (s, 1H), 8.27 (dd, <i>J</i> = 1.95, 8.30 Hz, 1H), 8.14 (d, <i>J</i> = 8.30 Hz, 2H), 8.04 (d, <i>J</i> = 2.93 Hz, 1H), 7.89–7.92 (m, 3H), 7.76 (dd, <i>J</i> = 2.69, 9.03 Hz, 1H), 7.46–7.51 (m, 1H), 7.31–7.36 (m, 3H), 7.20 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 5.28 (s, 2H), 2.95–2.98 (m, 4H), 1.55–1.60 (m, 4H), 1.39–1.40 (m, 2H). MS: <i>m</i>/<i>z</i> = 603.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(3-(piperidin-1-ylsulfonyl)phenyl)quinazolin-4-amine (<b>10m</b>)</h3><div class="NLM_p last">Yield: 24.8%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.01 (s, 1H), 8.84 (d, <i>J</i> = 1.95 Hz, 1H), 8.62 (s, 1H), 8.24 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.21 (d, <i>J</i> = 7.35 Hz, 1H), 8.11 (t, <i>J</i> = 1.71 Hz, 1H), 8.02 (d, <i>J</i> = 2.44 Hz, 1H), 7.90 (d, <i>J</i> = 8.30 Hz, 1H), 7.82–7.86 (m, 1H), 7.79–7.81 (m, 1H), 7.72 (dd, <i>J</i> = 2.69, 9.03 Hz, 1H), 7.45–7.51 (m, 1H), 7.29–7.36 (m, 3H), 7.19 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 5.27 (s, 2H), 2.96 (t, <i>J</i> = 5.4 Hz, 4Hm, 4H), 1.52–1.60 (m, 4H), 1.33–1.40 (m, 2H). MS: <i>m</i>/<i>z</i> = 603.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(pyrrolidin-1-ylsulfonyl)phenyl)quinazolin-4-amine (<b>10n</b>)</h3><div class="NLM_p last">Yield: 19.6%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.00 (s, 1H), 8.91 (d, <i>J</i> = 1.95 Hz, 1H), 8.63 (s, 1H), 8.27 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.13 (d, <i>J</i> = 8.30 Hz, 2H), 8.03 (d, <i>J</i> = 2.44 Hz, 1H), 7.98 (d, <i>J</i> = 8.79 Hz, 2H), 7.90 (d, <i>J</i> = 8.79 Hz, 1H), 7.76 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.45–7.52 (m, 1H), 7.29–7.36 (m, 3H), 7.20 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 5.28 (s, 2H), 3.22 (t, <i>J</i> = 6.84 Hz, 4H), 1.66–1.72 (m, 4H). MS: <i>m</i>/<i>z</i> = 589.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(3-(pyrrolidin-1-ylsulfonyl)phenyl)quinazolin-4-amine (<b>10o</b>)</h3><div class="NLM_p last">Yield: 28.2%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.03 (s, 1H), 8.85 (d, <i>J</i> = 1.46 Hz, 1H), 8.62 (s, 1H), 8.26 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.18–8.23 (m, 2H), 8.03 (d, <i>J</i> = 2.44 Hz, 1H), 7.88–7.93 (m, 2H), 7.81–7.87 (m, 1H), 7.73 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.45–7.52 (m, 1H), 7.30–7.37 (m, 3H), 7.20 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 5.28 (s, 2H), 3.23 (t, <i>J</i> = 6.84 Hz, 4H), 1.68 (td, <i>J</i> = 3.54, 6.59 Hz, 4H). MS: <i>m</i>/<i>z</i> = 589.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-((4-methylpiperazin-1-yl)sulfonyl)phenyl)quinazolin-4-amine (<b>10p</b>)</h3><div class="NLM_p last">Yield: 30.6%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.95 (s, 1H), 8.87 (d, <i>J</i> = 1.46 Hz, 1H), 8.59 (s, 1H), 8.23 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.11 (d, <i>J</i> = 8.30 Hz, 2H), 7.99 (d, <i>J</i> = 2.44 Hz, 1H), 7.83–7.90 (m, 3H), 7.71 (dd, <i>J</i> = 2.69, 9.03 Hz, 1H), 7.40–7.47 (m, 1H), 7.25–7.32 (m, 3H), 7.15 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 5.23 (s, 2H), 2.91 (br s, 4H), 2.34 (br s, 4H), 2.11 (s, 3H). MS: <i>m</i>/<i>z</i> = 618.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-((4-methyl-1,4-diazepan-1-yl)sulfonyl)phenyl)quinazolin-4-amine (<b>10q</b>)</h3><div class="NLM_p last">Yield: 42.8%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.00 (s, 1H), 8.91 (d, <i>J</i> = 1.95 Hz, 1H), 8.63 (s, 1H), 8.27 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.12 (d, <i>J</i> = 8.80 Hz, 2H), 8.03 (d, <i>J</i> = 2.44 Hz, 1H), 7.96 (d, <i>J</i> = 8.30 Hz, 2H), 7.90 (d, <i>J</i> = 8.79 Hz, 1H), 7.76 (dd, <i>J</i> = 2.69, 9.03 Hz, 1H), 7.45–7.50 (m, 1H), 7.30–7.36 (m, 3H), 7.20 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 5.28 (s, 2H), 3.37–3.39 (m, 2H), 3.34 (t, <i>J</i> = 6.10 Hz, 2H), 2.61–2.64 (m, 2H), 2.54–2.58 (m, 2H), 2.28 (s, 3H), 1.74–1.80 (m, 2H). MS: <i>m</i>/<i>z</i> = 632.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(thiomorpholinosulfonyl)phenyl)quinazolin-4-amine (<b>10r</b>)</h3><div class="NLM_p last">Yield: 5.6%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.00 (s, 1H), 8.92 (d, <i>J</i> = 1.47 Hz, 1H), 8.64 (s, 1H), 8.28 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.16 (d, <i>J</i> = 8.79 Hz, 2H), 8.04 (d, <i>J</i> = 2.44 Hz, 1H), 7.89–7.95 (m, 3H), 7.76 (dd, <i>J</i> = 2.45, 8.80 Hz, 1H), 7.46–7.52 (m, 1H), 7.30–7.37 (m, 3H), 7.20 (dt, <i>J</i> = 2.20, 8.67 Hz, 1H), 5.28 (s, 2H), 3.28 (t, <i>J</i> = 4.35 Hz, 4H), 2.71 (t, <i>J</i> = 5.35 Hz, 4H). MS: <i>m</i>/<i>z</i> = 621.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(piperazin-1-ylsulfonyl)phenyl)quinazolin-4-amine (<b>10s</b>)</h3><div class="NLM_p last">To glass vials was weighed 46 mg of <b>14</b> (0.085 mmoL) and <i>tert</i>-butyl 4-((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)piperazine-1-carboxylate (38.4 mg 0.085 mmol) and tetrakis(triphenylphosphine)palladium(0) (0.006 mmol). To the reaction mixture was added 1,2-dimethoxyethane (0.4 mL), ethanol (0.3 mL), and a 2 M aqueous solution of sodium carbonate (0.255 mL, 0.51 mmol). The vials were capped and shaken at 85 °C for 12 h, and progress of the reaction was monitored by LC-MS. The reaction mixture was evaporated to dryness, and the residue was dissolved in DMSO and purified by reverse phase HPLC using a gradient of 5–100% acetonitrile in water containing 0.1% formic acid, providing the Boc-protected compound in 23.7% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.99 (s, 1H), 8.91 (d, <i>J</i> = 1.95 Hz, 1H), 8.64 (s, 1H), 8.28 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.16 (d, <i>J</i> = 8.79 Hz, 2H), 8.04 (d, <i>J</i> = 2.44 Hz, 1H), 7.89–7.93 (m, 3H), 7.76 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.46–7.52 (m, 1H), 7.30–7.36 (m, 3H), 7.20 (dt, <i>J</i> = 2.44, 8.79 Hz, 1H), 5.28 (s, 2H), 3.41–3.46 (m, 4H), 2.94 (t, <i>J</i> = 4.64 Hz, 4H), 1.34 (s, 9H). MS: <i>m</i>/<i>z</i> = 704.3 (M + H)<sup>+</sup>. To a solution of this compound (0.015 mmol) in 0.4 mL of dichloromethane was added trifluoroacetic acid (200 μmol, 0.154 mL). The reaction mixture was stirred for 12 h at 25 °C. Volatiles were removed in vacuo, and the crude product was triturated with hexanes to afford a crude solid that was purified via flash column chromatography (0–10% MeOH–DCM) to afford the desired compound <b>10t</b>. Yield: 78%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.01 (s, 1H), 8.80 (br s, 1H), 8.59 (br s, 2H), 8.39 (d, <i>J</i> = 7.81 Hz, 1H), 8.22 (d, <i>J</i> = 8.30 Hz, 2H), 7.92–8.03 (m, 4H), 7.72 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.47–7.52 (m, 1H), 7.32–7.37 (m, 3H), 7.21 (dt, <i>J</i> = 2.20, 8.67 Hz, 1H), 5.31 (s, 2H), 3.25 (br s, 4H), 3.18 (br s, 4H). MS: <i>m</i>/<i>z</i> = 604.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(methylsulfonyl)phenyl)quinazolin-4-amine (<b>10t</b>)</h3><div class="NLM_p last">Yield: 31.8%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.00 (s, 1H), 8.92 (d, <i>J</i> = 1.95 Hz, 1H), 8.64 (s, 1H), 8.29 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.14 (d, <i>J</i> = 8.80 Hz, 2H), 8.11 (d, <i>J</i> = 8.30 Hz, 2H), 8.03 (d, <i>J</i> = 2.44 Hz, 1H), 7.92 (d, <i>J</i> = 8.79 Hz, 1H), 7.76 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.45–7.53 (m, 1H), 7.31–7.37 (m, 3H), 7.20 (dt, <i>J</i> = 2.20, 8.42 Hz, 1H), 5.28 (s, 2H), 3.31 (s, 3H). MS: <i>m</i>/<i>z</i> = 534.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(3-(methylsulfonyl)phenyl)quinazolin-4-amine (<b>10u</b>)</h3><div class="NLM_p last">Yield: 34.9%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.02 (s, 1H), 8.88 (s, 1H), 8.63 (s, 1H), 8.38 (s, 1H), 8.30 (dd, <i>J</i> = 1.46, 8.79 Hz, 1H), 8.25 (d, <i>J</i> = 8.30 Hz, 1H), 7.99–8.06 (m, 2H), 7.92 (d, <i>J</i> = 8.79 Hz, 1H), 7.84–7.87 (m, 1H), 7.74 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.45–7.53 (m, 1H), 7.30–7.36 (m, 3H), 7.20 (dt, <i>J</i> = 1.71, 8.67 Hz, 1H), 5.28 (s, 2H), 3.35 (s, 3H). MS: <i>m</i>/<i>z</i> = 534.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)-<i>N</i>,<i>N</i>-dimethylbenzenesulfonamide (<b>10v</b>)</h3><div class="NLM_p last">Yield: 35%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.78 (s, 1H), 8.65 (s, 1H), 8.52 (d, <i>J</i> = 0.98 Hz, 1H), 8.06 (d, <i>J</i> = 2.44 Hz, 1H), 8.01 (dd, <i>J</i> = 0.98, 7.81 Hz, 1H), 7.83 (dt, <i>J</i> = 1.46, 9.03 Hz, 1H), 7.76–7.81 (m, 3H), 7.72 (dt, <i>J</i> = 1.22, 7.69 Hz, 1H), 7.54 (dd, <i>J</i> = 0.98, 7.81 Hz, 1H), 7.45–7.50 (m, 1H), 7.30–7.34 (m, 2H), 7.27 (d, <i>J</i> = 8.79 Hz, 1H), 7.19 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 5.26 (s, 2H), 2.45 (s, 6H). MS: <i>m</i>/<i>z</i> = 563.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-(<i>tert</i>-Butyl)-2-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)benzenesulfonamide (<b>10w</b>)</h3><div class="NLM_p last">Yield: 12.5%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.79 (s, 1H), 8.64 (s, 1H), 8.53 (d, <i>J</i> = 1.95 Hz, 1H), 8.11 (dd, <i>J</i> = 1.22, 8.06 Hz, 1H), 8.05 (d, <i>J</i> = 2.44 Hz, 1H), 7.86 (dd, <i>J</i> = 1.71, 8.55 Hz, 1H), 7.70–7.79 (m, 3H), 7.63–7.67 (m, 1H), 7.45–7.50 (m, 2H), 7.30–7.35 (m, 2H), 7.27 (d, <i>J</i> = 9.28 Hz, 1H), 7.19 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 6.90 (s, 1H), 5.26 (s, 2H), 1.04 (s, 9H). MS: <i>m</i>/<i>z</i> = 591.2(M + H)<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(3-morpholinophenyl)quinazolin-4-amine (<b>23a</b>)</h3><div class="NLM_p last">Yield: 38%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.90 (s, 1H), 8.76 (d, <i>J</i> = 1.95 Hz, 1H), 8.60 (s, 1H), 8.18 (dd, <i>J</i> = 1.71, 8.55 Hz, 1H), 8.04 (d, <i>J</i> = 2.93 Hz, 1H), 7.84 (d, <i>J</i> = 8.79 Hz, 1H), 7.76 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.45–7.51 (m, 1H), 7.39–7.42 (m, 1H), 7.28–7.35 (m, 5H), 7.19 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 7.03 (dd, <i>J</i> = 1.95, 8.30 Hz, 1H), 5.27 (s, 2H), 3.79 (t, <i>J</i> = 4.9 Hz, 4H), 3.24 (t, <i>J</i> = 4.86 Hz, 4H). MS: <i>m</i>/<i>z</i> = 541.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-morpholinophenyl)quinazolin-4-amine (<b>23b</b>)</h3><div class="NLM_p last">Yield: 35.2%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.87 (s, 1H), 8.72 (d, <i>J</i> = 1.95 Hz, 1H), 8.55 (s, 1H), 8.16 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.03 (d, <i>J</i> = 2.93 Hz, 1H), 7.78–7.82 (m, 3H), 7.76 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.45–7.51 (m, 1H), 7.28–7.35 (m, 3H), 7.19 (dt, <i>J</i> = 2.69, 8.67 Hz, 1H), 7.11 (d, <i>J</i> = 8.79 Hz, 2H), 5.27 (s, 2H), 3.76–3.80 (m, 4H), 3.19–3.23 (m, 4H). MS: <i>m</i>/<i>z</i> = 541.04 (M + H)<sup>+</sup>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(3-(morpholinomethyl)phenyl)quinazolin-4-amine (<b>23c</b>)</h3><div class="NLM_p last">Yield: 54.5%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.92 (s, 1H), 8.77 (s, 1H), 8.59 (s, 1H), 8.15 (d, <i>J</i> = 8.79 Hz, 1H), 8.03 (d, <i>J</i> = 1.95 Hz, 1H), 7.85 (d, <i>J</i> = 8.79 Hz, 1H), 7.72–7.80 (m, 3H), 7.43–7.54 (m, 2H), 7.39 (d, <i>J</i> = 7.32 Hz, 1H), 7.25–7.35 (m, 3H), 7.14–7.22 (m, 1H), 5.26 (s, 2H), 3.52–3.68 (m, 6H), 2.40 (br s, 4H). MS: <i>m</i>/<i>z</i> = 554.3 (M)<sup>+</sup>.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(morpholinomethyl)phenyl)quinazolin-4-amine (<b>23d</b>)</h3><div class="NLM_p last">Yield: 36.8%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.92 (s, 1H), 8.80 (d, <i>J</i> = 1.95 Hz, 1H), 8.60 (s, 1H), 8.20 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.04 (d, <i>J</i> = 2.44 Hz, 1H), 7.84–7.87 (m, 3H), 7.77 (dd, <i>J</i> = 2.69, 9.03 Hz, 1H), 7.46–7.54 (m, 3H), 7.28–7.36 (m, 3H), 7.20 (dt, <i>J</i> = 1.95, 8.55 Hz, 1H), 5.28 (s, 2H), 3.61 (t, <i>J</i> = 4.64 Hz, 4H), 3.56 (s, 2H), 2.40 (br s, 4H). MS: <i>m</i>/<i>z</i> = 555.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (3-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)phenyl)(morpholino)methanone (<b>23e</b>)</h3><div class="NLM_p last">Yield: 53.2%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.99 (br s, 1H), 8.83 (d, <i>J</i> = 1.46 Hz, 1H), 8.61 (s, 1H), 8.23 (dd, <i>J</i> = 1.46, 8.79 Hz, 1H), 8.01 (d, <i>J</i> = 2.44 Hz, 1H), 7.97 (d, <i>J</i> = 7.81 Hz, 1H), 7.92 (s, 1H), 7.86 (d, <i>J</i> = 8.79 Hz, 1H), 7.73 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.63 (t, <i>J</i> = 7.81 Hz, 1H), 7.47 (q, <i>J</i> = 7.65 Hz, 2H), 7.26–7.36 (m, 3H), 7.18 (dt, <i>J</i> = 2.20, 8.67 Hz, 1H), 5.26 (s, 2H), 3.20–3.78 (m, 8H). MS: <i>m</i>/<i>z</i> = 568.2 (M)<sup>+</sup>.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (4-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)phenyl)(morpholino)methanone (<b>23f</b>)</h3><div class="NLM_p last">Yield: 58.9%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.93 (br s, 1H), 8.84 (br s, 1H), 8.60 (s, 1H), 8.21 (d, <i>J</i> = 8.30 Hz, 1H), 7.93–8.05 (m, 3H), 7.86 (d, <i>J</i> = 8.30 Hz, 1H), 7.76 (d, <i>J</i> = 7.81 Hz, 1H), 7.60 (d, <i>J</i> = 7.81 Hz, 2H), 7.43–7.51 (m, 1H), 7.26–7.36 (m, 3H), 7.18 (t, <i>J</i> = 8.06 Hz, 1H), 5.26 (s, 2H), 3.37–3.80 (m, 8H). MS: <i>m</i>/<i>z</i> = 568.2183 (M).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(3-(piperidin-1-yl)phenyl)quinazolin-4-amine (<b>23g</b>)</h3><div class="NLM_p last">Yield: 21%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.90 (s, 1H), 8.74 (d, <i>J</i> = 1.95 Hz, 1H), 8.58 (s, 1H), 8.16 (dd, <i>J</i> = 1.71, 8.55 Hz, 1H), 8.03 (d, <i>J</i> = 2.44 Hz, 1H), 7.83 (d, <i>J</i> = 8.79 Hz, 1H), 7.75 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.44–7.51 (m, 1H), 7.27–7.39 (m, 5H), 7.23 (d, <i>J</i> = 7.81 Hz, 1H), 7.19 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 7.00 (dd, <i>J</i> = 1.95, 8.30 Hz, 1H), 5.27 (s, 2H), 3.23–3.27 (m, 4H), 1.64–1.69 (m, 4H), 1.53–1.59 (m, 2H). MS: <i>m</i>/<i>z</i> = 539.16 (M + H)<sup>+</sup>.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(piperidin-1-yl)phenyl)quinazolin-4-amine (<b>23h</b>)</h3><div class="NLM_p last">Yield: 41.4%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.87 (s, 1H), 8.69 (d, <i>J</i> = 0.98 Hz, 1H), 8.55 (s, 1H), 8.12 (dd, <i>J</i> = 1.71, 8.55 Hz, 1H), 8.03 (d, <i>J</i> = 2.44 Hz, 1H), 7.72–7.81 (m, 4H), 7.43–7.51 (m, 1H), 7.25–7.37 (m, 3H), 7.18 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 7.06 (d, <i>J</i> = 8.79 Hz, 2H), 5.26 (s, 2H), 3.18–3.26 (m, 4H), 1.49–1.70 (m, 6H). MS: <i>m</i>/<i>z</i> = 532.4 (M)<sup>+</sup>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(3-(piperidin-1-ylmethyl)phenyl)quinazolin-4-amine (<b>23i</b>)</h3><div class="NLM_p last">Yield: 66.7%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.91 (br s, 1H), 8.81 (d, <i>J</i> = 1.95 Hz, 1H), 8.60 (s, 1H), 8.19 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.01 (d, <i>J</i> = 2.93 Hz, 1H), 7.87–7.97 (m, 3H), 7.74 (dd, <i>J</i> = 2.90, 9.25 Hz, 1H), 7.63 (t, <i>J</i> = 7.57 Hz, 1H), 7.52 (d, <i>J</i> = 7.32 Hz, 1H), 7.46 (dt, <i>J</i> = 6.35, 8.06 Hz, 1H), 7.26–7.35 (m, 3H), 7.17 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 5.25 (s, 2H), 4.22 (br s, 2H), 3.00 (d, <i>J</i> = 5.86 Hz, 4H), 1.42–1.77 (m, 6H). MS: <i>m</i>/<i>z</i> = 552.3 (M)<sup>+</sup>.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i>-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(4-(piperidin-1-ylmethyl)phenyl)quinazolin-4-amine (<b>23j</b>)</h3><div class="NLM_p last">Yield: 52.3%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.89 (br s, 1H), 8.80 (d, <i>J</i> = 1.46 Hz, 1H), 8.58 (s, 1H), 8.19 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.01 (d, <i>J</i> = 2.44 Hz, 1H), 7.90 (d, <i>J</i> = 8.30 Hz, 2H), 7.85 (d, <i>J</i> = 8.79 Hz, 1H), 7.74 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.56 (d, <i>J</i> = 8.30 Hz, 2H), 7.41–7.50 (m, 1H), 7.25–7.35 (m, 3H), 7.17 (dt, <i>J</i> = 2.20, 8.67 Hz, 1H), 5.25 (s, 2H), 3.93 (br s, 2H), 2.74 (br s, 4H), 1.56–1.69 (m, 4H), 1.45 (br s, 2H). MS: <i>m</i>/<i>z</i> = 552.3 (M)<sup>+</sup>.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (3-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)phenyl)(piperidin-1-yl)methanone (<b>23k</b>)</h3><div class="NLM_p last">Yield: 66.3%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.91 (s, 1H), 8.76 (br s, 1H), 8.35 (d, <i>J</i> = 9.28 Hz, 1H), 7.96–8.00 (m, 2H), 7.87–7.93 (m, 2H), 7.70 (dd, <i>J</i> = 2.45, 8.80 Hz, 1H), 7.59–7.65 (m, 2H), 7.44–7.52 (m, 2H), 7.32–7.36 (m, 3H), 7.20 (dt, <i>J</i> = 2.44, 8.79 Hz, 1H), 5.30 (s, 2H), 3.65 (br s, 3H), 1.41–1.70 (m, 7H). MS: <i>m</i>/<i>z</i> = 567.3 (M + H)<sup>+</sup>.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (4-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)phenyl)(piperidin-1-yl)methanone (<b>23l</b>)</h3><div class="NLM_p last">Yield: 73.3%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.93 (s, 1H), 8.83 (s, 1H), 8.59 (s, 1H), 8.21 (dd, <i>J</i> = 1.95, 8.30 Hz, 1H), 8.01 (d, <i>J</i> = 2.44 Hz, 1H), 7.93 (d, <i>J</i> = 8.30 Hz, 2H), 7.86 (d, <i>J</i> = 8.79 Hz, 1H), 7.74 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.53 (d, <i>J</i> = 8.30 Hz, 3H), 7.43–7.49 (m, 1H), 7.27–7.34 (m, 3H), 7.17 (dt, <i>J</i> = 1.95, 8.55 Hz, 1H), 5.25 (s, 2H), 3.60 (br s, 2H), 1.38–1.67 (m, 7H). MS: <i>m</i>/<i>z</i> = 567.3 (M + H)<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>-(4-(Benzyloxy)-3-chlorophenyl)-6-(3-morpholinophenyl)quinazolin-4-amine (<b>23m</b>)</h3><div class="NLM_p last">Yield: 38%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.88 (s, 1H), 8.75 (d, <i>J</i> = 1.95 Hz, 1H), 8.58 (s, 1H), 8.18 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 8.01 (d, <i>J</i> = 2.93 Hz, 1H), 7.84 (d, <i>J</i> = 8.30 Hz, 1H), 7.74 (dd, <i>J</i> = 2.69, 9.03 Hz, 1H), 7.50 (d, <i>J</i> = 7.32 Hz, 2H), 7.39–7.45 (m, 3H), 7.33–7.37 (m, 2H), 7.30 (d, <i>J</i> = 8.79 Hz, 2H), 7.03 (dd, <i>J</i> = 1.95, 8.30 Hz, 1H), 5.24 (s, 2H), 3.77–3.81 (m, 4H), 3.22–3.25 (m, 4H). MS: <i>m</i>/<i>z</i> = 523.07 (M + H)<sup>+</sup>.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-(4-(Benzyloxy)phenyl)-6-(3-morpholinophenyl)quinazolin-4-amine (<b>23n</b>)</h3><div class="NLM_p last">Yield: 18%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.84 (s, 1H), 8.76 (d, <i>J</i> = 1.46 Hz, 1H), 8.51 (s, 1H), 8.16 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 7.81 (d, <i>J</i> = 8.30 Hz, 1H), 7.68 (d, <i>J</i> = 9.30 Hz, 2H), 7.48 (d, <i>J</i> = 7.32 Hz, 2H), 7.38–7.43 (m, 3H), 7.28–7.37 (m, 3H), 7.07 (d, <i>J</i> = 8.80 Hz, 2H), 7.02 (dd, <i>J</i> = 1.95, 7.80 Hz, 1H), 5.14 (s, 2H), 3.78 (t, <i>J</i> = 4.87 Hz, 4H), 3.24 (t, <i>J</i> = 4.87 Hz, 4H). MS: <i>m</i>/<i>z</i> = 489.11 (M + H)<sup>+</sup>.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 6-(3-Morpholinophenyl)-<i>N</i>-phenylquinazolin-4-amine (<b>23o</b>)</h3><div class="NLM_p last">Yield: 57.5%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.92 (s, 1H), 8.80 (d, <i>J</i> = 1.46 Hz, 1H), 8.58 (s, 1H), 8.19 (dd, <i>J</i> = 1.95, 8.79 Hz, 1H), 7.82–7.87 (m, 3H), 7.39–7.45 (m, 3H), 7.36 (d, <i>J</i> = 2.44 Hz, 1H), 7.30–7.33 (m, 1H), 7.15–7.18 (m, 1H), 7.03 (dd, <i>J</i> = 2.20, 8.06 Hz, 1H), 3.79 (t, <i>J</i> = 4.85 Hz, 4H), 3.24 (t, <i>J</i> = 4.85 Hz, 4H). MS: <i>m</i>/<i>z</i> = 383.06 (M + H)<sup>+</sup>.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Aniline Synthesis</h3><div class="NLM_p last">Anilines <b>17</b> were synthesized using general procedure B. In a 20 mL glass vial, a solution of substituted 4-nitrophenol (1.5 mmol) in 5 mL of acetonitrile was combined with potassium carbonate (3 mmol) and the appropriate benzyl bromide (1.5 mmol) at 25 °C. The reaction mixture was stirred at 50 °C for 12 h. After completion of the alkylation reaction, the reaction mixture was triturated with 10 mL of 10% MeOH/DCM and was filtered through a silica gel plug. The organic filtrate was evaporated and redissolved in 5 mL of MeOH:H<sub>2</sub>O (5:1). To this solution was added zinc (0.29 g, 4.5 mmol), followed by ammonium chloride (0.48 g, 9 mmol) at 25 °C. The temperature was raised to 50 °C, and the stirring was continued for 6 h. Progress of the reaction was followed by LC-MS. Upon completion of the reaction, 15 mL of DCM:MeOH (1:1) was added to the reaction mixture and inorganic residues were removed by filtration. The filtrate was evaporated, and the residue was purified via flash chromatography (0–50% EtOAc/hexanes) to afford the desired substituted anilines.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-(Benzyloxy)-3-chloroaniline (<b>17e</b>)</h3><div class="NLM_p last">Yield: 24.3%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ: 7.47 (d, <i>J</i> = 7.32 Hz, 2H), 7.37–7.41 (m, 2H), 7.30–7.35 (m, 1H), 6.81 (d, <i>J</i> = 8.79 Hz, 1H), 6.76 (d, <i>J</i> = 2.93 Hz, 1H), 6.51 (dd, <i>J</i> = 2.69, 8.55 Hz, 1H), 5.06 (s, 2H), 3.49 (br s, 2H). MS: <i>m</i>/<i>z</i> = 234.02 (M + H)<sup>+</sup>.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 4-((3-Bromobenzyl)oxy)-3-chloroaniline (<b>17f</b>)</h3><div class="NLM_p last">Yield: 25%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ: 7.62 (s, 1H), 7.45 (d, <i>J</i> = 8.30 Hz, 1H), 7.39 (d, <i>J</i> = 7.81 Hz, 1H), 7.22–7.26 (m, 1H), 6.75–6.80 (m, 2H), 6.52 (dd, <i>J</i> = 2.93, 8.79 Hz, 1H), 5.01 (s, 2H), 3.52 (br s, 2H). MS: <i>m</i>/<i>z</i> = 311.89 (M + H)<sup>+</sup>.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 3-Chloro-4-((3-chlorobenzyl)oxy)aniline (<b>17g</b>)</h3><div class="NLM_p last">Yield: 38%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ: 7.47 (s, 1H), 7.29–7.36 (m, 3H), 6.78 (d, <i>J</i> = 8.30 Hz, 1H), 6.75 (d, <i>J</i> = 2.44 Hz, 1H), 6.50 (dd, <i>J</i> = 2.93, 8.79 Hz, 1H), 5.01 (s, 2H), 3.52 (br s, 2H). MS: <i>m</i>/<i>z</i> = 267.96 (M + H)<sup>+</sup>.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 3-Chloro-4-((2,3-difluorobenzyl)oxy)aniline (<b>17h</b>)</h3><div class="NLM_p last">Yield: 31%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ: 7.35 (t, <i>J</i> = 6.59 Hz, 1H), 7.07–7.16 (m, 2H), 6.83 (d, <i>J</i> = 8.79 Hz, 1H), 6.75 (d, <i>J</i> = 2.93 Hz, 1H), 6.52 (dd, <i>J</i> = 2.69, 8.55 Hz, 1H), 5.12 (s, 2H), 3.51 (br s, 2H). MS: <i>m</i>/<i>z</i> = 270.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 3-Chloro-4-((2-fluorobenzyl)oxy)aniline (<b>17i</b>)</h3><div class="NLM_p last">Yield: 37%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ: 7.58 (dt, <i>J</i> = 1.71, 7.45 Hz, 1H), 7.27–7.32 (m, 1H), 7.16 (dt, <i>J</i> = 0.98, 7.57 Hz, 1H), 7.04–7.08 (m, 1H), 6.83 (d, <i>J</i> = 8.79 Hz, 1H), 6.75 (d, <i>J</i> = 2.93 Hz, 1H), 6.51 (dd, <i>J</i> = 2.69, 8.55 Hz, 1H), 5.12 (s, 2H), 3.50 (br s, 2H). MS: <i>m</i>/<i>z</i> = 251.99 (M + H)<sup>+</sup>.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 3-Chloro-4-((4-fluorobenzyl)oxy)aniline (<b>17j</b>)</h3><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ: 7.40–7.44 (m, 2H), 7.03–7.10 (m, 2H), 6.78 (d, <i>J</i> = 8.79 Hz, 1H), 6.75 (d, <i>J</i> = 2.44 Hz, 1H), 6.50 (dd, <i>J</i> = 2.93, 8.79 Hz, 1H), 5.00 (s, 2H), 3.50 (br s, 2H). MS: <i>m</i>/<i>z</i> = 252.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 3-Chloro-4-((3-methoxybenzyl)oxy)aniline (<b>17k</b>)</h3><div class="NLM_p last">Yield: %. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ: 7.27–7.32 (m, 1H), 7.01–7.05 (m, 2H), 6.86 (dd, <i>J</i> = 2.69, 8.06 Hz, 1H), 6.79 (d, <i>J</i> = 8.79 Hz, 1H), 6.74 (d, <i>J</i> = 2.93 Hz, 1H), 6.49 (dd, <i>J</i> = 2.45, 8.80 Hz, 1H), 5.04 (s, 2H), 3.83 (s, 3H), 3.44 (br s, 2H). MS: <i>m</i>/<i>z</i> = 264.01 (M + H)<sup>+</sup>.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 3-Chloro-4-((3-fluoro-4-(trifluoromethyl)benzyl)oxy)aniline (<b>17l</b>)</h3><div class="NLM_p last">Yield: 35.2%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ: 7.60 (t, <i>J</i> = 7.81 Hz, 1H), 7.29–7.36 (m, 2H), 6.77 (d, <i>J</i> = 4.39 Hz, 1H), 6.76 (d, <i>J</i> = 1.47 Hz, 1H), 6.51 (dd, <i>J</i> = 2.93, 8.79 Hz, 1H), 5.06 (s, 2H), 3.54 (br s, 2H). MS: <i>m</i>/<i>z</i> = 319.93 (M + H)<sup>+</sup>.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 3-Chloro-4-((2,3,5-trifluorobenzyl)oxy)aniline (<b>17m</b>)</h3><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ: 7.13–7.18 (m, 1H), 6.85–6.93 (m, 1H), 6.81 (d, <i>J</i> = 8.30 Hz, 1H), 6.76 (d, <i>J</i> = 2.93 Hz, 1H), 6.53 (dd, <i>J</i> = 2.93, 8.79 Hz, 1H), 5.09 (s, 2H), 3.54 (br s, 2H). MS: <i>m</i>/<i>z</i> = 287.96 (M + H)<sup>+</sup>.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 4-((3-Fluorobenzyl)oxy)aniline (<b>17n</b>)</h3><div class="NLM_p last">Yield: 28%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ: 7.34 (m, 1H), 7.14–7.21 (m, 2H), 7.01 (dt, <i>J</i> = 2.44, 8.55 Hz, 1H), 6.81 (d, <i>J</i> = 8.30 Hz, 2H), 6.64 (d, <i>J</i> = 8.30 Hz, 2H), 4.99 (s, 2H), 3.32 (br s, 2H). MS: <i>m</i>/<i>z</i> = 218.07 (M + H)<sup>+</sup>.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 4-((3-Fluorobenzyl)oxy)-3-methoxyaniline (<b>17o</b>)</h3><div class="NLM_p last">Yield: 7.52%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ: 7.28–7.33 (m, 1H), 7.14–7.21 (m, 2H), 6.97 (dt, <i>J</i> = 2.20, 8.67 Hz, 1H), 6.70 (d, <i>J</i> = 8.30 Hz, 1H), 6.32 (d, <i>J</i> = 2.93 Hz, 1H), 6.16 (dd, <i>J</i> = 2.69, 8.55 Hz, 1H), 5.02 (s, 2H), 3.84 (s, 3H), 3.51 (br s, 2H). MS: <i>m</i>/<i>z</i> = 248.06 (M + H)<sup>+</sup>.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 6-(4-(Morpholinosulfonyl)phenyl)quinazolin-4(3<i>H</i>)-one (<b>18</b>)</h3><div class="NLM_p last">A mixture of 6-iodoquinazolin-4(3<i>H</i>)-one (4.5 g, 16.54 mmol), (4-(morpholinosulfonyl)phenyl)boronic acid (4.93 g, 18.20 mmol), sodium carbonate (10.52 g, 99 mmol), and tetrakis(triphenylphosphine)palladium(0) (1.338 g, 1.158 mmol) were combined in a flask, and 400 mL of 1,2-dimethoxyethane was added with ethanol (26.7 mL) and water (33.3 mL). The reaction mixture was heated with stirring at 80 °C for 30 h. The reaction progress was monitored by LC-MS. Upon completion of the reaction, the mixture was cooled to room temperature and the product precipitated. Solids were collected by filtration, washed with cold water, and air-dried, affording <b>18</b> (5.35 g, 14.40 mmol, 87% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.40 (br s, 1H), 8.44 (d, <i>J</i> = 2.44 Hz, 1H), 8.22 (dd, <i>J</i> = 2.20, 8.55 Hz, 1H), 8.16 (d, <i>J</i> = 3.42 Hz, 1H), 8.07 (d, <i>J</i> = 8.30 Hz, 2H), 7.84 (d, <i>J</i> = 8.30 Hz, 2H), 7.80 (d, <i>J</i> = 8.79 Hz, 1H), 3.64 (t, <i>J</i> = 4.65 Hz, 4H), 2.91 (t, <i>J</i> = 4.65 Hz, 4H). MS: <i>m</i>/<i>z</i> = 372.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 4-((4-(4-Chloroquinazolin-6-yl)phenyl)sulfonyl)morpholine Hydrochloride (<b>19</b>)</h3><div class="NLM_p">Thionyl chloride (9.83 mL, 135 mmol) was added slowly to 1.0 g of <b>18</b> (1 g, 2.69 mmol), followed by <i>N</i>,<i>N</i>-dimethylformamide (2.085 μL, 0.027 mmol). The reaction mixture was refluxed for 36 h, monitoring reaction progress with LC-MS. The volatile components were removed via distillation, providing <b>19</b> (1.12 g, 1.683 mmol, 80% pure, 78% yield), which was used for subsequent reactions without further purification. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.45 (d, <i>J</i> = 1.95 Hz, 1H), 8.32 (s, 1H), 8.26 (dd, <i>J</i> = 2.20, 8.55 Hz, 1H), 8.07 (d, <i>J</i> = 8.79 Hz, 2H), 7.79–7.86 (m, 3H), 3.65 (t, <i>J</i> = 4.60 Hz, 4H), 2.92 (t, <i>J</i> = 4.65 Hz, 4H). MS: <i>m</i>/<i>z</i> = 390.04 (M + H)<sup>+</sup>.</div><div class="NLM_p last">6-(4-(Morpholinosulfonyl)phenyl)-<i>N</i>-arylquinazolin-4-amines hydrochloride <b>20</b> were synthesized following general procedure C. To a solution of <b>19</b> (100 μmol) in <i>N</i>,<i>N</i>-dimethylformamide (0.5 mL) was added aryl amine (110 μmol), and the mixture was heated on a shaker plate at 80 °C for 12 h. After cooling the reaction mixture to room temperature, 0.5 mL of 2-propanol was added. The resulting yellowish precipitate was filtered and washed with 2 mL of 2-propanol, affording the amines <b>20.</b></div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 6-(4-(Morpholinosulfonyl)phenyl)-<i>N</i>-phenylquinazolin-4-amine Hydrochloride (<b>20a</b>)</h3><div class="NLM_p last">Yield: 50.8%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.51 (br s, 1H), 9.20 (s, 1H), 8.93 (s, 1H), 8.50 (d, <i>J</i> = 8.79 Hz, 1H), 8.21 (d, <i>J</i> = 8.30 Hz, 2H), 8.01 (d, <i>J</i> = 8.30 Hz, 1H), 7.95 (d, <i>J</i> = 8.30 Hz, 2H), 7.75 (d, <i>J</i> = 8.30 Hz, 2H), 7.51–7.55 (m, 2H), 7.34–7.37 (m, 1H), 3.65–3.67 (br m, 4H), 2.92–2.95 (br m, 4H). MS: <i>m</i>/<i>z</i> = 447.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 6-(4-(Morpholinosulfonyl)phenyl)-<i>N</i>-(<i>p</i>-tolyl)quinazolin-4-amine Hydrochloride (<b>20b</b>)</h3><div class="NLM_p last">Yield: 54.9%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.62 (br s, 1H), 9.24 (s, 1H), 8.93 (s, 1H), 8.51 (d, <i>J</i> = 8.30 Hz, 1H), 8.22 (d, <i>J</i> = 8.30 Hz, 3H), 8.03 (d, <i>J</i> = 8.79 Hz, 1H), 7.95 (d, <i>J</i> = 8.79 Hz, 2H), 7.63 (d, <i>J</i> = 7.81 Hz, 2H), 7.34 (d, <i>J</i> = 7.81 Hz, 2H), 3.67 (t, <i>J</i> = 4.4 Hz, 4H), 2.95 (t, <i>J</i> = 4.4 Hz, 4H), 2.38 (s, 3H). MS: <i>m</i>/<i>z</i> = 461.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 2-Chloro-4-((6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-yl)amino)phenol Hydrochloride (<b>20c</b>)</h3><div class="NLM_p last">Yield: 52.7%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.60 (br s, 1H), 10.55 (br s, 1H), 9.22 (s, 1H), 8.96 (s, 1H), 8.51 (dd, <i>J</i> = 1.47, 8.79 Hz, 1H), 8.22 (d, <i>J</i> = 8.30 Hz, 2H), 8.02 (d, <i>J</i> = 8.79 Hz, 1H), 7.95 (d, <i>J</i> = 8.30 Hz, 2H), 7.81 (d, <i>J</i> = 2.93 Hz, 1H), 7.52 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.12 (d, <i>J</i> = 8.79 Hz, 1H), 3.7 (t, <i>J</i> = 4.40 Hz, 4H), 2.95 (t, <i>J</i> = 4.4 Hz, 4H). MS: <i>m</i>/<i>z</i> = 497.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>N</i>-(3-Chloro-4-methoxyphenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine Hydrochloride (<b>20d</b>)</h3><div class="NLM_p last">Yield: 43.4%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.34 (br s, 1H), 9.14 (s, 1H), 8.94 (s, 1H), 8.49 (d, <i>J</i> = 8.79 Hz, 1H), 8.20 (d, <i>J</i> = 8.79 Hz, 2H), 8.00 (d, <i>J</i> = 8.79 Hz, 1H), 7.96 (d, <i>J</i> = 8.30 Hz, 2H), 7.93 (d, <i>J</i> = 2.44 Hz, 1H), 7.70 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.31 (d, <i>J</i> = 9.28 Hz, 1H), 3.93 (s, 3H), 3.67 (t, <i>J</i> = 4.6 Hz, 4H), 2.95 (t, <i>J</i> = 4.6 Hz, 4H). MS: <i>m</i>/<i>z</i> = 511.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-(4-(Benzyloxy)-3-chlorophenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine Hydrochloride (<b>20e</b>)</h3><div class="NLM_p last">Yield: 70.1%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.49 (br s, 1H), 9.18 (s, 1H), 8.95 (s, 1H), 8.50 (dd, <i>J</i> = 1.71, 8.55 Hz, 1H), 8.20–8.22 (m, 2H), 8.01 (d, <i>J</i> = 8.79 Hz, 1H), 7.93–7.96 (m, 3H), 7.68 (dd, <i>J</i> = 2.69, 9.03 Hz, 1H), 7.51–7.53 (m, 2H), 7.35–7.46 (m, 4H), 5.30 (s, 2H), 3.66–3.68 (t, <i>J</i> = 4.9 Hz, 4H), 2.5 (t, <i>J</i> = 4.4 Hz, 4H). MS: <i>m</i>/<i>z</i> = 587.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>N</i>-(4-((3-Bromobenzyl)oxy)-3-chlorophenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine Hydrochloride (<b>20f</b>)</h3><div class="NLM_p last">Yield: 51.6%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.45 (br s, 1H), 9.17 (s, 1H), 8.95 (s, 1H), 8.50 (d, <i>J</i> = 8.79 Hz, 1H), 8.21 (d, <i>J</i> = 8.79 Hz, 2H), 8.01 (d, <i>J</i> = 8.30 Hz, 1H), 7.94–7.97 (m, 3H), 7.72 (s, 1H), 7.69 (dd, <i>J</i> = 2.69, 9.03 Hz, 1H), 7.58 (d, <i>J</i> = 7.81 Hz, 1H), 7.52 (d, <i>J</i> = 7.81 Hz, 1H), 7.37–7.43 (m, 2H), 5.31 (s, 2H), 3.67 (t, <i>J</i> = 4.4 Hz, 4H), 2.95 (t, <i>J</i> = 4.35 Hz, 4H). MS: <i>m</i>/<i>z</i> = 665.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>N</i>-(3-Chloro-4-((3-chlorobenzyl)oxy)phenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine Hydrochloride (<b>20g</b>)</h3><div class="NLM_p last">Yield: 49.1%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.54 (br s, 1H), 9.19 (br s, 1H), 8.96 (br s, 1H), 8.50 (d, <i>J</i> = 8.79 Hz, 1H), 8.21 (d, <i>J</i> = 8.30 Hz, 2H), 7.98–8.08 (m, 1H), 7.94–7.96 (m, 3H), 7.69 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.58 (br s, 1H), 7.37–7.50 (m, 4H), 5.31 (br s, 2H), 3.67 (br s, 4H), 2.95 (br s, 4H). MS: <i>m</i>/<i>z</i> = 621.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>N</i>-(3-Chloro-4-((2,3-difluorobenzyl)oxy)phenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine Hydrochloride (<b>20h</b>)</h3><div class="NLM_p last">Yield: 53.3%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.58 (br s, 1H), 9.22 (s, 1H), 8.97 (s, 1H), 8.51 (dd, <i>J</i> = 1.46, 8.79 Hz, 1H), 8.22 (d, <i>J</i> = 8.30 Hz, 2H), 8.03 (d, <i>J</i> = 8.79 Hz, 1H), 7.93–7.97 (m, 3H), 7.73 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.43–7.53 (m, 3H), 7.28–7.34 (m, 1H), 5.38 (s, 2H), 3.67 (t, <i>J</i> = 4.4 Hz, 4H), 2.95 (t, <i>J</i> = 4.6 Hz, 4H). MS: <i>m</i>/<i>z</i> = 623.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>N</i>-(3-Chloro-4-((2-fluorobenzyl)oxy)phenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine Hydrochloride (<b>20i</b>)</h3><div class="NLM_p last">Yield: 41.2%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.32 (br s, 1H), 9.12 (br s, 1H), 8.93 (br s, 1H), 8.47 (d, <i>J</i> = 8.79 Hz, 1H), 8.18 (d, <i>J</i> = 8.30 Hz, 2H), 7.98 (d, <i>J</i> = 8.79 Hz, 1H), 7.92–7.96 (m, 3H), 7.70 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.60–7.63 (m, 1H), 7.43–7.46 (m, 2H), 7.25–7.32 (m, 2H), 5.31 (s, 2H), 3.65 (t, <i>J</i> = 4.6 Hz, 4H), 2.93 (t, <i>J</i> = 4.6 Hz, 4H). MS: <i>m</i>/<i>z</i> = 605.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> <i>N</i>-(3-Chloro-4-((4-fluorobenzyl)oxy)phenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine Hydrochloride (<b>20j</b>)</h3><div class="NLM_p last">Yield: 67.1%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.66 (br s, 1H), 9.24 (br s, 1H), 8.97 (s, 1H), 8.52 (d, <i>J</i> = 8.79 Hz, 1H), 8.23 (d, <i>J</i> = 8.30 Hz, 2H), 8.03 (d, <i>J</i> = 8.79 Hz, 1H), 7.94–7.96 (m, 3H), 7.70 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.55–7.58 (m, 2H), 7.41 (d, <i>J</i> = 8.79 Hz, 1H), 7.26–7.30 (m, 2H), 5.28 (s, 2H), 3.7 (t, <i>J</i> = 4.9 Hz, 4H), 2.95 (t, <i>J</i> = 4.6 Hz, 4H). MS: <i>m</i>/<i>z</i> = 605.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>N</i>-(3-Chloro-4-((3-methoxybenzyl)oxy)phenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine Hydrochloride (<b>20k</b>)</h3><div class="NLM_p last">Yield: 43.1%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.40 (br s, 1H), 9.15 (s, 1H), 8.94 (s, 1H), 8.49 (d, <i>J</i> = 8.30 Hz, 1H), 8.20 (d, <i>J</i> = 8.30 Hz, 2H), 8.00 (d, <i>J</i> = 8.79 Hz, 1H), 7.93–7.97 (m, 3H), 7.68 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.33–7.39 (m, 2H), 7.06–7.08 (m, 2H), 6.91–6.96 (m, 1H), 5.27 (s, 2H), 3.78 (s, 3H), 3.67 (t, <i>J</i> = 4.9 Hz, 4H), 2.95 (t, <i>J</i> = 4.4 Hz, 4H). MS: <i>m</i>/<i>z</i> = 617.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> <i>N</i>-(3-Chloro-4-((3-fluoro-4-(trifluoromethyl)benzyl)oxy)phenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine Hydrochloride (<b>20l</b>)</h3><div class="NLM_p last">Yield: 40.9%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.74 (br s, 1H), 9.29 (s, 1H), 8.98 (s, 1H), 8.52 (dd, <i>J</i> = 1.46, 8.79 Hz, 1H), 8.24 (d, <i>J</i> = 8.79 Hz, 2H), 8.05 (d, <i>J</i> = 8.79 Hz, 1H), 7.99 (d, <i>J</i> = 2.44 Hz, 1H), 7.95 (d, <i>J</i> = 8.30 Hz, 2H), 7.89 (t, <i>J</i> = 7.81 Hz, 1H), 7.72 (dd, <i>J</i> = 2.44, 8.79 Hz, 1H), 7.63 (d, <i>J</i> = 11.23 Hz, 1H), 7.55 (d, <i>J</i> = 7.81 Hz, 1H), 7.38 (d, <i>J</i> = 8.79 Hz, 1H), 5.43 (s, 2H), 3.67 (t, <i>J</i> = 4.4 Hz, 4H), 2.95 (t, <i>J</i> = 4.4 Hz, 4H). MS: <i>m</i>/<i>z</i> = 673.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>N</i>-(3-Chloro-4-((2,3,5-trifluorobenzyl)oxy)phenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine Hydrochloride (<b>20m</b>)</h3><div class="NLM_p last">Yield: 42%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.49 (br s, 1H), 9.19 (s, 1H), 8.96 (s, 1H), 8.51 (d, <i>J</i> = 9.77 Hz, 1H), 8.21 (d, <i>J</i> = 8.30 Hz, 2H), 8.02 (d, <i>J</i> = 8.79 Hz, 1H), 7.95–7.98 (m, 3H), 7.73 (dd, <i>J</i> = 2.69, 9.03 Hz, 1H), 7.56- 7.65 (m, 1H), 7.48 (d, <i>J</i> = 8.79 Hz, 1H), 7.34–7.36 (m, 1H), 5.38 (s, 2H), 3.67 (t, <i>J</i> = 4.9 Hz, 4H), 2.95 (t, <i>J</i> = 4.4 Hz, 4H). MS: <i>m</i>/<i>z</i> = 641.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> <i>N</i>-(4-((3-Fluorobenzyl)oxy)phenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine (<b>20n</b>)</h3><div class="NLM_p last">Yield: 45.8%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.40 (br s, 1H), 9.15 (s, 1H), 8.88 (s, 1H), 8.49 (d, <i>J</i> = 8.79 Hz, 1H), 8.20 (d, <i>J</i> = 8.79 Hz, 2H), 7.92–8.02 (m, 3H), 7.65 (d, <i>J</i> = 9.30 Hz, 2H), 7.45–7.51 (m, 1H), 7.31–7.35 (m, 2H), 7.16–7.22 (m, 3H), 5.21 (s, 2H), 3.67 (t, <i>J</i> = 4.4 Hz, 4H), 2.95 (t, <i>J</i> = 4.4 Hz, 4H). MS: <i>m</i>/<i>z</i> = 571.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> <i>N</i>-(4-((3-Fluorobenzyl)oxy)-3-methoxyphenyl)-6-(4-(morpholinosulfonyl)phenyl)quinazolin-4-amine (<b>20o</b>)</h3><div class="NLM_p last">Yield: 18%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.32 (br s, 1H), 9.14 (s, 1H), 8.90 (s, 1H), 8.49 (d, <i>J</i> = 8.30 Hz, 1H), 8.20 (d, <i>J</i> = 8.79 Hz, 2H), 7.99 (d, <i>J</i> = 8.79 Hz, 1H), 7.96 (d, <i>J</i> = 8.30 Hz, 2H), 7.45–7.50 (m, 1H), 7.41 (d, <i>J</i> = 2.44 Hz, 1H), 7.28–7.34 (m, 3H), 7.15–7.22 (m, 2H), 5.19 (s, 2H), 3.84 (s, 3H), 3.67 (t, <i>J</i> = 4.9 Hz, 4H), 2.95 (t, <i>J</i> = 4.4 Hz, 4H). MS: <i>m</i>/<i>z</i> = 601.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Trypanosome Replication Assays</h3><div class="NLM_p last">Bloodstream <i>T. brucei brucei</i> Lister 427 cells were seeded at a density of 2 × 10<sup>3</sup> cells/mL and cultured in HMI-9 medium<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> in a 24-well plate. Then 2 μL of DMSO (control) or different concentrations of drugs prepared from 200× DMSO stocks were added to the cultures. Cells were incubated at 37 °C for 48 h and counted with a hemocytometer. Drugs were initially tested at concentrations of 10 μM, 1 μM, 100 nM, and 10 nM to determine the range of potency of each compound. Thereafter, a set of five concentrations centered around a dose that prevented replication of 50% of cells (compared to DMSO) was used to establish the EC<sub>50</sub>. All experiments were repeated thrice in independent studies where each dose was administered in duplicate (total <i>n</i> = 6).</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> HepG2 Cell Toxicity Assay</h3><div class="NLM_p last">The 384 well MTT cytotoxicity assay is a modification of the MTT method described by Ferrari et al.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> optimized for 384-well throughput, with modifications described in detail in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The 50% inhibitory concentrations (IC<sub>50</sub>) were generated for each toxicity dose response test using GraphPad Prism (GraphPad Software Inc., San Diego, CA) using the nonlinear regression (sigmoidal dose–response/variable slope) equation.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88"><a href="/doi/suppl/10.1021/jm400349k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthesis of selected boronates and a tabulation of all the inhibitors, with their Northeastern registry numbers and screening data. Also included are biological assay details, data from pharmacokinetic, and in vivo efficacy studies, plasma protein binding, and results from cell cycle analysis following inhibitor treatment. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400349k/suppl_file/jm400349k_si_001.pdf">jm400349k_si_001.pdf (603.58 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400349k" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13481" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13481" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kojo Mensa-Wilmot</span> - <span class="hlFld-Affiliation affiliation">Department of Cellular Biology,
University of Georgia, Athens, Georgia 30602, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b5d89bc5dad9d9d4c6c1c7dcf5dbd0c09bd0d1c095d8d0dbc6d4c2dcd9f5c0d2d49bd0d1c0"><span class="__cf_email__" data-cfemail="abc685dbc4c7c7cad8dfd9c2ebc5cede85cecfde">[email protected]</span> <span class="__cf_email__" data-cfemail="771a12190416001e1b3702101659121302">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael P. Pollastri</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and
Chemical Biology and Center for Drug Discovery, Northeastern University,
Boston, Massachusetts 02115, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#afc281dfc0c3c3cedcdbddc6efc1cada81cacbda8fc2cac1dcced8c6c3efdac8ce81cacbda"><span class="__cf_email__" data-cfemail="660b4816090a0a071512140f2608031348030213">[email protected]</span> <span class="__cf_email__" data-cfemail="7a171f14091b0d13163a0f1d1b541f1e0f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gautam Patel</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and
Chemical Biology and Center for Drug Discovery, Northeastern University,
Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caitlin E. Karver</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and
Chemical Biology and Center for Drug Discovery, Northeastern University,
Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ranjan Behera</span> - <span class="hlFld-Affiliation affiliation">Department of Cellular Biology,
University of Georgia, Athens, Georgia 30602, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul J. Guyett</span> - <span class="hlFld-Affiliation affiliation">Department of Cellular Biology,
University of Georgia, Athens, Georgia 30602, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Sullenberger</span> - <span class="hlFld-Affiliation affiliation">Department of Cellular Biology,
University of Georgia, Athens, Georgia 30602, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Edwards</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and
Chemical Biology and Center for Drug Discovery, Northeastern University,
Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Norma E. Roncal</span> - <span class="hlFld-Affiliation affiliation">Walter Reed Army Institute of
Research, Silver Spring, Maryland 20910, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>M.P.P. developed the medicinal chemistry strategy and contributed to compound designs. K.M.-W. initiated the project. G.P., C.E.K., and P.E. contributed to compound designs and performed chemical synthesis and characterization. R.B., P.G., and C.S. performed trypanosome assays, and N.E.R. performed the HepG2 assays.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d413e4469-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Funding from the National Institutes of Health (R01AI082577 to M.P., and R21AI076647 to K.M.-W.), the National Science Foundation (MCB-0843603), Northeastern University, and a gift of compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) from GlaxoSmithKline, Inc.. is gratefully acknowledged. We appreciate helpful discussions with Dr. Richard Sciotti at Walter Reed Army Institute of Research and Dr. Franco Lombardo at Novartis.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i91" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i91"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i92" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i92"> Abbreviations Used</h2><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">concentration at which cell growth is inhibited by 50%</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">PDE</td><td class="NLM_def"><p class="first last">phosphodiesterase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 51 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>Uniting to Combat NTDs Homepage; <a href="http://www.unitingtocombatntds.org" class="extLink">www.unitingtocombatntds.org</a>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><div class="note"><p class="first last">(accessed 12 April 2013)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Uniting+to+Combat+NTDs+Homepage%3B+www.unitingtocombatntds.org%2C+2013%3B+%28accessed+12+April+2013%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DUniting%2520to%2520Combat%2520NTDs%2520Homepage%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Pollastri, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. K.</span><span> </span><span class="NLM_article-title">Target repurposing for neglected diseases</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">1315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.4155%2Ffmc.11.92" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=21859304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKjtrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1307-1315&author=M.+P.+Pollastriauthor=R.+K.+Campbell&title=Target+repurposing+for+neglected+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Target repurposing for neglected diseases</span></div><div class="casAuthors">Pollastri, Michael P.; Campbell, Robert K.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1307-1315</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Infectious diseases are an enormous burden to global health and ,since drug discovery is costly, those infectious diseases that affect the developing world are often not pursued by com. drug-discovery efforts.  Therefore, pragmatic means by which new therapeutics can be discovered are needed.  One such approach is target repurposing, where pathogen targets are matched with homologous human targets that have been pursued for drug discovery for other indications.  In many cases, the medicinal chem., structural biol. and biochem. knowledge around these human targets can be directly repurposed to launch and accelerate new drug-discovery efforts against the pathogen targets.  This article describes the overarching strategy of target repurposing as a tool for initiating and prosecuting neglected disease drug-discovery programs, highlighting this approach with three case studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyF0eLS_dzUrVg90H21EOLACvtfcHk0li7whA5zZBAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKjtrzK&md5=886d8cc9e04cbbc4a0b139c78f0d3df7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.92%26sid%3Dliteratum%253Aachs%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26aulast%3DCampbell%26aufirst%3DR.%2BK.%26atitle%3DTarget%2520repurposing%2520for%2520neglected%2520diseases%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D1307%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gould, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Koning, H. P.</span><span> </span><span class="NLM_article-title">Cyclic-nucleotide signalling in protozoa</span> <span class="citation_source-journal">FEMS Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=515-541&author=M.+K.+Gouldauthor=H.+P.+de+Koning&title=Cyclic-nucleotide+signalling+in+protozoa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DM.%2BK.%26aulast%3Dde%2BKoning%26aufirst%3DH.%2BP.%26atitle%3DCyclic-nucleotide%2520signalling%2520in%2520protozoa%26jtitle%3DFEMS%2520Microbiol.%2520Rev.%26date%3D2011%26volume%3D35%26spage%3D515%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Parsons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthey, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mottram, J. C.</span><span> </span><span class="NLM_article-title">Comparative analysis of the kinomes of three pathogenic trypanosomatids: <i>Leishmania major</i>, <i>Trypanosoma brucei</i> and <i>Trypanosoma cruzi</i></span> <span class="citation_source-journal">BMC Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1186%2F1471-2164-6-127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=16164760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A280%3ADC%252BD2MrmvVKrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=127&author=M.+Parsonsauthor=E.+A.+Wortheyauthor=P.+N.+Wardauthor=J.+C.+Mottram&title=Comparative+analysis+of+the+kinomes+of+three+pathogenic+trypanosomatids%3A+Leishmania+major%2C+Trypanosoma+brucei+and+Trypanosoma+cruzi"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi</span></div><div class="casAuthors">Parsons Marilyn; Worthey Elizabeth A; Ward Pauline N; Mottram Jeremy C</div><div class="citationInfo"><span class="NLM_cas:title">BMC genomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The trypanosomatids Leishmania major, Trypanosoma brucei and Trypanosoma cruzi cause some of the most debilitating diseases of humankind: cutaneous leishmaniasis, African sleeping sickness, and Chagas disease.  These protozoa possess complex life cycles that involve development in mammalian and insect hosts, and a tightly coordinated cell cycle ensures propagation of the highly polarized cells.  However, the ways in which the parasites respond to their environment and coordinate intracellular processes are poorly understood.  As a part of an effort to understand parasite signaling functions, we report the results of a genome-wide analysis of protein kinases (PKs) of these three trypanosomatids.  RESULTS:  Bioinformatic searches of the trypanosomatid genomes for eukaryotic PKs (ePKs) and atypical PKs (aPKs) revealed a total of 176 PKs in T. brucei, 190 in T. cruzi and 199 in L. major, most of which are orthologous across the three species.  This is approximately 30% of the number in the human host and double that of the malaria parasite, Plasmodium falciparum.  The representation of various groups of ePKs differs significantly as compared to humans: trypanosomatids lack receptor-linked tyrosine and tyrosine kinase-like kinases, although they do possess dual-specificity kinases.  A relative expansion of the CMGC, STE and NEK groups has occurred.  A large number of unique ePKs show no strong affinity to any known group.  The trypanosomatids possess few ePKs with predicted transmembrane domains, suggesting that receptor ePKs are rare.  Accessory Pfam domains, which are frequently present in human ePKs, are uncommon in trypanosomatid ePKs.  CONCLUSION:  Trypanosomatids possess a large set of PKs, comprising approximately 2% of each genome, suggesting a key role for phosphorylation in parasite biology.  Whilst it was possible to place most of the trypanosomatid ePKs into the seven established groups using bioinformatic analyses, it has not been possible to ascribe function based solely on sequence similarity.  Hence the connection of stimuli to protein phosphorylation networks remains enigmatic.  The presence of numerous PKs with significant sequence similarity to known drug targets, as well as a large number of unusual kinases that might represent novel targets, strongly argue for functional analysis of these molecules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT76DpkTfbK3P9pSBfyDvp7fW6udTcc2eYVyFOwsjkPXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrmvVKrtA%253D%253D&md5=85170d5fb5d963fbf768a31b4cebff4c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2F1471-2164-6-127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2164-6-127%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DWorthey%26aufirst%3DE.%2BA.%26aulast%3DWard%26aufirst%3DP.%2BN.%26aulast%3DMottram%26aufirst%3DJ.%2BC.%26atitle%3DComparative%2520analysis%2520of%2520the%2520kinomes%2520of%2520three%2520pathogenic%2520trypanosomatids%253A%2520Leishmania%2520major%252C%2520Trypanosoma%2520brucei%2520and%2520Trypanosoma%2520cruzi%26jtitle%3DBMC%2520Genomics%26date%3D2005%26volume%3D6%26spage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bland, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashton, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiana, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gechijian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garceau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangurde, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortenberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ondrechen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Pharmacological validation of <i>Trypanosoma brucei</i> phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8188</span><span class="NLM_x">–</span> <span class="NLM_lpage">8194</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201148s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8188-8194&author=N.+D.+Blandauthor=C.+Wangauthor=C.+Tallmanauthor=A.+E.+Gustafsonauthor=Z.+Wangauthor=T.+D.+Ashtonauthor=S.+O.+Ochianaauthor=G.+McAllisterauthor=K.+Cotterauthor=A.+P.+Fangauthor=L.+Gechijianauthor=N.+Garceauauthor=R.+Gangurdeauthor=R.+Ortenbergauthor=M.+J.+Ondrechenauthor=R.+K.+Campbellauthor=M.+P.+Pollastri&title=Pharmacological+validation+of+Trypanosoma+brucei+phosphodiesterases+B1+and+B2+as+druggable+targets+for+African+sleeping+sickness"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm201148s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201148s%26sid%3Dliteratum%253Aachs%26aulast%3DBland%26aufirst%3DN.%2BD.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DTallman%26aufirst%3DC.%26aulast%3DGustafson%26aufirst%3DA.%2BE.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DAshton%26aufirst%3DT.%2BD.%26aulast%3DOchiana%26aufirst%3DS.%2BO.%26aulast%3DMcAllister%26aufirst%3DG.%26aulast%3DCotter%26aufirst%3DK.%26aulast%3DFang%26aufirst%3DA.%2BP.%26aulast%3DGechijian%26aufirst%3DL.%26aulast%3DGarceau%26aufirst%3DN.%26aulast%3DGangurde%26aufirst%3DR.%26aulast%3DOrtenberg%26aufirst%3DR.%26aulast%3DOndrechen%26aufirst%3DM.%2BJ.%26aulast%3DCampbell%26aufirst%3DR.%2BK.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DPharmacological%2520validation%2520of%2520Trypanosoma%2520brucei%2520phosphodiesterases%2520B1%2520and%2520B2%2520as%2520druggable%2520targets%2520for%2520African%2520sleeping%2520sickness%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8188%26epage%3D8194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ochiana, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandarinath, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ondrechen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruben, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">The human Aurora kinase inhibitor danusertib is a lead compound for anti-trypanosomal drug discovery via target repurposing</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=777-784&author=S.+O.+Ochianaauthor=V.+Pandarinathauthor=Z.+Wangauthor=R.+Kapoorauthor=M.+J.+Ondrechenauthor=L.+Rubenauthor=M.+P.+Pollastri&title=The+human+Aurora+kinase+inhibitor+danusertib+is+a+lead+compound+for+anti-trypanosomal+drug+discovery+via+target+repurposing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOchiana%26aufirst%3DS.%2BO.%26aulast%3DPandarinath%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DKapoor%26aufirst%3DR.%26aulast%3DOndrechen%26aufirst%3DM.%2BJ.%26aulast%3DRuben%26aufirst%3DL.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DThe%2520human%2520Aurora%2520kinase%2520inhibitor%2520danusertib%2520is%2520a%2520lead%2520compound%2520for%2520anti-trypanosomal%2520drug%2520discovery%2520via%2520target%2520repurposing%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D62%26spage%3D777%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Diaz-Gonzalez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhlmann, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galan-Rodriguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira da Silva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saldivia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karver, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beverley, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing</span> <span class="citation_source-journal">PLoS Negl. Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=e1297&author=R.+Diaz-Gonzalezauthor=F.+M.+Kuhlmannauthor=C.+Galan-Rodriguezauthor=L.+Madeira+da+Silvaauthor=M.+Saldiviaauthor=C.+E.+Karverauthor=A.+Rodriguezauthor=S.+M.+Beverleyauthor=M.+Navarroauthor=M.+P.+Pollastri&title=The+susceptibility+of+trypanosomatid+pathogens+to+PI3%2FmTOR+kinase+inhibitors+affords+a+new+opportunity+for+drug+repurposing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz-Gonzalez%26aufirst%3DR.%26aulast%3DKuhlmann%26aufirst%3DF.%2BM.%26aulast%3DGalan-Rodriguez%26aufirst%3DC.%26aulast%3DMadeira%2Bda%2BSilva%26aufirst%3DL.%26aulast%3DSaldivia%26aufirst%3DM.%26aulast%3DKarver%26aufirst%3DC.%2BE.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DBeverley%26aufirst%3DS.%2BM.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DThe%2520susceptibility%2520of%2520trypanosomatid%2520pathogens%2520to%2520PI3%252FmTOR%2520kinase%2520inhibitors%2520affords%2520a%2520new%2520opportunity%2520for%2520drug%2520repurposing%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2011%26volume%3D5%26spage%3De1297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">de Koning, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterk, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenor, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luginbuehl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seebeck, T.</span><span> </span><span class="NLM_article-title">Pharmacological validation of <i>Trypanosoma brucei</i> phosphodiesterases as novel drug targets</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1093%2Finfdis%2Fjir857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=22291195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVaiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2012&pages=229-237&author=H.+P.+de+Koningauthor=M.+K.+Gouldauthor=G.+J.+Sterkauthor=H.+Tenorauthor=S.+Kunzauthor=E.+Luginbuehlauthor=T.+Seebeck&title=Pharmacological+validation+of+Trypanosoma+brucei+phosphodiesterases+as+novel+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Validation of Trypanosoma brucei Phosphodiesterases as Novel Drug Targets</span></div><div class="casAuthors">de Koning, Harry P.; Gould, Matthew K.; Sterk, Geert Jan; Tenor, Hermann; Kunz, Stefan; Luginbuehl, Edith; Seebeck, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-237</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The development of drugs for neglected infectious diseases often uses parasite-specific enzymes as targets.  We here demonstrate that parasite enzymes with highly conserved human homologs may represent a promising reservoir of new potential drug targets.  The cyclic nucleotide-specific phosphodiesterases (PDEs) of Trypanosoma brucei, causative agent of the fatal human sleeping sickness, are essential for the parasite.  The highly conserved human homologs are well-established drug targets.  We here describe what is to our knowledge the first pharmacol. validation of trypanosomal PDEs as drug targets.  High-throughput screening of a proprietary compd. library identified a no. of potent hits.  One compd., the tetrahydrophthalazinone compd. A (Cpd A), was further characterized.  It causes a dramatic increase of intracellular cyclic adenosine monophosphate (cAMP).  Short-term cell viability is not affected, but cell proliferation is inhibited immediately, and cell death occurs within 3 days.  Cpd A prevents cytokinesis, resulting in multinucleated, multiflagellated cells that eventually lyse.  These observations pharmacol. validate the highly conserved trypanosomal PDEs as potential drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7qBOV9RqH9LVg90H21EOLACvtfcHk0lhnh2Fm6EBWRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVaiurg%253D&md5=541bc0e9cf3f9a30c102d873abeb7181</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjir857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjir857%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BKoning%26aufirst%3DH.%2BP.%26aulast%3DGould%26aufirst%3DM.%2BK.%26aulast%3DSterk%26aufirst%3DG.%2BJ.%26aulast%3DTenor%26aufirst%3DH.%26aulast%3DKunz%26aufirst%3DS.%26aulast%3DLuginbuehl%26aufirst%3DE.%26aulast%3DSeebeck%26aufirst%3DT.%26atitle%3DPharmacological%2520validation%2520of%2520Trypanosoma%2520brucei%2520phosphodiesterases%2520as%2520novel%2520drug%2520targets%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D206%26spage%3D229%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Beghyn, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laconde, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span> </span><span class="NLM_article-title">Drug to genome to drug: discovery of new antiplasmodial compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3222</span><span class="NLM_x">–</span> <span class="NLM_lpage">3240</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1014617" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3222-3240&author=T.+B.+Beghynauthor=J.+Chartonauthor=F.+Lerouxauthor=G.+Lacondeauthor=A.+Bourinauthor=P.+Cosauthor=L.+Maesauthor=B.+Deprez&title=Drug+to+genome+to+drug%3A+discovery+of+new+antiplasmodial+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Drug to Genome to Drug: Discovery of New Antiplasmodial Compounds</span></div><div class="casAuthors">Beghyn, Terence B.; Charton, Julie; Leroux, Florence; Laconde, Guillaume; Bourin, Arnaud; Cos, Paul; Maes, Louis; Deprez, Benoit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3222-3240</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dominant strategy for discovery of new antimalarial drugs relies on cell-free assays on specific biochem. pathways of Plasmodium falciparum.  However, it appears that screening directly on the parasite is a more rewarding approach.  The "drug to genome to drug" approach consists of testing a small set of structural analogs of a drug acting on human proteins that have plasmodial orthologues.  Both man and plasmodium possess cyclic nucleotide phosphodiesterases (PDEs) that are key players of cell homeostasis.  We synthesized and tested 40 analogs of tadalafil, a human PDE5 inhibitor, on P. falciparum in culture and obtained potent inhibitors of parasite growth.  We discuss the structure-activity relationships, which support the hypothesis that our compds. kill the parasite via inhibition of plasmodial PDE activity.  We also prove that antiplasmodial derivs. inhibit the hydrolysis of cyclic nucleotides of the parasite, validating the cAMP/cGMP pathways as therapeutic targets against Plasmodium falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYOJ83XRZb3bVg90H21EOLACvtfcHk0lhnh2Fm6EBWRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVCmu7Y%253D&md5=970cf7f4d8dbd6d9fbd597bc9bf13a35</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm1014617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1014617%26sid%3Dliteratum%253Aachs%26aulast%3DBeghyn%26aufirst%3DT.%2BB.%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DLaconde%26aufirst%3DG.%26aulast%3DBourin%26aufirst%3DA.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DDeprez%26aufirst%3DB.%26atitle%3DDrug%2520to%2520genome%2520to%2520drug%253A%2520discovery%2520of%2520new%2520antiplasmodial%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3222%26epage%3D3240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Nwaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, A.</span><span> </span><span class="NLM_article-title">Innovative lead discovery strategies for tropical diseases</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=941-955&author=S.+Nwakaauthor=A.+Hudson&title=Innovative+lead+discovery+strategies+for+tropical+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNwaka%26aufirst%3DS.%26aulast%3DHudson%26aufirst%3DA.%26atitle%3DInnovative%2520lead%2520discovery%2520strategies%2520for%2520tropical%2520diseases%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D941%26epage%3D955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Chahrour, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omran, Z.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitors as anti-cancer therapeutics</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=399-411&author=O.+Chahrourauthor=D.+Cairnsauthor=Z.+Omran&title=Small+molecule+kinase+inhibitors+as+anti-cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChahrour%26aufirst%3DO.%26aulast%3DCairns%26aufirst%3DD.%26aulast%3DOmran%26aufirst%3DZ.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitors%2520as%2520anti-cancer%2520therapeutics%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D399%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Page, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smolinska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbaniak, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foxwell, B. M.</span><span> </span><span class="NLM_article-title">Tyrosine kinases and inflammatory signalling</span> <span class="citation_source-journal">Curr. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.2174%2F156652409787314507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=19199943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=69-85&author=T.+H.+Pageauthor=M.+Smolinskaauthor=J.+Gillespieauthor=A.+M.+Urbaniakauthor=B.+M.+Foxwell&title=Tyrosine+kinases+and+inflammatory+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinases and inflammatory signalling</span></div><div class="casAuthors">Page, Theresa H.; Smolinska, Maria; Gillespie, Justin; Urbaniak, Anna M.; Foxwell, Brian M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Molecular Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-85</span>CODEN:
                <span class="NLM_cas:coden">CMMUBP</span>;
        ISSN:<span class="NLM_cas:issn">1566-5240</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The activity of tyrosine kinases is central to many cellular processes, and accumulating evidence suggests that their role in inflammation is no less profound.  Three main tyrosine kinase families, the Src, Tec and Syk kinase families are intimately involved in TLR signalling, the crit. first step in cellular recognition of invading pathogens and tissue damage.  Their activity results in changes in gene expression in affected cells.  Key amongst these genes are the cytokines, which orchestrate both the duration and extent of inflammation.  Tyrosine kinases also play important roles in cytokine function, and are implicated in signalling through both pro- and anti-inflammatory cytokines such as TNF, IL-6 and IL-10.  Thus, strategies to modulate tyrosine kinase activity have significant therapeutic potential in combating the chronic inflammatory state that is typical of many major health issues that face us today, including Rheumatoid Arthritis, Cardiovascular disease and cancer.  Here we review current knowledge of the role of tyrosine kinases in inflammation with particular emphasis on their role in TLR signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP5SfZlsc1LrVg90H21EOLACvtfcHk0lgabvyNKEChfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSgsb8%253D&md5=921639d539c31fe42df8a56236bd13c9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F156652409787314507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156652409787314507%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DT.%2BH.%26aulast%3DSmolinska%26aufirst%3DM.%26aulast%3DGillespie%26aufirst%3DJ.%26aulast%3DUrbaniak%26aufirst%3DA.%2BM.%26aulast%3DFoxwell%26aufirst%3DB.%2BM.%26atitle%3DTyrosine%2520kinases%2520and%2520inflammatory%2520signalling%26jtitle%3DCurr.%2520Mol.%2520Med.%26date%3D2009%26volume%3D9%26spage%3D69%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caramori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adcock, I. M.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Phosphatidylinositol 3-Kinase Inhibitors in Inflammatory Respiratory Disease</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1124%2Fjpet.106.111674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=17021257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVSks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=1-8&author=K.+Itoauthor=G.+Caramoriauthor=I.+M.+Adcock&title=Therapeutic+Potential+of+Phosphatidylinositol+3-Kinase+Inhibitors+in+Inflammatory+Respiratory+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease</span></div><div class="casAuthors">Ito, Kazuhiro; Caramori, Gaetano; Adcock, Ian M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase(s) (PI3K) are a family of proteins that catalyze the phosphorylation of the 3-OH position of phosphoinositides and generate lipids that control a wide variety of intracellular signaling pathways.  They are classified into three families according to their structure and substrate specificity and are thought to have distinct biol. roles.  Recent studies suggested that numerous components of the PI3K pathway play a crucial role in the expression and activation of inflammatory mediators, inflammatory cell recruitment, immune cell function, airway remodeling, and corticosteroid insensitivity in chronic inflammatory respiratory disease.  Selective PI3K inhibitors have been developed that reduce inflammation and some characteristics of disease in exptl. animal models.  Targeting specific PI3K isoforms that may be overexpressed or overactive in disease should allow for selective treatment of respiratory diseases.  Encouraging data from animal models, primary cells and clin. studies in other diseases suggest that inhibitors of PI3K/Akt may prove to be useful novel therapies in the treatment of asthma and chronic obstructive pulmonary disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGragTLs5kLAG7Vg90H21EOLACvtfcHk0lgabvyNKEChfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVSks70%253D&md5=560fb10d63224617939f976512dd06c2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.111674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.111674%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DK.%26aulast%3DCaramori%26aufirst%3DG.%26aulast%3DAdcock%26aufirst%3DI.%2BM.%26atitle%3DTherapeutic%2520Potential%2520of%2520Phosphatidylinositol%25203-Kinase%2520Inhibitors%2520in%2520Inflammatory%2520Respiratory%2520Disease%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Louvet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szot, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bluestone, J. A.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">18895</span><span class="NLM_x">–</span> <span class="NLM_lpage">18900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=18895-18900&author=C.+Louvetauthor=G.+L.+Szotauthor=J.+Langauthor=M.+R.+Leeauthor=N.+Martinierauthor=G.+Bollagauthor=S.+Zhuauthor=A.+Weissauthor=J.+A.+Bluestone&title=Tyrosine+kinase+inhibitors+reverse+type+1+diabetes+in+nonobese+diabetic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLouvet%26aufirst%3DC.%26aulast%3DSzot%26aufirst%3DG.%2BL.%26aulast%3DLang%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DMartinier%26aufirst%3DN.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DBluestone%26aufirst%3DJ.%2BA.%26atitle%3DTyrosine%2520kinase%2520inhibitors%2520reverse%2520type%25201%2520diabetes%2520in%2520nonobese%2520diabetic%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D18895%26epage%3D18900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wagman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, D. E.</span><span> </span><span class="NLM_article-title">Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1105</span><span class="NLM_x">–</span> <span class="NLM_lpage">1137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.2174%2F1381612043452668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=15078145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivF2iu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1105-1137&author=A.+S.+Wagmanauthor=K.+W.+Johnsonauthor=D.+E.+Bussiere&title=Discovery+and+development+of+GSK3+inhibitors+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes</span></div><div class="casAuthors">Wagman, Allan S.; Johnson, Kirk W.; Bussiere, Dirksen E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1105-1137</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Originally identified as a modulator of glycogen metab., glycogen synthase kinase-3 (GSK3) is now understood to play an important regulatory role in a variety of pathways including initiation of protein synthesis, cell proliferation, cell differentiation, apoptosis, and is essential for embryonic development as a component of the Wnt signaling cascade.  GSK3 can be considered as a target for both metabolic and neurol. disorders.  GSK3's assocn. with neuronal apoptosis and hyper-phosphorylation of tau make this kinase an attractive therapeutic target for neurodegenerative conditions such as head trauma, stroke, and Alzheimer's disease.  While noting GSK3's many assocd. functions, this review will focus on GSK3 as a central neg. regulator in the insulin signaling pathway, its role in insulin resistance, and the utility of GSK3 inhibitors for intervention and control of metabolic diseases including type 2 diabetes.  Recent crystal structures, including the active (phosphorylated Tyr-216) form of GSK3β, provide a wealth of structural information and greater understanding of GSK3's unique regulation and substrate specificity.  Many potent and selective small mol. inhibitors of GSK3 have now been identified, and used in vitro to modulate glycogen metab. and gene transcription, increase glycogen synthase activity and enhance insulin-stimulated glucose transport.  The pharmacol. of potent and selective GSK3 inhibitors (CT 99021 and CT 20026) is described in a no. of in vitro and in vivo models following acute or chronic exposure.  The efficacy of clin. candidates in diabetic primates and the implications for clin. development are discussed.  The profile of activity is consistent with a unique form of insulin sensitization which is well suited for indications such as metabolic syndrome X and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqncX-9ISkjCLVg90H21EOLACvtfcHk0lisMaELmp_IkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivF2iu74%253D&md5=9f4663cd4bf90fc0916fe49e0ed8076c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1381612043452668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043452668%26sid%3Dliteratum%253Aachs%26aulast%3DWagman%26aufirst%3DA.%2BS.%26aulast%3DJohnson%26aufirst%3DK.%2BW.%26aulast%3DBussiere%26aufirst%3DD.%2BE.%26atitle%3DDiscovery%2520and%2520development%2520of%2520GSK3%2520inhibitors%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D1105%26epage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Chico, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, D. M.</span><span> </span><span class="NLM_article-title">Targeting protein kinases in central nervous system disorders</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=892-909&author=L.+K.+Chicoauthor=L.+J.+Van+Eldikauthor=D.+M.+Watterson&title=Targeting+protein+kinases+in+central+nervous+system+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChico%26aufirst%3DL.%2BK.%26aulast%3DVan%2BEldik%26aufirst%3DL.%2BJ.%26aulast%3DWatterson%26aufirst%3DD.%2BM.%26atitle%3DTargeting%2520protein%2520kinases%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D892%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Natoli, C.</span><span> </span><span class="NLM_article-title">Tyrosine Kinase Inhibitors</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.2174%2F156800910791517208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=20384577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWlsLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=462&author=C.+Natoli&title=Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinase inhibitors</span></div><div class="casAuthors">Natoli, C.; Perrucci, B.; Perrotti, F.; Falchi, L.; Iacobelli, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">462-483</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the last ten years, several new and therapeutically relevant cancer drugs targeting tyrosine kinase signaling pathways have been developed.  Tyrosine kinase inhibitors (TKIs) are a pharmaceutical class of small mols., orally available, well-tolerated, worldwide approved drugs for the treatment of several neoplasms, including lung, breast, kidney and pancreatic cancer as well as gastro-intestinal stromal tumors and chronic myeloid leukemia.  This comprehensive review focuses on the most relevant members of the first and the second generation TKIs designed to interact with receptor and nonreceptor TKs.  Attention is mainly focused on mol. mechanisms in in vitro and in vivo models related to the clin. activity of the drugs and to the development of resistance to treatment, still the major challenge in cancer research and care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLC0hSF4ig7rVg90H21EOLACvtfcHk0lisMaELmp_IkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWlsLnE&md5=eefddbc808fc8075376e1cc06fc92566</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F156800910791517208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800910791517208%26sid%3Dliteratum%253Aachs%26aulast%3DNatoli%26aufirst%3DC.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2010%26volume%3D10%26spage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lackey, K. E.</span><span> </span><span class="NLM_article-title">Lessons from the drug discovery of lapatinib, a dual ErbB1/2 tyrosine kinase inhibitor</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.2174%2F156802606776743156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=16719802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtV2juro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=435-460&author=K.+E.+Lackey&title=Lessons+from+the+drug+discovery+of+lapatinib%2C+a+dual+ErbB1%2F2+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from the drug discovery of Lapatinib, a dual ErbB1/2 tyrosine Kinase inhibitor</span></div><div class="casAuthors">Lackey, Karen E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">435-460</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein Kinases offer many opportunities for drug intervention points since phosphorylation is the most common post-translational modification.  Phosphorylation regulates activity, location, degrdn., and conformation and the aberrant activity is implicated in many diseases, including cancer, inflammation, cardiovascular, and central nervous system diseases.  The focus of this review will be on the generation of highly effective signaling inhibitors targeting members of the erbB family of receptor tyrosine kinases, EGFR and ErbB-2, also known as transmembrane Type 1 receptor tyrosine kinases of the HER family of receptors.  Ligand binding to the receptor causes a conformational change which activates the tyrosine kinase domain leading to autophosphorylation.  This autophosphorylation activates the RAS/mitogen-activated protein (MAP) kinase and phosphoinositol-3-kinase (PI3K) pathways leading to a myriad of signaling and cellular activities.  Type 1 receptors are overexpressed in a variety of cancers and generally correlate with poor prognosis.  For this reason, scientists at GlaxoSmithKline and many others in the scientific community target the ATP binding site of the intracellular portion of the protein to block the aberrant signaling event.  This review intends to cover the lessons learned in the discovery of Lapatinib (GW572016, GW2016) by pulling together the various different publications that have been generated in distinct disciplines on aspects of the drug discovery program.  Data analyses and correlation of assay data to help with the design of drug-like mols. are included and demonstrate a break from the traditional focus on abs. potency as a guiding factor in lead compd. selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnKhQE45WWsbVg90H21EOLACvtfcHk0lisMaELmp_IkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtV2juro%253D&md5=5bb70c03abc1fb8c301cac0f5f713fbe</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F156802606776743156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776743156%26sid%3Dliteratum%253Aachs%26aulast%3DLackey%26aufirst%3DK.%2BE.%26atitle%3DLessons%2520from%2520the%2520drug%2520discovery%2520of%2520lapatinib%252C%2520a%2520dual%2520ErbB1%252F2%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D435%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Johannessen, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringerike, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madshus, I. H.</span><span> </span><span class="NLM_article-title">Epidermal growth factor receptor efficiently activates mitogen-activated protein kinase in HeLa cells and Hep2 cells conditionally defective in clathrin-dependent endocytosis</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1006%2Fexcr.2000.5004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=11010818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVeitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=2000&pages=136-145&author=L.+E.+Johannessenauthor=T.+Ringerikeauthor=J.+Molnesauthor=I.+H.+Madshus&title=Epidermal+growth+factor+receptor+efficiently+activates+mitogen-activated+protein+kinase+in+HeLa+cells+and+Hep2+cells+conditionally+defective+in+clathrin-dependent+endocytosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal growth factor receptor efficiently activates mitogen-activated protein kinase in HeLa cells and Hep2 cells conditionally defective in clathrin-dependent endocytosis</span></div><div class="casAuthors">Johannessen, Lene Elisabeth; Ringerike, Tove; Molnes, Janne; Madshus, Inger Helene</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">136-145</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Epidermal growth factor (EGF)-induced signaling was investigated in cells conditionally defective in clathrin-dependent endocytosis by overexpression of K44A dynamin in HeLa cells and potassium depletion in Hep2 cells.  Overexpression of mutant dynamin disrupts high-affinity EGF-EGF receptor (EGFR) interaction.  However, the EGFR substrates Shc and c-Cbl were as efficiently tyrosine phosphorylated in endocytosis-deficient HeLa cells exhibiting only low-affinity EGFRs as in HeLa cells with intact endocytosis and with both high- and low-affinity EGFRs.  Both Raf and mitogen-activated protein kinase (MAPK) were activated to the same extent and with the same kinetics.  HeLa cells distributed equally in the cell cycle regardless of EGFR internalization.  Upon potassium depletion of Hep2 cells, EGF-induced EGFR endocytosis was inhibited.  However, the EGFR and MAPK were efficiently activated by EGF in both the absence and the presence of clathrin-dependent endocytosis.  The EGFR was weakly tyrosine phosphorylated by potassium depletion even in the absence of EGF, and this activation resulted in detectable activation of MAPK.  The authors' results demonstrate that internalization of EGFR by clathrin-dependent endocytosis is not required for activation of MAPK.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWJNrMDja0crVg90H21EOLACvtfcHk0lisMaELmp_IkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVeitbY%253D&md5=48a9cb8198da4909bf9982096eb44886</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1006%2Fexcr.2000.5004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.2000.5004%26sid%3Dliteratum%253Aachs%26aulast%3DJohannessen%26aufirst%3DL.%2BE.%26aulast%3DRingerike%26aufirst%3DT.%26aulast%3DMolnes%26aufirst%3DJ.%26aulast%3DMadshus%26aufirst%3DI.%2BH.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520efficiently%2520activates%2520mitogen-activated%2520protein%2520kinase%2520in%2520HeLa%2520cells%2520and%2520Hep2%2520cells%2520conditionally%2520defective%2520in%2520clathrin-dependent%2520endocytosis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2000%26volume%3D260%26spage%3D136%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Naula, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mottram, J. C.</span><span> </span><span class="NLM_article-title">Protein kinases as drug targets in trypanosomes and <i>Leishmania</i></span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1754</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1754&publication_year=2005&pages=151-159&author=C.+Naulaauthor=M.+Parsonsauthor=J.+C.+Mottram&title=Protein+kinases+as+drug+targets+in+trypanosomes+and+Leishmania"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaula%26aufirst%3DC.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DMottram%26aufirst%3DJ.%2BC.%26atitle%3DProtein%2520kinases%2520as%2520drug%2520targets%2520in%2520trypanosomes%2520and%2520Leishmania%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1754%26spage%3D151%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Oduor, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkinson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holler, T. P.</span><span> </span><span class="NLM_article-title"><i>Trypanosoma brucei</i> Glycogen Synthase Kinase-3, A Target for Anti-Trypanosomal Drug Development: A Public–Private Partnership to Identify Novel Leads</span> <span class="citation_source-journal">PLoS Negl. Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1017</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=e1017&author=R.+O.+Oduorauthor=K.+K.+Ojoauthor=G.+P.+Williamsauthor=F.+Bertelliauthor=J.+Millsauthor=L.+Maesauthor=D.+C.+Prydeauthor=T.+Parkinsonauthor=W.+C.+Van+Voorhisauthor=T.+P.+Holler&title=Trypanosoma+brucei+Glycogen+Synthase+Kinase-3%2C+A+Target+for+Anti-Trypanosomal+Drug+Development%3A+A+Public%E2%80%93Private+Partnership+to+Identify+Novel+Leads"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOduor%26aufirst%3DR.%2BO.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DWilliams%26aufirst%3DG.%2BP.%26aulast%3DBertelli%26aufirst%3DF.%26aulast%3DMills%26aufirst%3DJ.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DParkinson%26aufirst%3DT.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DHoller%26aufirst%3DT.%2BP.%26atitle%3DTrypanosoma%2520brucei%2520Glycogen%2520Synthase%2520Kinase-3%252C%2520A%2520Target%2520for%2520Anti-Trypanosomal%2520Drug%2520Development%253A%2520A%2520Public%25E2%2580%2593Private%2520Partnership%2520to%2520Identify%2520Novel%2520Leads%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2011%26volume%3D5%26spage%3De1017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Nett, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda-Saavedra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamont, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehlert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, M. A.</span><span> </span><span class="NLM_article-title">The phosphoproteome of bloodstream form <i>Trypanonosoma brucei</i>, causative agent of African sleeping sickness</span> <span class="citation_source-journal">Mol. Cell Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1527</span><span class="NLM_x">–</span> <span class="NLM_lpage">1538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1074%2Fmcp.M800556-MCP200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=19346560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1Gjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1527-1538&author=I.+R.+Nettauthor=D.+M.+Martinauthor=D.+Miranda-Saavedraauthor=D.+Lamontauthor=J.+D.+Barberauthor=A.+Mehlertauthor=M.+A.+Ferguson&title=The+phosphoproteome+of+bloodstream+form+Trypanonosoma+brucei%2C+causative+agent+of+African+sleeping+sickness"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphoproteome of bloodstream form Trypanosoma brucei, causative agent of African sleeping sickness</span></div><div class="casAuthors">Nett, Isabelle R. E.; Martin, David M. A.; Miranda-Saavedra, Diego; Lamont, Douglas; Barber, Jonathan D.; Mehlert, Angela; Ferguson, Michael A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Proteomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1527-1538</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9476</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The protozoan parasite Trypanosoma brucei is the causative agent of human African sleeping sickness and related animal diseases, and it has over 170 predicted protein kinases.  Protein phosphorylation is a key regulatory mechanism for cellular function that, thus far, has been studied in T. brucei principally through putative kinase mRNA knockdown and observation of the resulting phenotype.  However, despite the relatively large kinome of this organism and the demonstrated essentiality of several T. brucei kinases, very few specific phosphorylation sites have been detd. in this organism.  Using a gel-free, phosphopeptide enrichment-based proteomics approach the authors performed the first large scale phosphorylation site analyses for T. brucei.  Serine, threonine, and tyrosine phosphorylation sites were detd. for a cytosolic protein fraction of the bloodstream form of the parasite, resulting in the identification of 491 phosphoproteins based on the identification of 852 unique phosphopeptides and 1204 phosphorylation sites.  The phosphoproteins detected in this study are predicted from their genome annotations to participate in a wide variety of biol. processes, including signal transduction, processing of DNA and RNA, protein synthesis, and degrdn. and to a minor extent in metabolic pathways.  The anal. of phosphopeptides and phosphorylation sites was facilitated by inhouse developed software, and this automated approach was validated by manual annotation of spectra of the kinase subset of proteins.  Anal. of the cytosolic bloodstream form T. brucei kinome revealed the presence of 44 phosphorylated protein kinases in the authors' data set that could be classified into the major eukaryotic protein kinase groups by applying a multilevel hidden Markov model library of the kinase catalytic domain.  Identification of the kinase phosphorylation sites showed conserved phosphorylation sequence motifs in several kinase activation segments, supporting the view that phosphorylation-based signaling is a general and fundamental regulatory process that extends to this highly divergent lower eukaryote.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJpegvn6bdjLVg90H21EOLACvtfcHk0lj4NkZETg7JCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1Gjtbo%253D&md5=2df640c6ffcfbba8998d38c40decd9fc</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M800556-MCP200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M800556-MCP200%26sid%3Dliteratum%253Aachs%26aulast%3DNett%26aufirst%3DI.%2BR.%26aulast%3DMartin%26aufirst%3DD.%2BM.%26aulast%3DMiranda-Saavedra%26aufirst%3DD.%26aulast%3DLamont%26aufirst%3DD.%26aulast%3DBarber%26aufirst%3DJ.%2BD.%26aulast%3DMehlert%26aufirst%3DA.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%26atitle%3DThe%2520phosphoproteome%2520of%2520bloodstream%2520form%2520Trypanonosoma%2520brucei%252C%2520causative%2520agent%2520of%2520African%2520sleeping%2520sickness%26jtitle%3DMol.%2520Cell%2520Proteomics%26date%3D2009%26volume%3D8%26spage%3D1527%26epage%3D1538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Nett, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamont, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, M. A.</span><span> </span><span class="NLM_article-title">Identification and specific localization of tyrosine-phosphorylated proteins in <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">Eukaryotic Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=617-626&author=I.+R.+Nettauthor=L.+Davidsonauthor=D.+Lamontauthor=M.+A.+Ferguson&title=Identification+and+specific+localization+of+tyrosine-phosphorylated+proteins+in+Trypanosoma+brucei"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNett%26aufirst%3DI.%2BR.%26aulast%3DDavidson%26aufirst%3DL.%26aulast%3DLamont%26aufirst%3DD.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520and%2520specific%2520localization%2520of%2520tyrosine-phosphorylated%2520proteins%2520in%2520Trypanosoma%2520brucei%26jtitle%3DEukaryotic%2520Cell%26date%3D2009%26volume%3D8%26spage%3D617%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Katiyar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span> </span><span class="NLM_article-title">Lapatinib-Binding Protein Kinases in the African Trypanosome: A General Method for Identification of Targets for Kinase-Directed Drugs in a Cell</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e56150</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e56150&author=S.+Katiyarauthor=I.+Kufarevaauthor=R.+Beheraauthor=Y.+Ogataauthor=M.+P.+Pollastriauthor=R.+Abagyanauthor=K.+Mensa-Wilmot&title=Lapatinib-Binding+Protein+Kinases+in+the+African+Trypanosome%3A+A+General+Method+for+Identification+of+Targets+for+Kinase-Directed+Drugs+in+a+Cell"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatiyar%26aufirst%3DS.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DBehera%26aufirst%3DR.%26aulast%3DOgata%26aufirst%3DY.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26atitle%3DLapatinib-Binding%2520Protein%2520Kinases%2520in%2520the%2520African%2520Trypanosome%253A%2520A%2520General%2520Method%2520for%2520Identification%2520of%2520Targets%2520for%2520Kinase-Directed%2520Drugs%2520in%2520a%2520Cell%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De56150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Slichenmyer, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">CI-1033, a pan-erbB tyrosine kinase inhibitor</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2FS0093-7754%2801%2990285-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=11706399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1Wgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=80-85&author=W.+J.+Slichenmyerauthor=W.+L.+Elliottauthor=D.+W.+Fry&title=CI-1033%2C+a+pan-erbB+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">CI-1033, a pan-erbB tyrosine kinase inhibitor</span></div><div class="casAuthors">Slichenmyer, William J.; Elliott, William L.; Fry, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5, Suppl. 16</span>),
    <span class="NLM_cas:pages">80-85</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">A review.  Overexpression of the erbB family of receptor tyrosine kinases has been implicated in a variety of tumors including breast, lung, prostate, and brain.  Most solid tumors express one or more of these receptors, which can often be related to tumor aggressiveness and poor patient prognosis.  CI-1033, a pan-erbB tyrosine kinase inhibitor, is a clin. promising agent that is active against all four members of the erbB receptor tyrosine kinase family.  In vitro studies of human cancer cell lines indicate that CI-1033 results in prompt, potent, and sustained inhibition of tyrosine kinase activity.  This inhibition is highly selective for erbBI (epidermal growth factor receptor), erbB2, erbB3, and erbB4 without inhibiting tyrosine kinase activity of receptors such as platelet-derived growth factor receptor, fibroblast growth factor receptor, and insulin receptor, even at high concns.  Treatment of athymic nude mice bearing xenografts of human A431 epidermoid carcinoma, H125 non-small cell lung carcinoma, and SF-767 glioblastoma results in highly significant suppression of tumor growth.  The major toxicity in animals is diarrhea, which is more severe at higher doses.  In animal models, all side effects are reversible on cessation of treatment.  Thus, CI-1033, which is currently undergoing phase I clin. trials, holds significant potential for use in a broad range of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWblWCZGMLQLVg90H21EOLACvtfcHk0lhhxI30FC_sLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1Wgu7c%253D&md5=cc0507480a4182c3e52314750347b4c2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0093-7754%2801%2990285-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0093-7754%252801%252990285-4%26sid%3Dliteratum%253Aachs%26aulast%3DSlichenmyer%26aufirst%3DW.%2BJ.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DCI-1033%252C%2520a%2520pan-erbB%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DSemin.%2520Oncol.%26date%3D2001%26volume%3D28%26spage%3D80%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, N. L.</span><span> </span><span class="NLM_article-title">Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6255</span><span class="NLM_x">–</span> <span class="NLM_lpage">6263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1038%2Fsj.onc.1205794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=12214266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1yrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=6255-6263&author=W.+Xiaauthor=R.+J.+Mullinauthor=B.+R.+Keithauthor=L.+H.+Liuauthor=H.+Maauthor=D.+W.+Rusnakauthor=G.+Owensauthor=K.+J.+Alligoodauthor=N.+L.+Spector&title=Anti-tumor+activity+of+GW572016%3A+a+dual+tyrosine+kinase+inhibitor+blocks+EGF+activation+of+EGFR%2FerbB2+and+downstream+Erk1%2F2+and+AKT+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways</span></div><div class="casAuthors">Xia, Wenle; Mullin, Robert J.; Keith, Barry R.; Liu, Lei-Hua; Ma, Hong; Rusnak, David W.; Owens, Gary; Alligood, Krystal J.; Spector, Neil L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">6255-6263</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Dual EGFR/erbB2 inhibition is an attractive therapeutic strategy for epithelial tumors, as ligand-induced erbB2/EGFR heterodimerization triggers potent proliferative and survival signals.  Here we show that a small mol., GW572016, potently inhibits both EGFR and erbB2 tyrosine kinases leading to growth arrest and/or apoptosis in EGFR and erbB2-dependent tumor cell lines.  GW572016 markedly reduced tyrosine phosphorylation of EGFR and erbB2, and inhibited activation of Erk1/2 and AKT, downstream effectors of proliferation and cell survival, resp.  Complete inhibition of activated AKT in erbB2 overexpressing cells correlated with a 23-fold increase in apoptosis compared with vehicle controls.  EGF, often elevated in cancer patients, did not reverse the inhibitory effects of GW572016.  These observations were reproduced in vivo, where GW572016 treatment inhibited activation of EGFR, erbB2, Erk1/2 and AKT in human tumor xenografts.  Erk1/2 and AKT represent potential biomarkers to assess the clin. activity of GW572016.  Inhibition of activated AKT in EGFR or erbB2-dependent tumors by GW572016 may lead to tumor regressions when used as a monotherapy, or may enhance the anti-tumor activity of chemotherapeutics, since constitutive activation of AKT has been linked to chemo-resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYPkZ4sa88irVg90H21EOLACvtfcHk0lhhxI30FC_sLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1yrs7w%253D&md5=38d6e25a7cfa1fdfe77fa2fea2c0aa0c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1205794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1205794%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DW.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DKeith%26aufirst%3DB.%2BR.%26aulast%3DLiu%26aufirst%3DL.%2BH.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DOwens%26aufirst%3DG.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DSpector%26aufirst%3DN.%2BL.%26atitle%3DAnti-tumor%2520activity%2520of%2520GW572016%253A%2520a%2520dual%2520tyrosine%2520kinase%2520inhibitor%2520blocks%2520EGF%2520activation%2520of%2520EGFR%252FerbB2%2520and%2520downstream%2520Erk1%252F2%2520and%2520AKT%2520pathways%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D6255%26epage%3D6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Traxler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegrini, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosios, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McSheehy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wartmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caravatti, G.</span><span> </span><span class="NLM_article-title">AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">4931</span><span class="NLM_x">–</span> <span class="NLM_lpage">4941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4931-4941&author=P.+Traxlerauthor=P.+R.+Allegriniauthor=R.+Brandtauthor=J.+Brueggenauthor=R.+Cozensauthor=D.+Fabbroauthor=K.+Grosiosauthor=H.+A.+Laneauthor=P.+McSheehyauthor=J.+Mestanauthor=T.+Meyerauthor=C.+Tangauthor=M.+Wartmannauthor=J.+Woodauthor=G.+Caravatti&title=AEE788%3A+a+dual+family+epidermal+growth+factor+receptor%2FErbB2+and+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitor+with+antitumor+and+antiangiogenic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26aulast%3DAllegrini%26aufirst%3DP.%2BR.%26aulast%3DBrandt%26aufirst%3DR.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DCozens%26aufirst%3DR.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGrosios%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DH.%2BA.%26aulast%3DMcSheehy%26aufirst%3DP.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DJ.%26aulast%3DCaravatti%26aufirst%3DG.%26atitle%3DAEE788%253A%2520a%2520dual%2520family%2520epidermal%2520growth%2520factor%2520receptor%252FErbB2%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%2520with%2520antitumor%2520and%2520antiangiogenic%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D4931%26epage%3D4941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Steverding, D.</span><span> </span><span class="NLM_article-title">The transferrin receptor of <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">Parasitol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2FS1383-5769%2899%2900018-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=11227758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADyaK1MXnvFelurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2000&pages=191-198&author=D.+Steverding&title=The+transferrin+receptor+of+Trypanosoma+brucei"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The transferrin receptor of Trypanosoma brucei</span></div><div class="casAuthors">Steverding, D.</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology International</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">191-198</span>CODEN:
                <span class="NLM_cas:coden">PAINFD</span>;
        ISSN:<span class="NLM_cas:issn">1383-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 48 refs.  Bloodstream forms of Trypanosoma brucei, the causative agent of sleeping sickness in humans, require transferrin for growth.  Uptake of host transferrin is mediated by a heterodimeric glycosylphosphatidylinositol-anchored receptor.  The trypanosomal transferrin receptor is homologous to the N-terminal domain of the variant surface glycoprotein (VSG) and bears no structural similarity with the human transferrin receptor.  In this review, the structure, biochem. properties and function of the transferrin receptor of T. brucei are summarized and compared to the transferrin receptor of mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX6PmydLq4M7Vg90H21EOLACvtfcHk0lhhxI30FC_sLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvFelurY%253D&md5=908454a736df5585098660d048e7b2ca</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS1383-5769%2899%2900018-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1383-5769%252899%252900018-5%26sid%3Dliteratum%253Aachs%26aulast%3DSteverding%26aufirst%3DD.%26atitle%3DThe%2520transferrin%2520receptor%2520of%2520Trypanosoma%2520brucei%26jtitle%3DParasitol.%2520Int.%26date%3D2000%26volume%3D48%26spage%3D191%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Subramanya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardin, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steverding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span> </span><span class="NLM_article-title">Glycosylphosphatidylinositol-specific phospholipase C regulates transferrin endocytosis in the African trypanosome</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">417</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2009&pages=685-694&author=S.+Subramanyaauthor=C.+F.+Hardinauthor=D.+Steverdingauthor=K.+Mensa-Wilmot&title=Glycosylphosphatidylinositol-specific+phospholipase+C+regulates+transferrin+endocytosis+in+the+African+trypanosome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanya%26aufirst%3DS.%26aulast%3DHardin%26aufirst%3DC.%2BF.%26aulast%3DSteverding%26aufirst%3DD.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26atitle%3DGlycosylphosphatidylinositol-specific%2520phospholipase%2520C%2520regulates%2520transferrin%2520endocytosis%2520in%2520the%2520African%2520trypanosome%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D417%26spage%3D685%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Subramanya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span> </span><span class="NLM_article-title">Diacylglycerol-stimulated endocytosis of transferrin in trypanosomatids is dependent on tyrosine kinase activity</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e8538</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e8538&author=S.+Subramanyaauthor=K.+Mensa-Wilmot&title=Diacylglycerol-stimulated+endocytosis+of+transferrin+in+trypanosomatids+is+dependent+on+tyrosine+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanya%26aufirst%3DS.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26atitle%3DDiacylglycerol-stimulated%2520endocytosis%2520of%2520transferrin%2520in%2520trypanosomatids%2520is%2520dependent%2520on%2520tyrosine%2520kinase%2520activity%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De8538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Behera, R.; Guyett, P.; Thomas, S.; Katiyar, S.; Ogata, Y.; Mensa-Wilmot, K.</span>,unpublished results</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Behera%2C+R.%3B+Guyett%2C+P.%3B+Thomas%2C+S.%3B+Katiyar%2C+S.%3B+Ogata%2C+Y.%3B+Mensa-Wilmot%2C+K.%2Cunpublished+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBehera%26aufirst%3DR." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Affleck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span> </span><span class="NLM_article-title">The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=12467226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=85-94&author=D.+W.+Rusnakauthor=K.+Lackeyauthor=K.+Affleckauthor=E.+R.+Woodauthor=K.+J.+Alligoodauthor=N.+Rhodesauthor=B.+R.+Keithauthor=D.+M.+Murrayauthor=W.+B.+Knightauthor=R.+J.+Mullinauthor=T.+M.+Gilmer&title=The+effects+of+the+novel%2C+reversible+epidermal+growth+factor+receptor%2FErbB-2+tyrosine+kinase+inhibitor%2C+GW2016%2C+on+the+growth+of+human+normal+and+tumor-derived+cell+lines+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo</span></div><div class="casAuthors">Rusnak, David W.; Lackey, Karen; Affleck, Karen; Wood, Edgar R.; Alligood, Krystal J.; Rhodes, Nelson; Keith, Barry R.; Murray, Doris M.; Knight, W. Blaine; Mullin, Robert J.; Gilmer, Tona M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-94</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) and ErbB-2 transmembrane tyrosine kinases are currently being targeted by various mechanisms in the treatment of cancer.  GW2016 is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, resp.  This report describes the efficacy in cell growth assays of GW2016 on human tumor cell lines overexpressing either EGFR or ErbB-2: HN5 (head and neck), A-431 (vulva), BT474 (breast), CaLu-3 (lung), and N87 (gastric).  Normal human foreskin fibroblasts, nontumorigenic epithelial cells (HB4a), and nonoverexpressing tumor cells (MCF-7 and T47D) were tested as neg. controls.  After 3 days of compd. exposure, av. IC50 values for growth inhibition in the EGFR- and ErbB-2-overexpressing tumor cell lines were <0.16 μM.  The av. selectivity for the tumor cells vs. the human foreskin fibroblast cell line was 100-fold.  Inhibition of EGFR and ErbB-2 receptor autophosphorylation and phosphorylation of the downstream modulator, AKT, was verified by Western blot anal. in the BT474 and HN5 cell lines.  As a measure of cytotoxicity vs. growth arrest, the HN5 and BT474 cells were assessed in an outgrowth assay after a transient exposure to GW2016.  The cells were treated for 3 days in five concns. of GW2016, and cell growth was monitored for an addnl. 12 days after removal of the compd.  In each of these tumor cell lines, concns. of GW2016 were reached where outgrowth did not occur.  Furthermore, growth arrest and cell death were obsd. in parallel expts., as detd. by bromodeoxyuridine incorporation and propidium iodide staining.  GW2016 treatment inhibited tumor xenograft growth of the HN5 and BT474 cells in a dose-responsive manner at 30 and 100 mg/kg orally, twice daily, with complete inhibition of tumor growth at the higher dose.  Together, these results indicate that GW2016 achieves excellent potency on tumor cells with selectivity for tumor vs. normal cells and suggest that GW2016 has value as a therapy for patients with tumors overexpressing either EGFR or ErbB-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5OJ41zsWu6rVg90H21EOLACvtfcHk0ljNbJBjt-4xnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmtbs%253D&md5=64fd8cadce83eda3b9b82ab50f1e57b0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DLackey%26aufirst%3DK.%26aulast%3DAffleck%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DRhodes%26aufirst%3DN.%26aulast%3DKeith%26aufirst%3DB.%2BR.%26aulast%3DMurray%26aufirst%3DD.%2BM.%26aulast%3DKnight%26aufirst%3DW.%2BB.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26atitle%3DThe%2520effects%2520of%2520the%2520novel%252C%2520reversible%2520epidermal%2520growth%2520factor%2520receptor%252FErbB-2%2520tyrosine%2520kinase%2520inhibitor%252C%2520GW2016%252C%2520on%2520the%2520growth%2520of%2520human%2520normal%2520and%2520tumor-derived%2520cell%2520lines%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2001%26volume%3D1%26spage%3D85%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Petrov, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook, R. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K. E.</span><span> </span><span class="NLM_article-title">Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4686</span><span class="NLM_x">–</span> <span class="NLM_lpage">4691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2Fj.bmcl.2006.05.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=16777410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFOlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4686-4691&author=K.+G.+Petrovauthor=Y.+M.+Zhangauthor=M.+Carterauthor=G.+S.+Cockerillauthor=S.+Dickersonauthor=C.+A.+Gauthierauthor=Y.+Guoauthor=R.+A.+Mookauthor=D.+W.+Rusnakauthor=A.+L.+Walkerauthor=E.+R.+Woodauthor=K.+E.+Lackey&title=Optimization+and+SAR+for+dual+ErbB-1%2FErbB-2+tyrosine+kinase+inhibition+in+the+6-furanylquinazoline+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series</span></div><div class="casAuthors">Petrov, Kimberly G.; Zhang, Yue-Mei; Carter, Malcolm; Cockerill, G. Stuart; Dickerson, Scott; Gauthier, Cassandra A.; Guo, Yu; Mook, Robert A.; Rusnak, David W.; Walker, Ann L.; Wood, Edgar R.; Lackey, Karen E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4686-4691</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthetic modifications on a 6-furanylquinazoline scaffold to optimize the dual ErbB-1/ErbB-2 tyrosine kinase inhibition afforded consistent SAR whereby a 4-(3-fluorobenzyloxy)-3-haloanilino structure provided the best enzyme potency and cellular selectivity.  Changes made to the 6-furanyl group had little impact on the enzyme activity, but appeared to dramatically affect the cellular efficacy.  The discovery of lapatinib emerged from this work.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtejUjyH9in7Vg90H21EOLACvtfcHk0ljNbJBjt-4xnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFOlu7o%253D&md5=946712927ab1a7940ea3ef2fea7574b5</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.05.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.05.090%26sid%3Dliteratum%253Aachs%26aulast%3DPetrov%26aufirst%3DK.%2BG.%26aulast%3DZhang%26aufirst%3DY.%2BM.%26aulast%3DCarter%26aufirst%3DM.%26aulast%3DCockerill%26aufirst%3DG.%2BS.%26aulast%3DDickerson%26aufirst%3DS.%26aulast%3DGauthier%26aufirst%3DC.%2BA.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DLackey%26aufirst%3DK.%2BE.%26atitle%3DOptimization%2520and%2520SAR%2520for%2520dual%2520ErbB-1%252FErbB-2%2520tyrosine%2520kinase%2520inhibition%2520in%2520the%25206-furanylquinazoline%2520series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4686%26epage%3D4691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Affleck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubberfield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guntrip, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jowett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stables, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignola, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadwell, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reep, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span> </span><span class="NLM_article-title">The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">7196</span><span class="NLM_x">–</span> <span class="NLM_lpage">7203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=11585755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsVeht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=7196-7203&author=D.+W.+Rusnakauthor=K.+Affleckauthor=S.+G.+Cockerillauthor=C.+Stubberfieldauthor=R.+Harrisauthor=M.+Pageauthor=K.+J.+Smithauthor=S.+B.+Guntripauthor=M.+C.+Carterauthor=R.+J.+Shawauthor=A.+Jowettauthor=J.+Stablesauthor=P.+Topleyauthor=E.+R.+Woodauthor=P.+S.+Brignolaauthor=S.+H.+Kadwellauthor=B.+R.+Reepauthor=R.+J.+Mullinauthor=K.+J.+Alligoodauthor=B.+R.+Keithauthor=R.+M.+Crosbyauthor=D.+M.+Murrayauthor=W.+B.+Knightauthor=T.+M.+Gilmerauthor=K.+Lackey&title=The+characterization+of+novel%2C+dual+ErbB-2%2FEGFR%2C+tyrosine+kinase+inhibitors%3A+potential+therapy+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer</span></div><div class="casAuthors">Rusnak, David W.; Affleck, Karen; Cockerill, Stuart G.; Stubberfield, Colin; Harris, Robert; Page, Martin; Smith, Kathryn J.; Guntrip, Stephen B.; Carter, Malcolm C.; Shaw, Robert J.; Jowett, Amanda; Stables, Jeremy; Topley, Peter; Wood, Edgar R.; Brignola, Perry S.; Kadwell, Sue H.; Reep, Bryan R.; Mullin, Robert J.; Alligood, Krystal J.; Keith, Barry R.; Crosby, Renae M.; Murray, Doris M.; Knight, W. Blaine; Gilmer, Tona M.; Lackey, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7196-7203</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The type 1 receptor tyrosine kinases constitute a family of transmembrane proteins involved in various aspects of cell growth and survival and have been implicated in the initiation and progression of several types of human malignancies.  The best characterized of these proteins are the epidermal growth factor receptor (EGFR) and ErbB-2 (HER-2/neu).  We have developed potent quinazoline and pyrido-[3,4-d]-pyrimidine small mols. that are dual inhibitors of ErbB-2 and EGFR.  The compds. demonstrate potent in vitro inhibition of the ErbB-2 and EGFR kinase domains with IC50s <80 nM.  Growth of ErbB-2- and EGFR-expressing tumor cell lines is inhibited at concns. <0.5 μM.  Selectivity for tumor cell growth inhibition vs. normal human fibroblast growth inhibition ranges from 10- to >75-fold.  Tumor growth in mouse s.c. xenograft models of the BT474 and HN5 cell lines is inhibited in a dose-responsive manner using oral doses of 10 and 30 mg/kg twice per day.  In addn., the tested compds. caused a redn. of ErbB-2 and EGFR autophosphorylation in tumor fragments from these xenograft models.  These data indicate that these compds. have potential use as therapy in the broad population of cancer patients overexpressing ErbB-2 and/or EGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoifUxgOrEfMLVg90H21EOLACvtfcHk0lgoBP3_wQEVLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsVeht70%253D&md5=374cb1b4451356866a5060c5ff39a1d1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DAffleck%26aufirst%3DK.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DStubberfield%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DPage%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DGuntrip%26aufirst%3DS.%2BB.%26aulast%3DCarter%26aufirst%3DM.%2BC.%26aulast%3DShaw%26aufirst%3DR.%2BJ.%26aulast%3DJowett%26aufirst%3DA.%26aulast%3DStables%26aufirst%3DJ.%26aulast%3DTopley%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DBrignola%26aufirst%3DP.%2BS.%26aulast%3DKadwell%26aufirst%3DS.%2BH.%26aulast%3DReep%26aufirst%3DB.%2BR.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DKeith%26aufirst%3DB.%2BR.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DMurray%26aufirst%3DD.%2BM.%26aulast%3DKnight%26aufirst%3DW.%2BB.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DLackey%26aufirst%3DK.%26atitle%3DThe%2520characterization%2520of%2520novel%252C%2520dual%2520ErbB-2%252FEGFR%252C%2520tyrosine%2520kinase%2520inhibitors%253A%2520potential%2520therapy%2520for%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D7196%26epage%3D7203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, H.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C.</span><span> </span><span class="NLM_article-title">Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-<i>N</i>-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2000</span><span class="NLM_x">–</span> <span class="NLM_lpage">2009</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901453q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2000-2009&author=X.+Caiauthor=H.-X.+Zhaiauthor=J.+Wangauthor=J.+Forresterauthor=H.+Quauthor=L.+Yinauthor=C.-J.+Laiauthor=R.+Baoauthor=C.+Qian&title=Discovery+of+7-%284-%283-Ethynylphenylamino%29-7-methoxyquinazolin-6-yloxy%29-N-hydroxyheptanamide+%28CUDC-101%29+as+a+Potent+Multi-Acting+HDAC%2C+EGFR%2C+and+HER2+Inhibitor+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm901453q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901453q%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26aulast%3DZhai%26aufirst%3DH.-X.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DForrester%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DLai%26aufirst%3DC.-J.%26aulast%3DBao%26aufirst%3DR.%26aulast%3DQian%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25207-%25284-%25283-Ethynylphenylamino%2529-7-methoxyquinazolin-6-yloxy%2529-N-hydroxyheptanamide%2520%2528CUDC-101%2529%2520as%2520a%2520Potent%2520Multi-Acting%2520HDAC%252C%2520EGFR%252C%2520and%2520HER2%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2000%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eb1nCGNpZ6Ahbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Webster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, W. R.</span><span> </span><span class="NLM_article-title">Endocytosis by African trypanosomes. II. Occurrence in different life-cycle stages and intracellular sorting</span> <span class="citation_source-journal">Eur. J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=2776776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A280%3ADyaL1Mznsl2htg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1989&pages=303-310&author=P.+Websterauthor=W.+R.+Fish&title=Endocytosis+by+African+trypanosomes.+II.+Occurrence+in+different+life-cycle+stages+and+intracellular+sorting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Endocytosis by African trypanosomes. II. Occurrence in different life-cycle stages and intracellular sorting</span></div><div class="casAuthors">Webster P; Fish W R</div><div class="citationInfo"><span class="NLM_cas:title">European journal of cell biology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-10</span>
        ISSN:<span class="NLM_cas:issn">0171-9335</span>.
    </div><div class="casAbstract">Horseradish peroxidase (HRP) and colloidal gold-labeled proteins enter many of the endocytic organelles of bloodstream forms of Trypanosoma brucei and T. congolense.  However, the colloidal gold markers were excluded from substantial parts of the pathway that contained HRP.  Morphometric studies revealed that HRP entered organelles that accounted for approximately 5% of the total cell volume while transferrin-gold entered organelles that comprised approximately 2% of the total cell volume.  In addition, large colloidal gold particles were excluded from organelles that contained smaller gold particles.  Antibodies, raised against the variable surface glycoprotein, when applied to thawed cryosections were found to label structures from which endocytosed colloidal gold coupled to bovine serum albumin (BSA) was excluded.  Endocytosis was shown to occur in two in vitro propagated forms of trypanosomes, similar to those found in the insect vector (Glossina spp.).  The mammal-infective metacyclic forms were similar to bloodstream forms in that they endocytosed HRP and colloidal gold markers but excluded colloidal gold from approximately 3% of the endocytic organelles.  Estimation of the flagellar pocket volumes of bloodstream form T. brucei showed that this organelle occupied 0.5% to 1.4% of the total cell volume.  The flagellar pocket volume of T. congolense varied between life-cycle stages, with a fractional volume of 4.4% for bloodstream forms, 2.3% for metacyclic forms and 1.4% for procyclic forms.  Endocytosis of HRP, but not of protein-gold markers, occurred in procyclic (uncoated) forms.  Endocytosis by procyclic forms has heretofore not been reported.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTJRIcIfUNTGlSCSgBhwJFfW6udTcc2ebj2XzOcvs1f7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1Mznsl2htg%253D%253D&md5=a90995c0c5ebcf04068d1ce34f6c5b7b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWebster%26aufirst%3DP.%26aulast%3DFish%26aufirst%3DW.%2BR.%26atitle%3DEndocytosis%2520by%2520African%2520trypanosomes.%2520II.%2520Occurrence%2520in%2520different%2520life-cycle%2520stages%2520and%2520intracellular%2520sorting%26jtitle%3DEur.%2520J.%2520Cell%2520Biol.%26date%3D1989%26volume%3D49%26spage%3D303%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Hall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, M. C.</span><span> </span><span class="NLM_article-title">Both of the Rab5 subfamily small GTPases of <i>Trypanosoma brucei</i> are essential and required for endocytosis</span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2Fj.molbiopara.2004.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=15500917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovV2iu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2004&pages=67-77&author=B.+Hallauthor=C.+L.+Allenauthor=D.+Gouldingauthor=M.+C.+Field&title=Both+of+the+Rab5+subfamily+small+GTPases+of+Trypanosoma+brucei+are+essential+and+required+for+endocytosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Both of the Rab5 subfamily small GTPases of Trypanosoma brucei are essential and required for endocytosis</span></div><div class="casAuthors">Hall, Belinda; Allen, Clare L.; Goulding, David; Field, Mark C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-77</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Endocytosis is an essential process in Trypanosoma brucei, and all evidence suggests it is exclusively clathrin-mediated.  The trypanosome genome encodes two Rab5 proteins, small GTPases that play a role in very early stages of endocytosis.  In the mammalian bloodstream stage, TbRAB5A localizes to compartments contg. internalized antibody, variant surface glycoprotein (VSG) and transferrin, while TbRAB5B localizes to compartments contg. the transmembrane protein ISG100.  Dominant-active forms of TbRAB5A stimulate endocytosis in procyclic forms and alter the kinetics of anti-VSG antibody and transferrin turnover in bloodstream stages.  Similar mutants of TbRAB5B increase fluid phase uptake in procyclic cells but do not significantly affect endocytosis in bloodstream forms.  Here, the authors use RNA interference to evaluate the relative importance of TbRAB5A and TbRAB5B and show that both GTPases are essential in the bloodstream form.  Depletion of either TbRAB5A or TbRAB5B results in morphol. abnormalities, including enlargement of the flagellar pocket, consistent with a potent block to endocytosis.  Also, RNAi compromises transferrin accumulation in both cases but induces distinct patterns of mislocalization of endosomal markers.  Finally, RNAi of either TbRAB5A or TbRAB5B results in a decrease in levels of clathrin.  These data indicate that both TbRAB5A and TbRAB5B are required for endocytosis in trypanosomes and demonstrate that there are multiple essential endocytic routes in this organism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooc53lbbDSB7Vg90H21EOLACvtfcHk0lhaU7Xi9jl77A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovV2iu7o%253D&md5=700e2296f179bb8e9421c12c4fbef86f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2004.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2004.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DB.%26aulast%3DAllen%26aufirst%3DC.%2BL.%26aulast%3DGoulding%26aufirst%3DD.%26aulast%3DField%26aufirst%3DM.%2BC.%26atitle%3DBoth%2520of%2520the%2520Rab5%2520subfamily%2520small%2520GTPases%2520of%2520Trypanosoma%2520brucei%2520are%2520essential%2520and%2520required%2520for%2520endocytosis%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2004%26volume%3D138%26spage%3D67%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Hammarton, T. C.</span><span> </span><span class="NLM_article-title">Cell cycle regulation in <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2Fj.molbiopara.2007.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=17335918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFaltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2007&pages=1-8&author=T.+C.+Hammarton&title=Cell+cycle+regulation+in+Trypanosoma+brucei"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle regulation in Trypanosoma brucei</span></div><div class="casAuthors">Hammarton, Tansy C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cell division is regulated by intricate and interconnected signal transduction pathways that precisely coordinate, in time and space, the complex series of events involved in replicating and segregating the component parts of the cell.  In Trypanosoma brucei, considerable progress has been made over recent years in identifying mol. regulators of the cell cycle and elucidating their functions, although many regulators undoubtedly remain to be identified, and there is still a long way to go with respect to detg. signal transduction pathways.  However, it is clear that cell cycle regulation in T. brucei is unusual in many respects.  Analyses of trypanosome orthologs of conserved eukaryotic cell cycle regulators have demonstrated divergence of their function in the parasite, and a no. of other key regulators are missing from T. brucei.  Cell cycle regulation differs in different parasite life cycle stages, and T. brucei appears to use different checkpoint control strategies compared to model eukaryotes.  It is therefore probable that T. brucei has evolved novel pathways to control its cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiOO78xMMvWrVg90H21EOLACvtfcHk0lhaU7Xi9jl77A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFaltLk%253D&md5=c0c5a4804d3d60e2d2c7ec12279045b8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2007.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2007.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DHammarton%26aufirst%3DT.%2BC.%26atitle%3DCell%2520cycle%2520regulation%2520in%2520Trypanosoma%2520brucei%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2007%26volume%3D153%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Siegel, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hekstra, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, G. A.</span><span> </span><span class="NLM_article-title">Analysis of the <i>Trypanosoma brucei</i> cell cycle by quantitative DAPI imaging</span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2Fj.molbiopara.2008.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=18501977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Sntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2008&pages=171-174&author=T.+N.+Siegelauthor=D.+R.+Hekstraauthor=G.+A.+Cross&title=Analysis+of+the+Trypanosoma+brucei+cell+cycle+by+quantitative+DAPI+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the Trypanosoma brucei cell cycle by quantitative DAPI imaging</span></div><div class="casAuthors">Siegel, T. Nicolai; Hekstra, Doeke R.; Cross, George A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-174</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Trypanosoma brucei has two DNA compartments: the nucleus and the kinetoplast.  DNA replication of these two compartments only partially coincides.  Woodward and Gull comprehensively studied the relative timing of the replication and segregation of nuclear DNA (nDNA) and kinetoplast DNA (kDNA).  Others have since assumed the consistency of morphol. indicators of cell-cycle stage among strains and conditions.  We report the use of quant. DAPI imaging to det. the cell-cycle stage of individual procyclic cells.  Using this approach, we found that kinetoplast elongation occurs mainly during nuclear S phase and not during G2, as previously assumed.  We confirmed this finding by sorting cells by DNA content, followed by fluorescence microscopy.  In addn., simultaneous quant. imaging at two wavelengths can be used to det. the abundance of cell-cycle-regulated proteins during the cell cycle.  We demonstrate this technique by co-staining for the non-acetylated state of lysine 4 of histone H4 (H4K4), which is enriched during nuclear S phase.  The imaging program imageJ is available at http://rsb.info.nih.gov/ij/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWKvCmTEJRLVg90H21EOLACvtfcHk0liaYP_WrbCMIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1Sntbw%253D&md5=72f28e288bb773ed9ec20b5f9097b669</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2008.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2008.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DT.%2BN.%26aulast%3DHekstra%26aufirst%3DD.%2BR.%26aulast%3DCross%26aufirst%3DG.%2BA.%26atitle%3DAnalysis%2520of%2520the%2520Trypanosoma%2520brucei%2520cell%2520cycle%2520by%2520quantitative%2520DAPI%2520imaging%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2008%26volume%3D160%26spage%3D171%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hammarton, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnerat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mottram, J. C.</span><span> </span><span class="NLM_article-title">Cytokinesis in trypanosomatids</span> <span class="citation_source-journal">Curr. Opin. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2Fj.mib.2007.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=18023244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlyksrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=520-527&author=T.+C.+Hammartonauthor=S.+Monneratauthor=J.+C.+Mottram&title=Cytokinesis+in+trypanosomatids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokinesis in trypanosomatids</span></div><div class="casAuthors">Hammarton, Tansy C.; Monnerat, Severine; Mottram, Jeremy C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">520-527</span>CODEN:
                <span class="NLM_cas:coden">COMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1369-5274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The process of cytokinesis, where the cytoplasm of one cell is divided to produce two daughter cells, is intricate in trypanosomatids because of the requirement to replicate and segregate a no. of single copy organelles, including the nucleus, kinetoplast, Golgi app., and flagellum.  Identifying regulators of the three stages of cytokinesis, initiation, furrow ingression, and abscission is complicated by the fact that cell division in trypanosomatids is easily perturbed and aberrant cells are readily produced during functional characterization of gene products.  In this review, we discuss direct and indirect effects on cytokinesis, using Trypanosoma brucei as a model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAMwdXHP2rl7Vg90H21EOLACvtfcHk0liaYP_WrbCMIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlyksrbF&md5=0411333499cfc5ecb8d79ea30c552213</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.mib.2007.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mib.2007.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DHammarton%26aufirst%3DT.%2BC.%26aulast%3DMonnerat%26aufirst%3DS.%26aulast%3DMottram%26aufirst%3DJ.%2BC.%26atitle%3DCytokinesis%2520in%2520trypanosomatids%26jtitle%3DCurr.%2520Opin.%2520Microbiol.%26date%3D2007%26volume%3D10%26spage%3D520%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Mackey, Z. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baca, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallari, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansell, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span> </span><span class="NLM_article-title">Discovery of trypanocidal compounds by whole cell HTS of <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1111%2Fj.1747-0285.2006.00389.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=16784460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVeqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=355-363&author=Z.+B.+Mackeyauthor=A.+M.+Bacaauthor=J.+P.+Mallariauthor=B.+Apselauthor=A.+Shelatauthor=E.+J.+Hansellauthor=P.+K.+Chiangauthor=B.+Wolffauthor=K.+R.+Guyauthor=J.+Williamsauthor=J.+H.+McKerrow&title=Discovery+of+trypanocidal+compounds+by+whole+cell+HTS+of+Trypanosoma+brucei"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei</span></div><div class="casAuthors">Mackey, Zachary B.; Baca, Arthur M.; Mallari, Jeremy P.; Apsel, Beth; Shelat, Anang; Hansell, Elizabeth J.; Chiang, Peter K.; Wolff, Brian; Guy, Kiplin R.; Williams, Janice; McKerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">355-363</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Chemotherapy against human African trypanosomiasis relies on four drugs that cause frequent and occasionally severe side-effects.  Because human African trypanosomiasis is a disease of poor people in Africa, the traditional market-driven pathways to drug development are not available.  One potentially rapid and cost-effective approach to identifying and developing new trypanocidal drugs would be high throughput-screening of existing drugs already approved for other uses, as well as clin. candidates in late development.  The authors have developed an ATP-bioluminescence assay that could be used to rapidly and efficiently screen compd. libraries against trypanosomes in a high throughput-screening format to validate this notion.  They screened a collection of 2160 FDA-approved drugs, bioactive compds. and natural products to identify hits that were cytotoxic to cultured Trypanosoma brucei at a concn. of 1 μM or less.  This meant that any hit identified would be effective at a concn. readily achievable by std. drug dosing in humans.  From the screen, 35 hits from seven different drug categories were identified.  These included the two approved trypanocidal drugs, suramin and pentamidine, several other drugs suspected but never validated as trypanocidal, and 17 novel trypanocidal drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe74ryTulvdrVg90H21EOLACvtfcHk0liaYP_WrbCMIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVeqsbo%253D&md5=5b61478d2b9c3e22924e42af51ffb31f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2006.00389.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2006.00389.x%26sid%3Dliteratum%253Aachs%26aulast%3DMackey%26aufirst%3DZ.%2BB.%26aulast%3DBaca%26aufirst%3DA.%2BM.%26aulast%3DMallari%26aufirst%3DJ.%2BP.%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DShelat%26aufirst%3DA.%26aulast%3DHansell%26aufirst%3DE.%2BJ.%26aulast%3DChiang%26aufirst%3DP.%2BK.%26aulast%3DWolff%26aufirst%3DB.%26aulast%3DGuy%26aufirst%3DK.%2BR.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DDiscovery%2520of%2520trypanocidal%2520compounds%2520by%2520whole%2520cell%2520HTS%2520of%2520Trypanosoma%2520brucei%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D355%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+Desirable+Central+Nervous+System+Drug+Space+through+the+Alignment+of+Molecular+Properties%2C+in+Vitro+ADME%2C+and+Safety+Attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0ljXvYLTOBZBew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520Desirable%2520Central%2520Nervous%2520System%2520Drug%2520Space%2520through%2520the%2520Alignment%2520of%2520Molecular%2520Properties%252C%2520in%2520Vitro%2520ADME%252C%2520and%2520Safety%2520Attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+To+Enable+Alignment+of+Druglike+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0ljXvYLTOBZBew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520To%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Iino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span> </span><span class="NLM_article-title">Discovery and structure–activity relationships of a novel class of quinazoline glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5531</span><span class="NLM_x">–</span> <span class="NLM_lpage">5538</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5531-5538&author=T.+Iinoauthor=Y.+Sasakiauthor=M.+Bambaauthor=M.+Mitsuyaauthor=A.+Ohnoauthor=K.+Kamataauthor=H.+Hosakaauthor=H.+Marukiauthor=M.+Futamuraauthor=R.+Yoshimotoauthor=S.+Ohyamaauthor=K.+Sasakiauthor=M.+Chibaauthor=N.+Ohtakeauthor=Y.+Nagataauthor=J.-i.+Eikiauthor=T.+Nishimura&title=Discovery+and+structure%E2%80%93activity+relationships+of+a+novel+class+of+quinazoline+glucokinase+activators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIino%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DBamba%26aufirst%3DM.%26aulast%3DMitsuya%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DA.%26aulast%3DKamata%26aufirst%3DK.%26aulast%3DHosaka%26aufirst%3DH.%26aulast%3DMaruki%26aufirst%3DH.%26aulast%3DFutamura%26aufirst%3DM.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DOhtake%26aufirst%3DN.%26aulast%3DNagata%26aufirst%3DY.%26aulast%3DEiki%26aufirst%3DJ.-i.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520a%2520novel%2520class%2520of%2520quinazoline%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5531%26epage%3D5538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Mahboobi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichhorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongratz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span> </span><span class="NLM_article-title">Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrids as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8546</span><span class="NLM_x">–</span> <span class="NLM_lpage">8555</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100665z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8546-8555&author=S.+Mahboobiauthor=A.+Sellmerauthor=M.+Winklerauthor=E.+Eichhornauthor=H.+Pongratzauthor=T.+Ciossekauthor=T.+Baerauthor=T.+Maierauthor=T.+Beckers&title=Novel+Chimeric+Histone+Deacetylase+Inhibitors%3A+A+Series+of+Lapatinib+Hybrids+as+Potent+Inhibitors+of+Epidermal+Growth+Factor+Receptor+%28EGFR%29%2C+Human+Epidermal+Growth+Factor+Receptor+2+%28HER2%29%2C+and+Histone+Deacetylase+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm100665z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100665z%26sid%3Dliteratum%253Aachs%26aulast%3DMahboobi%26aufirst%3DS.%26aulast%3DSellmer%26aufirst%3DA.%26aulast%3DWinkler%26aufirst%3DM.%26aulast%3DEichhorn%26aufirst%3DE.%26aulast%3DPongratz%26aufirst%3DH.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DBaer%26aufirst%3DT.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DBeckers%26aufirst%3DT.%26atitle%3DNovel%2520Chimeric%2520Histone%2520Deacetylase%2520Inhibitors%253A%2520A%2520Series%2520of%2520Lapatinib%2520Hybrids%2520as%2520Potent%2520Inhibitors%2520of%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528EGFR%2529%252C%2520Human%2520Epidermal%2520Growth%2520Factor%2520Receptor%25202%2520%2528HER2%2529%252C%2520and%2520Histone%2520Deacetylase%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8546%26epage%3D8555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Hirumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirumi, K.</span><span> </span><span class="NLM_article-title">Axenic culture of African trypanosome bloodstream forms</span> <span class="citation_source-journal">Parasitol. Today.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2F0169-4758%2894%2990402-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=15275508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A280%3ADC%252BD2cznsVKktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1994&pages=80-84&author=H.+Hirumiauthor=K.+Hirumi&title=Axenic+culture+of+African+trypanosome+bloodstream+forms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Axenic culture of African trypanosome bloodstream forms</span></div><div class="casAuthors">Hirumi H; Hirumi K</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology today (Personal ed.)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">80-4</span>
        ISSN:<span class="NLM_cas:issn">0169-4758</span>.
    </div><div class="casAbstract">In this article, Hiroyuki Hirumi and Kazuko Hirumi review recent technical developments of in vitro systems that support the growth of bloodstream forms of African trypanosomes in the absence of mammalian feeder layer cells, which were required in earlier methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTTzbk2bNA7hFwe7cAcrfPfW6udTcc2eYeaWobJXpAm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cznsVKktQ%253D%253D&md5=0df2e001948ddaa4f2c114d9beef19e8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0169-4758%2894%2990402-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0169-4758%252894%252990402-2%26sid%3Dliteratum%253Aachs%26aulast%3DHirumi%26aufirst%3DH.%26aulast%3DHirumi%26aufirst%3DK.%26atitle%3DAxenic%2520culture%2520of%2520African%2520trypanosome%2520bloodstream%2520forms%26jtitle%3DParasitol.%2520Today.%26date%3D1994%26volume%3D10%26spage%3D80%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Ferrari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornasiero, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isetta, A. M.</span><span> </span><span class="NLM_article-title">MTT colorimetric assay for testing macrophage cytotoxic activity in vitro</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2F0022-1759%2890%2990187-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=2391427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADyaK3cXmtV2nsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=1990&pages=165-172&author=M.+Ferrariauthor=M.+C.+Fornasieroauthor=A.+M.+Isetta&title=MTT+colorimetric+assay+for+testing+macrophage+cytotoxic+activity+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">MTT colorimetric assay for testing macrophage cytotoxic activity in vitro</span></div><div class="casAuthors">Ferrari, Mario; Fornasiero, Maria Chiara; Isetta, Anna Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-72</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">The MTT [3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide] cleavage assay, originally described by T. Mosmann (1983) for measuring cell survival/proliferation, was used successfully to quantitate macrophage-mediated cytotoxicity.  Peritoneal macrophages, from control or pyran copolymer MVE2-treated mice and from TU5 and L929 murine cell lines, were used as effectors and targets resp. in a 48 h cytotoxicity test, at 3 effector: target ratios (10:1, 5:1, 2:1).  The amt. of MTT reduced by cells to its blue formazan deriv. during an addnl. 4 h of culture was quantified spectrophotometrically at 570 nm using an ELISA reader.  A linear relationship between the formazan generated and the no. of viable TU5 and L929 cells was demonstrated, together with time-dependent growth characteristics for these cells.  The formazan produced by macrophages was independent of their functional state and did not interfere with the target cell signal.  MVE2-activated macrophages strongly inhibited the survival/growth of target cells in a dose-related way, whereas the cytotoxic activity of control macrophages was very low.  Finally, the MTT method compared favorably with the 3H-TdR uptake method in evaluating macrophage cytotoxicity, and both of them were more sensitive than the 3H-TdR release assay.  The MTT cleavage method is a useful alternative to radioisotopic methods for quantitating macrophage cytotoxicity for actively growing in vitro targets.  Its main advantages are: (a) sensitivity and reproducibility; (b) elimination of the need for radioactive compds.; (c) ease with which it can be performed and quantified; and (d) rapidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrezxA3w4p2ebVg90H21EOLACvtfcHk0ljdhM_zpssW-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtV2nsLo%253D&md5=e0b83e032dccb6f10faa9fc8a8ca16ce</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2890%2990187-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252890%252990187-Z%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DM.%26aulast%3DFornasiero%26aufirst%3DM.%2BC.%26aulast%3DIsetta%26aufirst%3DA.%2BM.%26atitle%3DMTT%2520colorimetric%2520assay%2520for%2520testing%2520macrophage%2520cytotoxic%2520activity%2520in%2520vitro%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1990%26volume%3D131%26spage%3D165%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Sykes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moawad, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganame, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioset, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span> </span><span class="NLM_article-title">Identification of Compounds with Anti-Proliferative Activity against <i>Trypanosoma brucei brucei</i> Strain 427 by a Whole Cell Viability Based HTS Campaign</span> <span class="citation_source-journal">PLoS Negl. Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1896</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=e1896&author=M.+L.+Sykesauthor=J.+B.+Baellauthor=M.+Kaiserauthor=E.+Chatelainauthor=S.+R.+Moawadauthor=D.+Ganameauthor=J.-R.+Iosetauthor=V.+M.+Avery&title=Identification+of+Compounds+with+Anti-Proliferative+Activity+against+Trypanosoma+brucei+brucei+Strain+427+by+a+Whole+Cell+Viability+Based+HTS+Campaign"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DMoawad%26aufirst%3DS.%2BR.%26aulast%3DGaname%26aufirst%3DD.%26aulast%3DIoset%26aufirst%3DJ.-R.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26atitle%3DIdentification%2520of%2520Compounds%2520with%2520Anti-Proliferative%2520Activity%2520against%2520Trypanosoma%2520brucei%2520brucei%2520Strain%2520427%2520by%2520a%2520Whole%2520Cell%2520Viability%2520Based%2520HTS%2520Campaign%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2012%26volume%3D6%26spage%3De1896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Sokolova, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyllie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oza, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlamb, A. H.</span><span> </span><span class="NLM_article-title">Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2893</span><span class="NLM_x">–</span> <span class="NLM_lpage">2900</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1128%2FAAC.00332-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=20439607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVeltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=2893-2900&author=A.+Y.+Sokolovaauthor=S.+Wyllieauthor=S.+Pattersonauthor=S.+L.+Ozaauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=Cross-resistance+to+nitro+drugs+and+implications+for+treatment+of+human+African+trypanosomiasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis</span></div><div class="casAuthors">Sokolova, Antoaneta Y.; Wyllie, Susan; Patterson, Stephen; Oza, Sandra L.; Read, Kevin D.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2893-2900</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The success of nifurtimox-eflornithine combination therapy (NECT) for the treatment of human African trypanosomiasis (HAT) has renewed interest in the potential of nitro drugs as chemotherapeutics.  In order to study the implications of the more widespread use of nitro drugs against these parasites, we examd. the in vivo and in vitro resistance potentials of nifurtimox and fexinidazole and its metabolites.  Following selection in vitro by exposure to increasing concns. of nifurtimox, Trypanosoma brucei brucei nifurtimox-resistant clones designated NfxR1 and NfxR2 were generated.  Both cell lines were found to be 8-fold less sensitive to nifurtimox than parental cells and demonstrated cross-resistance to a no. of other nitro drugs, most notably the clin. trial candidate fexinidazole (∼27-fold more resistant than parental cells).  Studies of mice confirmed that the generation of nifurtimox resistance in these parasites did not compromise virulence, and NfxR1 remained resistant to both nifurtimox and fexinidazole in vivo.  In the case of fexinidazole, drug metab. and pharmacokinetic studies indicate that the parent drug is rapidly metabolized to the sulfoxide and sulfone form of this compd.  These metabolites retained trypanocidal activity but were less effective in nifurtimox-resistant lines.  Significantly, trypanosomes selected for resistance to fexinidazole were 10-fold more resistant to nifurtimox than parental cells.  This reciprocal cross-resistance has important implications for the therapeutic use of nifurtimox in a clin. setting and highlights a potential danger in the use of fexinidazole as a monotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpwMvjfLmRaLVg90H21EOLACvtfcHk0ljdhM_zpssW-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVeltrY%253D&md5=3e34cfad24c02c4f41f5289b30fd9ad5</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1128%2FAAC.00332-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00332-10%26sid%3Dliteratum%253Aachs%26aulast%3DSokolova%26aufirst%3DA.%2BY.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DOza%26aufirst%3DS.%2BL.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DCross-resistance%2520to%2520nitro%2520drugs%2520and%2520implications%2520for%2520treatment%2520of%2520human%2520African%2520trypanosomiasis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D2893%26epage%3D2900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Jacobs, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nare, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sligar, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenks, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noe, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowling, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewerts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaukel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randolph, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacchi, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarlett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Don, R.</span><span> </span><span class="NLM_article-title">SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis</span> <span class="citation_source-journal">PLoS Negl. Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=e1151&author=R.+T.+Jacobsauthor=B.+Nareauthor=S.+A.+Wringauthor=M.+D.+Orrauthor=D.+Chenauthor=J.+M.+Sligarauthor=M.+X.+Jenksauthor=R.+A.+Noeauthor=T.+S.+Bowlingauthor=L.+T.+Mercerauthor=C.+Rewertsauthor=E.+Gaukelauthor=J.+Owensauthor=R.+Parhamauthor=R.+Randolphauthor=B.+Beaudetauthor=C.+J.+Bacchiauthor=N.+Yarlettauthor=J.+J.+Plattnerauthor=Y.+Freundauthor=C.+Dingauthor=T.+Akamaauthor=Y.+K.+Zhangauthor=R.+Brunauthor=M.+Kaiserauthor=I.+Scandaleauthor=R.+Don&title=SCYX-7158%2C+an+Orally-Active+Benzoxaborole+for+the+Treatment+of+Stage+2+Human+African+Trypanosomiasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DOrr%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DSligar%26aufirst%3DJ.%2BM.%26aulast%3DJenks%26aufirst%3DM.%2BX.%26aulast%3DNoe%26aufirst%3DR.%2BA.%26aulast%3DBowling%26aufirst%3DT.%2BS.%26aulast%3DMercer%26aufirst%3DL.%2BT.%26aulast%3DRewerts%26aufirst%3DC.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DOwens%26aufirst%3DJ.%26aulast%3DParham%26aufirst%3DR.%26aulast%3DRandolph%26aufirst%3DR.%26aulast%3DBeaudet%26aufirst%3DB.%26aulast%3DBacchi%26aufirst%3DC.%2BJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DDon%26aufirst%3DR.%26atitle%3DSCYX-7158%252C%2520an%2520Orally-Active%2520Benzoxaborole%2520for%2520the%2520Treatment%2520of%2520Stage%25202%2520Human%2520African%2520Trypanosomiasis%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2011%26volume%3D5%26spage%3De1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 51 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Baljinder Singh, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, Domingo I. Rojas-Barros, Naresh Gunaganti, Kirsten Gillingwater, Maria Santos Martinez-Martinez, Pilar Manzano, Miguel Navarro, <span class="NLM_string-name hlFld-ContribAuthor">Michael P. Pollastri</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry Optimization of a Diaminopurine Chemotype: Toward a Lead for Trypanosoma brucei Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9912-9927. <a href="https://doi.org/10.1021/acs.jmedchem.0c01017" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252BChemistry%252BOptimization%252Bof%252Ba%252BDiaminopurine%252BChemotype%25253A%252BToward%252Ba%252BLead%252Bfor%252BTrypanosoma%252Bbrucei%252BInhibitors%26aulast%3DSingh%26aufirst%3DBaljinder%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18062020%26date%3D13082020%26date%3D30072020%26volume%3D63%26issue%3D17%26spage%3D9912%26epage%3D9927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Melissa J. Buskes, Monica Clements, Kelly A. Bachovchin, Hitesh B. Jalani, Allison Leonard, Seema Bag, Dana M. Klug, Baljinder Singh, Robert F. Campbell, Richard J. Sciotti, Nelly El-Sakkary, Conor R. Caffrey, Michael P. Pollastri, <span class="NLM_string-name hlFld-ContribAuthor">Lori Ferrins</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Bioactivity Relationships of Lapatinib Derived Analogs against Schistosoma mansoni. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 258-265. <a href="https://doi.org/10.1021/acsmedchemlett.9b00455" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00455%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Bioactivity%252BRelationships%252Bof%252BLapatinib%252BDerived%252BAnalogs%252Bagainst%252BSchistosoma%252Bmansoni%26aulast%3DBuskes%26aufirst%3DMelissa%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D01102019%26date%3D10012020%26date%3D22012020%26date%3D10012020%26volume%3D11%26issue%3D3%26spage%3D258%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kelly
A. Bachovchin, Amrita Sharma, Seema Bag, Dana M. Klug, Katherine M. Schneider, Baljinder Singh, Hitesh B. Jalani, Melissa J. Buskes, Naimee Mehta, Scott Tanghe, Jeremiah D. Momper, Richard J. Sciotti, Ana Rodriguez, Kojo Mensa-Wilmot, Michael P. Pollastri, <span class="NLM_string-name hlFld-ContribAuthor">Lori Ferrins</span>. </span><span class="cited-content_cbyCitation_article-title">Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 665-687. <a href="https://doi.org/10.1021/acs.jmedchem.8b01365" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01365</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01365%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImprovement%252Bof%252BAqueous%252BSolubility%252Bof%252BLapatinib-Derived%252BAnalogues%25253A%252BIdentification%252Bof%252Ba%252BQuinolinimine%252BLead%252Bfor%252BHuman%252BAfrican%252BTrypanosomiasis%252BDrug%252BDevelopment%26aulast%3DBachovchin%26aufirst%3DKelly%2BA.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D31082018%26date%3D10012019%26date%3D19122018%26volume%3D62%26issue%3D2%26spage%3D665%26epage%3D687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jennifer
L. Woodring, Ranjan Behera, Amrita Sharma, Justin Wiedeman, Gautam Patel, Baljinder Singh, Paul Guyett, Emanuele Amata, Jessey Erath, Norma Roncal, Erica Penn, Susan E. Leed, Ana Rodriguez, Richard J. Sciotti, Kojo Mensa-Wilmot, <span class="NLM_string-name hlFld-ContribAuthor">Michael P. Pollastri</span>. </span><span class="cited-content_cbyCitation_article-title">Series of Alkynyl-Substituted Thienopyrimidines as Inhibitors of Protozoan Parasite Proliferation. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (10)
                                     , 996-1001. <a href="https://doi.org/10.1021/acsmedchemlett.8b00245" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00245%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSeries%252Bof%252BAlkynyl-Substituted%252BThienopyrimidines%252Bas%252BInhibitors%252Bof%252BProtozoan%252BParasite%252BProliferation%26aulast%3DWoodring%26aufirst%3DJennifer%2BL.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D29052018%26date%3D04092018%26date%3D07092018%26date%3D04092018%26volume%3D9%26issue%3D10%26spage%3D996%26epage%3D1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Naimee Mehta, Lori Ferrins, Susan E. Leed, Richard J. Sciotti, <span class="NLM_string-name hlFld-ContribAuthor">Michael P. Pollastri</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Physicochemical Properties for 4-Anilinoquinoline Inhibitors of Plasmodium falciparum Proliferation. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2018,</strong> <em>4 </em>
                                    (4)
                                     , 577-591. <a href="https://doi.org/10.1021/acsinfecdis.7b00212" title="DOI URL">https://doi.org/10.1021/acsinfecdis.7b00212</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.7b00212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.7b00212%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DOptimization%252Bof%252BPhysicochemical%252BProperties%252Bfor%252B4-Anilinoquinoline%252BInhibitors%252Bof%252BPlasmodium%252Bfalciparum%252BProliferation%26aulast%3DMehta%26aufirst%3DNaimee%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D02112017%26date%3D17012018%26date%3D04012018%26volume%3D4%26issue%3D4%26spage%3D577%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Devine</span>, <span class="hlFld-ContribAuthor ">Sarah M.  Thomas</span>, <span class="hlFld-ContribAuthor ">Jessey  Erath</span>, <span class="hlFld-ContribAuthor ">Kelly A.  Bachovchin</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Lee</span>, <span class="hlFld-ContribAuthor ">Susan E.  Leed</span>, <span class="hlFld-ContribAuthor ">Ana  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Richard J.  Sciotti</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>, and <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>  . </span><span class="cited-content_cbyCitation_article-title">Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan Parasites. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 350-354. <a href="https://doi.org/10.1021/acsmedchemlett.7b00011" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00011%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAntiparasitic%252BLead%252BDiscovery%25253A%252BToward%252BOptimization%252Bof%252Ba%252BChemotype%252Bwith%252BActivity%252BAgainst%252BMultiple%252BProtozoan%252BParasites%26aulast%3DDevine%26aufirst%3DWilliam%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D09012017%26date%3D05022017%26date%3D20022017%26date%3D09032017%26date%3D05022017%26volume%3D8%26issue%3D3%26spage%3D350%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciancetta</span>, <span class="hlFld-ContribAuthor ">Eugene  Warnick</span>, <span class="hlFld-ContribAuthor ">Steven  Crane</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, and <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Scaffold Repurposing for G Protein-Coupled Receptors: Transformation of Adenosine Derivatives into 5HT2B/5HT2C Serotonin Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (24)
                                     , 11006-11026. <a href="https://doi.org/10.1021/acs.jmedchem.6b01183" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01183%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BScaffold%252BRepurposing%252Bfor%252BG%252BProtein-Coupled%252BReceptors%25253A%252BTransformation%252Bof%252BAdenosine%252BDerivatives%252Binto%252B5HT2B%25252F5HT2C%252BSerotonin%252BReceptor%252BAntagonists%26aulast%3DTosh%26aufirst%3DDilip%2BK.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D05082016%26date%3D09122016%26date%3D22122016%26volume%3D59%26issue%3D24%26spage%3D11006%26epage%3D11026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephanie  Russell</span>, <span class="hlFld-ContribAuthor ">Raphaël  Rahmani</span>, <span class="hlFld-ContribAuthor ">Amy J.  Jones</span>, <span class="hlFld-ContribAuthor ">Harriet L.  Newson</span>, <span class="hlFld-ContribAuthor ">Kevin  Neilde</span>, <span class="hlFld-ContribAuthor ">Ignacio  Cotillo</span>, <span class="hlFld-ContribAuthor ">Marzieh  Rahmani Khajouei</span>, <span class="hlFld-ContribAuthor ">Lori  Ferrins</span>, <span class="hlFld-ContribAuthor ">Sana  Qureishi</span>, <span class="hlFld-ContribAuthor ">Nghi  Nguyen</span>, <span class="hlFld-ContribAuthor ">Maria S.  Martinez-Martinez</span>, <span class="hlFld-ContribAuthor ">Donald F.  Weaver</span>, <span class="hlFld-ContribAuthor ">Marcel  Kaiser</span>, <span class="hlFld-ContribAuthor ">Jennifer  Riley</span>, <span class="hlFld-ContribAuthor ">John  Thomas</span>, <span class="hlFld-ContribAuthor ">Manu  De Rycker</span>, <span class="hlFld-ContribAuthor ">Kevin D.  Read</span>, <span class="hlFld-ContribAuthor ">Gavin R.  Flematti</span>, <span class="hlFld-ContribAuthor ">Eileen  Ryan</span>, <span class="hlFld-ContribAuthor ">Scott  Tanghe</span>, <span class="hlFld-ContribAuthor ">Ana  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Susan A.  Charman</span>, <span class="hlFld-ContribAuthor ">Albane  Kessler</span>, <span class="hlFld-ContribAuthor ">Vicky M.  Avery</span>, <span class="hlFld-ContribAuthor ">Jonathan B.  Baell</span>, and <span class="hlFld-ContribAuthor ">Matthew J.  Piggott</span>  . </span><span class="cited-content_cbyCitation_article-title">Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (21)
                                     , 9686-9720. <a href="https://doi.org/10.1021/acs.jmedchem.6b00442" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00442%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHit-to-Lead%252BOptimization%252Bof%252Ba%252BNovel%252BClass%252Bof%252BPotent%25252C%252BBroad-Spectrum%252BTrypanosomacides%26aulast%3DRussell%26aufirst%3DStephanie%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26032016%26date%3D19092016%26date%3D10112016%26date%3D22082016%26volume%3D59%26issue%3D21%26spage%3D9686%26epage%3D9720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul J.  Guyett</span>, <span class="hlFld-ContribAuthor ">Shuangluo  Xia</span>, <span class="hlFld-ContribAuthor ">David C.  Swinney</span>, <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>, and <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>  . </span><span class="cited-content_cbyCitation_article-title">Glycogen Synthase Kinase 3β Promotes the Endocytosis of Transferrin in the African Trypanosome. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2016,</strong> <em>2 </em>
                                    (7)
                                     , 518-528. <a href="https://doi.org/10.1021/acsinfecdis.6b00077" title="DOI URL">https://doi.org/10.1021/acsinfecdis.6b00077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.6b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.6b00077%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%252BPromotes%252Bthe%252BEndocytosis%252Bof%252BTransferrin%252Bin%252Bthe%252BAfrican%252BTrypanosome%26aulast%3DGuyett%26aufirst%3DPaul%2BJ.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D11052016%26date%3D16062016%26date%3D08072016%26date%3D06062016%26volume%3D2%26issue%3D7%26spage%3D518%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuele  Amata</span>, <span class="hlFld-ContribAuthor ">Hualin  Xi</span>, <span class="hlFld-ContribAuthor ">Gonzalo  Colmenarejo</span>, <span class="hlFld-ContribAuthor ">Rosario  Gonzalez-Diaz</span>, <span class="hlFld-ContribAuthor ">Carlos  Cordon-Obras</span>, <span class="hlFld-ContribAuthor ">Manuela  Berlanga</span>, <span class="hlFld-ContribAuthor ">Pilar  Manzano</span>, <span class="hlFld-ContribAuthor ">Jessey  Erath</span>, <span class="hlFld-ContribAuthor ">Norma E.  Roncal</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Lee</span>, <span class="hlFld-ContribAuthor ">Susan E.  Leed</span>, <span class="hlFld-ContribAuthor ">Ana  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Richard J.  Sciotti</span>, <span class="hlFld-ContribAuthor ">Miguel  Navarro</span>, and <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of “Preferred” Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2016,</strong> <em>2 </em>
                                    (3)
                                     , 180-186. <a href="https://doi.org/10.1021/acsinfecdis.5b00136" title="DOI URL">https://doi.org/10.1021/acsinfecdis.5b00136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.5b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.5b00136%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DIdentification%252Bof%252B%2525E2%252580%25259CPreferred%2525E2%252580%25259D%252BHuman%252BKinase%252BInhibitors%252Bfor%252BSleeping%252BSickness%252BLead%252BDiscovery.%252BAre%252BSome%252BKinases%252BBetter%252Bthan%252BOthers%252Bfor%252BInhibitor%252BRepurposing%25253F%26aulast%3DAmata%26aufirst%3DEmanuele%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D11112015%26date%3D21012016%26date%3D11032016%26date%3D17012016%26volume%3D2%26issue%3D3%26spage%3D180%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Devine</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Woodring</span>, <span class="hlFld-ContribAuthor ">Uma  Swaminathan</span>, <span class="hlFld-ContribAuthor ">Emanuele  Amata</span>, <span class="hlFld-ContribAuthor ">Gautam  Patel</span>, <span class="hlFld-ContribAuthor ">Jessey  Erath</span>, <span class="hlFld-ContribAuthor ">Norma E.  Roncal</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Lee</span>, <span class="hlFld-ContribAuthor ">Susan E.  Leed</span>, <span class="hlFld-ContribAuthor ">Ana  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>, <span class="hlFld-ContribAuthor ">Richard J.  Sciotti</span>, and <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>  . </span><span class="cited-content_cbyCitation_article-title">Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (14)
                                     , 5522-5537. <a href="https://doi.org/10.1021/acs.jmedchem.5b00515" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00515%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProtozoan%252BParasite%252BGrowth%252BInhibitors%252BDiscovered%252Bby%252BCross-Screening%252BYield%252BPotent%252BScaffolds%252Bfor%252BLead%252BDiscovery%26aulast%3DDevine%26aufirst%3DWilliam%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D31032015%26date%3D08072015%26date%3D23072015%26date%3D18062015%26volume%3D58%26issue%3D14%26spage%3D5522%26epage%3D5537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathew  Njoroge</span>, <span class="hlFld-ContribAuthor ">Nicholas M.  Njuguna</span>, <span class="hlFld-ContribAuthor ">Peggoty  Mutai</span>, <span class="hlFld-ContribAuthor ">Dennis S. B.  Ongarora</span>, <span class="hlFld-ContribAuthor ">Paul W.  Smith</span>, and <span class="hlFld-ContribAuthor ">Kelly  Chibale</span>  . </span><span class="cited-content_cbyCitation_article-title">Recent Approaches to Chemical Discovery and Development Against Malaria and the Neglected Tropical Diseases Human African Trypanosomiasis and Schistosomiasis. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (22)
                                     , 11138-11163. <a href="https://doi.org/10.1021/cr500098f" title="DOI URL">https://doi.org/10.1021/cr500098f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500098f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500098f%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DRecent%252BApproaches%252Bto%252BChemical%252BDiscovery%252Band%252BDevelopment%252BAgainst%252BMalaria%252Band%252Bthe%252BNeglected%252BTropical%252BDiseases%252BHuman%252BAfrican%252BTrypanosomiasis%252Band%252BSchistosomiasis%26aulast%3DNjoroge%26aufirst%3DMathew%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D19022014%26date%3D11072014%26date%3D26112014%26volume%3D114%26issue%3D22%26spage%3D11138%26epage%3D11163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher  Merritt</span>, <span class="hlFld-ContribAuthor ">Lisseth E.  Silva</span>, <span class="hlFld-ContribAuthor ">Angela L.  Tanner</span>, <span class="hlFld-ContribAuthor ">Kenneth  Stuart</span>, and <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>  . </span><span class="cited-content_cbyCitation_article-title">Kinases as Druggable Targets in Trypanosomatid Protozoan Parasites. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (22)
                                     , 11280-11304. <a href="https://doi.org/10.1021/cr500197d" title="DOI URL">https://doi.org/10.1021/cr500197d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500197d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500197d%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DKinases%252Bas%252BDruggable%252BTargets%252Bin%252BTrypanosomatid%252BProtozoan%252BParasites%26aulast%3DMerritt%26aufirst%3DChristopher%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D07042014%26date%3D07102014%26date%3D26112014%26volume%3D114%26issue%3D22%26spage%3D11280%26epage%3D11304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">João D.  Seixas</span>, <span class="hlFld-ContribAuthor ">Sandra A.  Luengo-Arratta</span>, <span class="hlFld-ContribAuthor ">Rosario  Diaz</span>, <span class="hlFld-ContribAuthor ">Manuel  Saldivia</span>, <span class="hlFld-ContribAuthor ">Domingo I.  Rojas-Barros</span>, <span class="hlFld-ContribAuthor ">Pilar  Manzano</span>, <span class="hlFld-ContribAuthor ">Silvia  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Manuela  Berlanga</span>, <span class="hlFld-ContribAuthor ">Terry K.  Smith</span>, <span class="hlFld-ContribAuthor ">Miguel  Navarro</span>, and <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>  . </span><span class="cited-content_cbyCitation_article-title">Establishment of a Structure–Activity Relationship of 1H-Imidazo[4,5-c]quinoline-Based Kinase Inhibitor NVP-BEZ235 as a Lead for African Sleeping Sickness. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (11)
                                     , 4834-4848. <a href="https://doi.org/10.1021/jm500361r" title="DOI URL">https://doi.org/10.1021/jm500361r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500361r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500361r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEstablishment%252Bof%252Ba%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252B1H-Imidazo%25255B4%25252C5-c%25255Dquinoline-Based%252BKinase%252BInhibitor%252BNVP-BEZ235%252Bas%252Ba%252BLead%252Bfor%252BAfrican%252BSleeping%252BSickness%26aulast%3DSeixas%26aufirst%3DJo%25C3%25A3o%2BD.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D07032014%26date%3D21052014%26date%3D12062014%26date%3D07052014%26volume%3D57%26issue%3D11%26spage%3D4834%26epage%3D4848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Kryshchyshyn</span>, <span class="hlFld-ContribAuthor ">Danylo  Kaminskyy</span>, <span class="hlFld-ContribAuthor ">Philippe  Grellier</span>, <span class="hlFld-ContribAuthor ">Roman  Lesyk</span>. </span><span class="cited-content_cbyCitation_article-title">Thiazolidinone-Related Heterocyclic Compounds as Potential Antitrypanosomal Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.5772/intechopen.91861" title="DOI URL">https://doi.org/10.5772/intechopen.91861</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.91861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.91861%26sid%3Dliteratum%253Aachs%26atitle%3DThiazolidinone-Related%252BHeterocyclic%252BCompounds%252Bas%252BPotential%252BAntitrypanosomal%252BAgents%26aulast%3DKryshchyshyn%26aufirst%3DAnna%26date%3D2021%26date%3D2021%26pub%3DIntechOpen%26atitle%3DAzoles%252B-%252BSynthesis%25252C%252BProperties%25252C%252BApplications%252Band%252BPerspectives%26aulast%3DKuznetsov%26aufirst%3DAleksey%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seung‐Hwan  Shim</span>, <span class="hlFld-ContribAuthor ">Hyejun  Park</span>, <span class="hlFld-ContribAuthor ">Neeraj Kumar  Mishra</span>, <span class="hlFld-ContribAuthor ">In Su  Kim</span>, <span class="hlFld-ContribAuthor ">Jae Kyun  Lee</span>, <span class="hlFld-ContribAuthor ">Kiho  Lee</span>, <span class="hlFld-ContribAuthor ">Hitesh B.  Jalani</span>, <span class="hlFld-ContribAuthor ">Yongseok  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst‐Free One‐Pot Multi‐Component Synthesis of 2‐Substituted Quinazolin‐4‐carboxamides from 2‐Aminophenyl‐2‐oxoacetamides, Aldehydes, and Ammonium Acetate. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (22)
                                     , 5446-5450. <a href="https://doi.org/10.1002/slct.202100534" title="DOI URL">https://doi.org/10.1002/slct.202100534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100534%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DCatalyst%2525E2%252580%252590Free%252BOne%2525E2%252580%252590Pot%252BMulti%2525E2%252580%252590Component%252BSynthesis%252Bof%252B2%2525E2%252580%252590Substituted%252BQuinazolin%2525E2%252580%2525904%2525E2%252580%252590carboxamides%252Bfrom%252B2%2525E2%252580%252590Aminophenyl%2525E2%252580%2525902%2525E2%252580%252590oxoacetamides%25252C%252BAldehydes%25252C%252Band%252BAmmonium%252BAcetate%26aulast%3DShim%26aufirst%3DSeung%25E2%2580%2590Hwan%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D22%26spage%3D5446%26epage%3D5450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Conor R.  Caffrey</span>, <span class="hlFld-ContribAuthor ">Dietmar  Steverding</span>, <span class="hlFld-ContribAuthor ">Rafaela S.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Renata B.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Anthony J.  O'Donoghue</span>, <span class="hlFld-ContribAuthor ">Ludovica  Monti</span>, <span class="hlFld-ContribAuthor ">Carlo  Ballatore</span>, <span class="hlFld-ContribAuthor ">Kelly A.  Bachovchin</span>, <span class="hlFld-ContribAuthor ">Lori  Ferrins</span>, <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>, <span class="hlFld-ContribAuthor ">Kimberley M.  Zorn</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Foil</span>, <span class="hlFld-ContribAuthor ">Alex M.  Clark</span>, <span class="hlFld-ContribAuthor ">Melina  Mottin</span>, <span class="hlFld-ContribAuthor ">Carolina H.  Andrade</span>, <span class="hlFld-ContribAuthor ">Jair L.  Siqueira‐Neto</span>, <span class="hlFld-ContribAuthor ">Sean  Ekins</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery and Development for Kinetoplastid Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-79. <a href="https://doi.org/10.1002/0471266949.bmc235.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc235.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc235.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc235.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BDiscovery%252Band%252BDevelopment%252Bfor%252BKinetoplastid%252BDiseases%26aulast%3DCaffrey%26aufirst%3DConor%2BR.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D79%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joyce Villa Verde Bastos  Borba</span>, <span class="hlFld-ContribAuthor ">Arthur Carvalho  Silva</span>, <span class="hlFld-ContribAuthor ">Marilia Nunes Nascimento  Lima</span>, <span class="hlFld-ContribAuthor ">Sabrina Silva  Mendonca</span>, <span class="hlFld-ContribAuthor ">Nicholas  Furnham</span>, <span class="hlFld-ContribAuthor ">Fabio Trindade Maranhão  Costa</span>, <span class="hlFld-ContribAuthor ">Carolina Horta  Andrade</span>. </span><span class="cited-content_cbyCitation_article-title">Chemogenomics and bioinformatics approaches for prioritizing kinases as drug targets for neglected tropical diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 187-223. <a href="https://doi.org/10.1016/bs.apcsb.2020.10.006" title="DOI URL">https://doi.org/10.1016/bs.apcsb.2020.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apcsb.2020.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apcsb.2020.10.006%26sid%3Dliteratum%253Aachs%26atitle%3DChemogenomics%252Band%252Bbioinformatics%252Bapproaches%252Bfor%252Bprioritizing%252Bkinases%252Bas%252Bdrug%252Btargets%252Bfor%252Bneglected%252Btropical%252Bdiseases%26aulast%3DBorba%26aufirst%3DJoyce%2BVilla%2BVerde%2BBastos%26date%3D2021%26spage%3D187%26epage%3D223%26pub%3DElsevier%26atitle%3DProtein%252BKinases%252Bin%252BDrug%252BDiscovery%26date%3D2021%26volume%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natália M.  Moreira</span>, <span class="hlFld-ContribAuthor ">Lorena S. R.  Martelli</span>, <span class="hlFld-ContribAuthor ">Kiyara I. R.  de Julio</span>, <span class="hlFld-ContribAuthor ">Julio  Zukerman-Schpector</span>, <span class="hlFld-ContribAuthor ">Till  Opatz</span>, <span class="hlFld-ContribAuthor ">Arlene G.  Corrêa</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed One-Pot Synthesis of 3-(
              N
              -Heteroarenyl)acrylonitriles through Radical Conjugated Addition of β-Nitrostyrene to Methylazaarenes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (29)
                                     , 4563-4570. <a href="https://doi.org/10.1002/ejoc.202000673" title="DOI URL">https://doi.org/10.1002/ejoc.202000673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000673%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BOne-Pot%252BSynthesis%252Bof%252B3-%252528%252BN%252B-Heteroarenyl%252529acrylonitriles%252Bthrough%252BRadical%252BConjugated%252BAddition%252Bof%252B%2525CE%2525B2-Nitrostyrene%252Bto%252BMethylazaarenes%26aulast%3DMoreira%26aufirst%3DNat%25C3%25A1lia%2BM.%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D29%26spage%3D4563%26epage%3D4570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baljinder  Singh</span>, <span class="hlFld-ContribAuthor ">Frederick S.  Buckner</span>, <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Drugs for Leishmaniases: A Progress Report. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 139-160. <a href="https://doi.org/10.1002/9783527808656.ch6" title="DOI URL">https://doi.org/10.1002/9783527808656.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527808656.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527808656.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252BDrugs%252Bfor%252BLeishmaniases%25253A%252BA%252BProgress%252BReport%26aulast%3DSingh%26aufirst%3DBaljinder%26date%3D2019%26date%3D2019%26spage%3D139%26epage%3D160%26pub%3DWiley%26atitle%3DNeglected%252BTropical%252BDiseases%26aulast%3DSwinney%26aufirst%3DDavid%26date%3D2019%26date%3D2019%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton G. L.  Veale</span>. </span><span class="cited-content_cbyCitation_article-title">Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (4)
                                     , 386-453. <a href="https://doi.org/10.1002/cmdc.201800755" title="DOI URL">https://doi.org/10.1002/cmdc.201800755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800755%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DUnpacking%252Bthe%252BPathogen%252BBox%2525E2%252580%252594An%252BOpen%252BSource%252BTool%252Bfor%252BFighting%252BNeglected%252BTropical%252BDisease%26aulast%3DVeale%26aufirst%3DClinton%2BG.%2BL.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D4%26spage%3D386%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dana M.  Klug</span>, <span class="hlFld-ContribAuthor ">Rosario  Diaz-Gonzalez</span>, <span class="hlFld-ContribAuthor ">Guiomar  Pérez-Moreno</span>, <span class="hlFld-ContribAuthor ">Gloria  Ceballos-Pérez</span>, <span class="hlFld-ContribAuthor ">Raquel  García-Hernández</span>, <span class="hlFld-ContribAuthor ">Veronica  Gomez-Pérez</span>, <span class="hlFld-ContribAuthor ">Luis Miguel  Ruiz-Pérez</span>, <span class="hlFld-ContribAuthor ">Domingo I.  Rojas-Barros</span>, <span class="hlFld-ContribAuthor ">Francisco  Gamarro</span>, <span class="hlFld-ContribAuthor ">Dolores  González-Pacanowska</span>, <span class="hlFld-ContribAuthor ">María S.  Martínez-Martínez</span>, <span class="hlFld-ContribAuthor ">Pilar  Manzano</span>, <span class="hlFld-ContribAuthor ">Lori  Ferrins</span>, <span class="hlFld-ContribAuthor ">Conor R.  Caffrey</span>, <span class="hlFld-ContribAuthor ">Miguel  Navarro</span>, <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>, . </span><span class="cited-content_cbyCitation_article-title">Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agents. </span><span class="cited-content_cbyCitation_journal-name">PLOS Neglected Tropical Diseases</span><span> <strong>2019,</strong> <em>13 </em>
                                    (2)
                                     , e0007129. <a href="https://doi.org/10.1371/journal.pntd.0007129" title="DOI URL">https://doi.org/10.1371/journal.pntd.0007129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pntd.0007129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pntd.0007129%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Neglected%2520Tropical%2520Diseases%26atitle%3DEvaluation%252Bof%252Ba%252Bclass%252Bof%252Bisatinoids%252Bidentified%252Bfrom%252Ba%252Bhigh-throughput%252Bscreen%252Bof%252Bhuman%252Bkinase%252Binhibitors%252Bas%252Banti-Sleeping%252BSickness%252Bagents%26aulast%3DKlug%26aufirst%3DDana%2BM.%26date%3D2019%26date%3D2019%26volume%3D13%26issue%3D2%26spage%3De0007129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helen W.  Hernandez</span>, <span class="hlFld-ContribAuthor ">Melinda  Soeung</span>, <span class="hlFld-ContribAuthor ">Kimberley M.  Zorn</span>, <span class="hlFld-ContribAuthor ">Norah  Ashoura</span>, <span class="hlFld-ContribAuthor ">Melina  Mottin</span>, <span class="hlFld-ContribAuthor ">Carolina Horta  Andrade</span>, <span class="hlFld-ContribAuthor ">Conor R.  Caffrey</span>, <span class="hlFld-ContribAuthor ">Jair Lage  de Siqueira-Neto</span>, <span class="hlFld-ContribAuthor ">Sean  Ekins</span>. </span><span class="cited-content_cbyCitation_article-title">High Throughput and Computational Repurposing for Neglected Diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Research</span><span> <strong>2019,</strong> <em>36 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s11095-018-2558-3" title="DOI URL">https://doi.org/10.1007/s11095-018-2558-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11095-018-2558-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11095-018-2558-3%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Research%26atitle%3DHigh%252BThroughput%252Band%252BComputational%252BRepurposing%252Bfor%252BNeglected%252BDiseases%26aulast%3DHernandez%26aufirst%3DHelen%2BW.%26date%3D2019%26date%3D2018%26volume%3D36%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>, <span class="hlFld-ContribAuthor ">Benjamin  Hoffman</span>, <span class="hlFld-ContribAuthor ">Justin  Wiedeman</span>, <span class="hlFld-ContribAuthor ">Catherine  Sullenberger</span>, <span class="hlFld-ContribAuthor ">Amrita  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Kinetoplast Division Factors in a Trypanosome. </span><span class="cited-content_cbyCitation_journal-name">Trends in Parasitology</span><span> <strong>2019,</strong> <em>35 </em>
                                    (2)
                                     , 119-128. <a href="https://doi.org/10.1016/j.pt.2018.11.002" title="DOI URL">https://doi.org/10.1016/j.pt.2018.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pt.2018.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pt.2018.11.002%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Parasitology%26atitle%3DKinetoplast%252BDivision%252BFactors%252Bin%252Ba%252BTrypanosome%26aulast%3DMensa-Wilmot%26aufirst%3DKojo%26date%3D2019%26volume%3D35%26issue%3D2%26spage%3D119%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lidija  Senerovic</span>, <span class="hlFld-ContribAuthor ">Dejan  Opsenica</span>, <span class="hlFld-ContribAuthor ">Ivana  Moric</span>, <span class="hlFld-ContribAuthor ">Ivana  Aleksic</span>, <span class="hlFld-ContribAuthor ">Marta  Spasić</span>, <span class="hlFld-ContribAuthor ">Branka  Vasiljevic</span>. </span><span class="cited-content_cbyCitation_article-title">Quinolines and Quinolones as Antibacterial, Antifungal, Anti-virulence, Antiviral and Anti-parasitic Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 37-69. <a href="https://doi.org/10.1007/5584_2019_428" title="DOI URL">https://doi.org/10.1007/5584_2019_428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/5584_2019_428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F5584_2019_428%26sid%3Dliteratum%253Aachs%26atitle%3DQuinolines%252Band%252BQuinolones%252Bas%252BAntibacterial%25252C%252BAntifungal%25252C%252BAnti-virulence%25252C%252BAntiviral%252Band%252BAnti-parasitic%252BAgents%26aulast%3DSenerovic%26aufirst%3DLidija%26date%3D2019%26date%3D2019%26spage%3D37%26epage%3D69%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAdvances%252Bin%252BMicrobiology%25252C%252BInfectious%252BDiseases%252Band%252BPublic%252BHealth%26aulast%3DDonelli%26aufirst%3DGianfranco%26date%3D2020%26volume%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher  Fernández-Prada</span>, <span class="hlFld-ContribAuthor ">Noelie  Douanne</span>, <span class="hlFld-ContribAuthor ">Aida  Minguez-Menendez</span>, <span class="hlFld-ContribAuthor ">Joan  Pena</span>, <span class="hlFld-ContribAuthor ">Luiza G.  Tunes</span>, <span class="hlFld-ContribAuthor ">Douglas E.V.  Pires</span>, <span class="hlFld-ContribAuthor ">Rubens L.  Monte-Neto</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposed Molecules: A New Hope in Tackling Neglected Infectious Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 119-160. <a href="https://doi.org/10.1016/B978-0-12-816125-8.00005-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-816125-8.00005-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816125-8.00005-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816125-8.00005-5%26sid%3Dliteratum%253Aachs%26atitle%3DRepurposed%252BMolecules%25253A%252BA%252BNew%252BHope%252Bin%252BTackling%252BNeglected%252BInfectious%252BDiseases%26aulast%3DFern%25C3%25A1ndez-Prada%26aufirst%3DChristopher%26date%3D2019%26spage%3D119%26epage%3D160%26pub%3DElsevier%26atitle%3DIn%252BSilico%252BDrug%252BDesign%26date%3D2019%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yicheng  Mei</span>, <span class="hlFld-ContribAuthor ">Baowei  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Rational application of drug promiscuity in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (15)
                                     , 1835-1851. <a href="https://doi.org/10.4155/fmc-2018-0018" title="DOI URL">https://doi.org/10.4155/fmc-2018-0018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0018%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bapplication%252Bof%252Bdrug%252Bpromiscuity%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DMei%26aufirst%3DYicheng%26date%3D2018%26volume%3D10%26issue%3D15%26spage%3D1835%26epage%3D1851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer L.  Woodring</span>, <span class="hlFld-ContribAuthor ">Kelly A.  Bachovchin</span>, <span class="hlFld-ContribAuthor ">Kimberly G.  Brady</span>, <span class="hlFld-ContribAuthor ">Mitchell F.  Gallerstein</span>, <span class="hlFld-ContribAuthor ">Jessey  Erath</span>, <span class="hlFld-ContribAuthor ">Scott  Tanghe</span>, <span class="hlFld-ContribAuthor ">Susan E.  Leed</span>, <span class="hlFld-ContribAuthor ">Ana  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>, <span class="hlFld-ContribAuthor ">Richard J.  Sciotti</span>, <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>141 </em>, 446-459. <a href="https://doi.org/10.1016/j.ejmech.2017.10.007" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.10.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.10.007%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Bphysicochemical%252Bproperties%252Bfor%252B4-anilinoquinazoline%252Binhibitors%252Bof%252Btrypanosome%252Bproliferation%26aulast%3DWoodring%26aufirst%3DJennifer%2BL.%26date%3D2017%26volume%3D141%26spage%3D446%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Dichiara</span>, <span class="hlFld-ContribAuthor ">Agostino  Marrazzo</span>, <span class="hlFld-ContribAuthor ">Orazio  Prezzavento</span>, <span class="hlFld-ContribAuthor ">Simona  Collina</span>, <span class="hlFld-ContribAuthor ">Antonio  Rescifina</span>, <span class="hlFld-ContribAuthor ">Emanuele  Amata</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (16)
                                     , 1235-1253. <a href="https://doi.org/10.1002/cmdc.201700259" title="DOI URL">https://doi.org/10.1002/cmdc.201700259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700259%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DRepurposing%252Bof%252BHuman%252BKinase%252BInhibitors%252Bin%252BNeglected%252BProtozoan%252BDiseases%26aulast%3DDichiara%26aufirst%3DMaria%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D16%26spage%3D1235%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Ding</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Yan-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Han</span>, <span class="hlFld-ContribAuthor ">Chun-Mei  Gao</span>, <span class="hlFld-ContribAuthor ">Chun-Yan  Tan</span>, <span class="hlFld-ContribAuthor ">Yu-Yang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of ErbB/HDAC inhibitors by combining the core pharmacophores of HDAC inhibitor vorinostat and kinase inhibitors vandetanib, BMS-690514, neratinib, and TAK-285. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2017,</strong> <em>28 </em>
                                    (6)
                                     , 1220-1227. <a href="https://doi.org/10.1016/j.cclet.2017.01.003" title="DOI URL">https://doi.org/10.1016/j.cclet.2017.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2017.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2017.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DDiscovery%252Bof%252BErbB%25252FHDAC%252Binhibitors%252Bby%252Bcombining%252Bthe%252Bcore%252Bpharmacophores%252Bof%252BHDAC%252Binhibitor%252Bvorinostat%252Band%252Bkinase%252Binhibitors%252Bvandetanib%25252C%252BBMS-690514%25252C%252Bneratinib%25252C%252Band%252BTAK-285%26aulast%3DDing%26aufirst%3DChao%26date%3D2017%26volume%3D28%26issue%3D6%26spage%3D1220%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catherine  Sullenberger</span>, <span class="hlFld-ContribAuthor ">Daniel  Piqué</span>, <span class="hlFld-ContribAuthor ">Yuko  Ogata</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>. </span><span class="cited-content_cbyCitation_article-title">AEE788 Inhibits Basal Body Assembly and Blocks DNA Replication in the African Trypanosome. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2017,</strong> <em>91 </em>
                                    (5)
                                     , 482-498. <a href="https://doi.org/10.1124/mol.116.106906" title="DOI URL">https://doi.org/10.1124/mol.116.106906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.116.106906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.116.106906%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DAEE788%252BInhibits%252BBasal%252BBody%252BAssembly%252Band%252BBlocks%252BDNA%252BReplication%252Bin%252Bthe%252BAfrican%252BTrypanosome%26aulast%3DSullenberger%26aufirst%3DCatherine%26date%3D2017%26date%3D2017%26volume%3D91%26issue%3D5%26spage%3D482%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul J.  Guyett</span>, <span class="hlFld-ContribAuthor ">Ranjan  Behera</span>, <span class="hlFld-ContribAuthor ">Yuko  Ogata</span>, <span class="hlFld-ContribAuthor ">Michael  Pollastri</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Effects of Lapatinib Revealed in the African Trypanosome by Using Hypothesis-Generating Proteomics and Chemical Biology Strategies. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2017,</strong> <em>61 </em>
                                    (2)
                                     <a href="https://doi.org/10.1128/AAC.01865-16" title="DOI URL">https://doi.org/10.1128/AAC.01865-16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01865-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01865-16%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DNovel%252BEffects%252Bof%252BLapatinib%252BRevealed%252Bin%252Bthe%252BAfrican%252BTrypanosome%252Bby%252BUsing%252BHypothesis-Generating%252BProteomics%252Band%252BChemical%252BBiology%252BStrategies%26aulast%3DGuyett%26aufirst%3DPaul%2BJ.%26date%3D2017%26volume%3D61%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.T.  Jacobs</span>. </span><span class="cited-content_cbyCitation_article-title">Antiparasitic Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 717-750. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12411-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12411-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12411-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12411-4%26sid%3Dliteratum%253Aachs%26atitle%3DAntiparasitic%252BAgents%26aulast%3DJacobs%26aufirst%3DR.T.%26date%3D2017%26spage%3D717%26epage%3D750%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Berninger</span>, <span class="hlFld-ContribAuthor ">Ines  Schmidt</span>, <span class="hlFld-ContribAuthor ">Alicia  Ponte-Sucre</span>, <span class="hlFld-ContribAuthor ">Ulrike  Holzgrabe</span>. </span><span class="cited-content_cbyCitation_article-title">Novel lead compounds in pre-clinical development against African sleeping sickness. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 1872-1890. <a href="https://doi.org/10.1039/C7MD00280G" title="DOI URL">https://doi.org/10.1039/C7MD00280G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00280G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00280G%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DNovel%252Blead%252Bcompounds%252Bin%252Bpre-clinical%252Bdevelopment%252Bagainst%252BAfrican%252Bsleeping%252Bsickness%26aulast%3DBerninger%26aufirst%3DMichael%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D10%26spage%3D1872%26epage%3D1890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan B.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Bruno N.  Falcone</span>, <span class="hlFld-ContribAuthor ">Sergio H.  Szajnman</span>. </span><span class="cited-content_cbyCitation_article-title">Detection and treatment of
              Trypanosoma cruzi
              : a patent review (2011-2015). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2016,</strong> <em>26 </em>
                                    (9)
                                     , 993-1015. <a href="https://doi.org/10.1080/13543776.2016.1209487" title="DOI URL">https://doi.org/10.1080/13543776.2016.1209487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2016.1209487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2016.1209487%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DDetection%252Band%252Btreatment%252Bof%252BTrypanosoma%252Bcruzi%252B%25253A%252Ba%252Bpatent%252Breview%252B%2525282011-2015%252529%26aulast%3DRodriguez%26aufirst%3DJuan%2BB.%26date%3D2016%26date%3D2016%26volume%3D26%26issue%3D9%26spage%3D993%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah M.  Thomas</span>, <span class="hlFld-ContribAuthor ">Andrei  Purmal</span>, <span class="hlFld-ContribAuthor ">Michael  Pollastri</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep32083" title="DOI URL">https://doi.org/10.1038/srep32083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep32083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep32083%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Bof%252Ba%252BCarbazole-Derived%252BLead%252BDrug%252Bfor%252BHuman%252BAfrican%252BTrypanosomiasis%26aulast%3DThomas%26aufirst%3DSarah%2BM.%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dana M.  Klug</span>, <span class="hlFld-ContribAuthor ">Michael H.  Gelb</span>, <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing strategies for tropical disease drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (11)
                                     , 2569-2576. <a href="https://doi.org/10.1016/j.bmcl.2016.03.103" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.103%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRepurposing%252Bstrategies%252Bfor%252Btropical%252Bdisease%252Bdrug%252Bdiscovery%26aulast%3DKlug%26aufirst%3DDana%2BM.%26date%3D2016%26volume%3D26%26issue%3D11%26spage%3D2569%26epage%3D2576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana  Cundell</span>, <span class="hlFld-ContribAuthor ">Michael  Piechoski</span>. </span><span class="cited-content_cbyCitation_article-title">Antiprotozoal agents derived from natural soil and aquatic actinobacteria: Fighting one microbe with another. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 457-478. <a href="https://doi.org/10.1201/b19224-29" title="DOI URL">https://doi.org/10.1201/b19224-29</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1201/b19224-29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1201%2Fb19224-29%26sid%3Dliteratum%253Aachs%26atitle%3DAntiprotozoal%252Bagents%252Bderived%252Bfrom%252Bnatural%252Bsoil%252Band%252Baquatic%252Bactinobacteria%25253A%252BFighting%252Bone%252Bmicrobe%252Bwith%252Banother%26aulast%3DCundell%26aufirst%3DDiana%26date%3D2015%26date%3D2015%26spage%3D457%26epage%3D478%26pub%3DCRC%2520Press%26atitle%3DAntimicrobials%26aulast%3DDhanasekaran%26aufirst%3DDharumadurai%26date%3D2015%26date%3D2015%26volume%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Osman A.  Gani</span>, <span class="hlFld-ContribAuthor ">Balmukund  Thakkar</span>, <span class="hlFld-ContribAuthor ">Dilip  Narayanan</span>, <span class="hlFld-ContribAuthor ">Kazi A.  Alam</span>, <span class="hlFld-ContribAuthor ">Peter  Kyomuhendo</span>, <span class="hlFld-ContribAuthor ">Ulli  Rothweiler</span>, <span class="hlFld-ContribAuthor ">Veronica  Tello-Franco</span>, <span class="hlFld-ContribAuthor ">Richard A.  Engh</span>. </span><span class="cited-content_cbyCitation_article-title">Assessing protein kinase target similarity: Comparing sequence, structure, and cheminformatics approaches. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2015,</strong> <em>1854 </em>
                                    (10)
                                     , 1605-1616. <a href="https://doi.org/10.1016/j.bbapap.2015.05.004" title="DOI URL">https://doi.org/10.1016/j.bbapap.2015.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2015.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2015.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DAssessing%252Bprotein%252Bkinase%252Btarget%252Bsimilarity%25253A%252BComparing%252Bsequence%25252C%252Bstructure%25252C%252Band%252Bcheminformatics%252Bapproaches%26aulast%3DGani%26aufirst%3DOsman%2BA.%26date%3D2015%26volume%3D1854%26issue%3D10%26spage%3D1605%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan O.  Ochiana</span>, <span class="hlFld-ContribAuthor ">Nicholas D.  Bland</span>, <span class="hlFld-ContribAuthor ">Luca  Settimo</span>, <span class="hlFld-ContribAuthor ">Robert K.  Campbell</span>, <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing Human PDE4 Inhibitors for Neglected Tropical Diseases. Evaluation of Analogs of the Human PDE4 Inhibitor GSK-256066 as Inhibitors of PDEB1 of
              Trypanosoma brucei. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>85 </em>
                                    (5)
                                     , 549-564. <a href="https://doi.org/10.1111/cbdd.12443" title="DOI URL">https://doi.org/10.1111/cbdd.12443</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12443%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DRepurposing%252BHuman%252BPDE4%252BInhibitors%252Bfor%252BNeglected%252BTropical%252BDiseases.%252BEvaluation%252Bof%252BAnalogs%252Bof%252Bthe%252BHuman%252BPDE4%252BInhibitor%252BGSK-256066%252Bas%252BInhibitors%252Bof%252BPDEB1%252Bof%252BTrypanosoma%252Bbrucei%26aulast%3DOchiana%26aufirst%3DStefan%2BO.%26date%3D2015%26date%3D2014%26volume%3D85%26issue%3D5%26spage%3D549%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer L.  Woodring</span>, <span class="hlFld-ContribAuthor ">Gautam  Patel</span>, <span class="hlFld-ContribAuthor ">Jessey  Erath</span>, <span class="hlFld-ContribAuthor ">Ranjan  Behera</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Lee</span>, <span class="hlFld-ContribAuthor ">Susan E.  Leed</span>, <span class="hlFld-ContribAuthor ">Ana  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Richard J.  Sciotti</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>, <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of aromatic 6-substituted thienopyrimidines as scaffolds against parasites that cause trypanosomiasis, leishmaniasis, and malaria. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (2)
                                     , 339-346. <a href="https://doi.org/10.1039/C4MD00441H" title="DOI URL">https://doi.org/10.1039/C4MD00441H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00441H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00441H%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DEvaluation%252Bof%252Baromatic%252B6-substituted%252Bthienopyrimidines%252Bas%252Bscaffolds%252Bagainst%252Bparasites%252Bthat%252Bcause%252Btrypanosomiasis%25252C%252Bleishmaniasis%25252C%252Band%252Bmalaria%26aulast%3DWoodring%26aufirst%3DJennifer%2BL.%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D2%26spage%3D339%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Graeme F.  Wilkinson</span>, <span class="hlFld-ContribAuthor ">Kevin  Pritchard</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro Screening for Drug Repositioning. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Screening</span><span> <strong>2015,</strong> <em>20 </em>
                                    (2)
                                     , 167-179. <a href="https://doi.org/10.1177/1087057114563024" title="DOI URL">https://doi.org/10.1177/1087057114563024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1087057114563024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1087057114563024%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Screening%26atitle%3DIn%252BVitro%252BScreening%252Bfor%252BDrug%252BRepositioning%26aulast%3DWilkinson%26aufirst%3DGraeme%2BF.%26date%3D2015%26date%3D2014%26volume%3D20%26issue%3D2%26spage%3D167%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Kryshchyshyn</span>, <span class="hlFld-ContribAuthor ">Danylo  Kaminskyy</span>, <span class="hlFld-ContribAuthor ">Philippe  Grellier</span>, <span class="hlFld-ContribAuthor ">Roman  Lesyk</span>. </span><span class="cited-content_cbyCitation_article-title">Trends in research of antitrypanosomal agents among synthetic heterocycles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>85 </em>, 51-64. <a href="https://doi.org/10.1016/j.ejmech.2014.07.092" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.092%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTrends%252Bin%252Bresearch%252Bof%252Bantitrypanosomal%252Bagents%252Bamong%252Bsynthetic%252Bheterocycles%26aulast%3DKryshchyshyn%26aufirst%3DAnna%26date%3D2014%26volume%3D85%26spage%3D51%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katherine T.  Andrews</span>, <span class="hlFld-ContribAuthor ">Gillian  Fisher</span>, <span class="hlFld-ContribAuthor ">Tina S.  Skinner-Adams</span>. </span><span class="cited-content_cbyCitation_article-title">Drug repurposing and human parasitic protozoan diseases. </span><span class="cited-content_cbyCitation_journal-name">International Journal for Parasitology: Drugs and Drug Resistance</span><span> <strong>2014,</strong> <em>4 </em>
                                    (2)
                                     , 95-111. <a href="https://doi.org/10.1016/j.ijpddr.2014.02.002" title="DOI URL">https://doi.org/10.1016/j.ijpddr.2014.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpddr.2014.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpddr.2014.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520for%2520Parasitology%253A%2520Drugs%2520and%2520Drug%2520Resistance%26atitle%3DDrug%252Brepurposing%252Band%252Bhuman%252Bparasitic%252Bprotozoan%252Bdiseases%26aulast%3DAndrews%26aufirst%3DKatherine%2BT.%26date%3D2014%26volume%3D4%26issue%3D2%26spage%3D95%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.  Sanderson</span>, <span class="hlFld-ContribAuthor ">V.  Yardley</span>, <span class="hlFld-ContribAuthor ">S. L.  Croft</span>. </span><span class="cited-content_cbyCitation_article-title">Activity of anti-cancer protein kinase inhibitors against Leishmania spp.. </span><span class="cited-content_cbyCitation_journal-name">Journal of Antimicrobial Chemotherapy</span><span> <strong>2014,</strong> <em>69 </em>
                                    (7)
                                     , 1888-1891. <a href="https://doi.org/10.1093/jac/dku069" title="DOI URL">https://doi.org/10.1093/jac/dku069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jac/dku069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjac%2Fdku069%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Antimicrobial%2520Chemotherapy%26atitle%3DActivity%252Bof%252Banti-cancer%252Bprotein%252Bkinase%252Binhibitors%252Bagainst%252BLeishmania%252Bspp.%26aulast%3DSanderson%26aufirst%3DL.%26date%3D2014%26date%3D2014%26volume%3D69%26issue%3D7%26spage%3D1888%26epage%3D1891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin M.  Brown</span>, <span class="hlFld-ContribAuthor ">Elena  Suvorova</span>, <span class="hlFld-ContribAuthor ">Andrew  Farrell</span>, <span class="hlFld-ContribAuthor ">Aaron  McLain</span>, <span class="hlFld-ContribAuthor ">Ashley  Dittmar</span>, <span class="hlFld-ContribAuthor ">Graham B.  Wiley</span>, <span class="hlFld-ContribAuthor ">Gabor  Marth</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Gaffney</span>, <span class="hlFld-ContribAuthor ">Marc Jan  Gubbels</span>, <span class="hlFld-ContribAuthor ">Michael  White</span>, <span class="hlFld-ContribAuthor ">Ira J.  Blader</span>, . </span><span class="cited-content_cbyCitation_article-title">Forward Genetic Screening Identifies a Small Molecule That Blocks Toxoplasma gondii Growth by Inhibiting Both Host- and Parasite-Encoded Kinases. </span><span class="cited-content_cbyCitation_journal-name">PLoS Pathogens</span><span> <strong>2014,</strong> <em>10 </em>
                                    (6)
                                     , e1004180. <a href="https://doi.org/10.1371/journal.ppat.1004180" title="DOI URL">https://doi.org/10.1371/journal.ppat.1004180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1004180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1004180%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520Pathogens%26atitle%3DForward%252BGenetic%252BScreening%252BIdentifies%252Ba%252BSmall%252BMolecule%252BThat%252BBlocks%252BToxoplasma%252Bgondii%252BGrowth%252Bby%252BInhibiting%252BBoth%252BHost-%252Band%252BParasite-Encoded%252BKinases%26aulast%3DBrown%26aufirst%3DKevin%2BM.%26date%3D2014%26date%3D2014%26volume%3D10%26issue%3D6%26spage%3De1004180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imtiaz  Khan</span>, <span class="hlFld-ContribAuthor ">Aliya  Ibrar</span>, <span class="hlFld-ContribAuthor ">Naeem  Abbas</span>, <span class="hlFld-ContribAuthor ">Aamer  Saeed</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: Synthetic approaches and multifarious applications. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>76 </em>, 193-244. <a href="https://doi.org/10.1016/j.ejmech.2014.02.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.02.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.02.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bstructural%252Blibrary%252Bof%252Bfunctionalized%252Bquinazoline%252Band%252Bquinazolinone%252Bscaffolds%25253A%252BSynthetic%252Bapproaches%252Band%252Bmultifarious%252Bapplications%26aulast%3DKhan%26aufirst%3DImtiaz%26date%3D2014%26volume%3D76%26spage%3D193%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranjan  Behera</span>, <span class="hlFld-ContribAuthor ">Sarah M.  Thomas</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>. </span><span class="cited-content_cbyCitation_article-title">New Chemical Scaffolds for Human African Trypanosomiasis Lead Discovery from a Screen of Tyrosine Kinase Inhibitor Drugs. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2014,</strong> <em>58 </em>
                                    (4)
                                     , 2202-2210. <a href="https://doi.org/10.1128/AAC.01691-13" title="DOI URL">https://doi.org/10.1128/AAC.01691-13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01691-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01691-13%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DNew%252BChemical%252BScaffolds%252Bfor%252BHuman%252BAfrican%252BTrypanosomiasis%252BLead%252BDiscovery%252Bfrom%252Ba%252BScreen%252Bof%252BTyrosine%252BKinase%252BInhibitor%252BDrugs%26aulast%3DBehera%26aufirst%3DRanjan%26date%3D2014%26date%3D2014%26volume%3D58%26issue%3D4%26spage%3D2202%26epage%3D2210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gautam  Patel</span>, <span class="hlFld-ContribAuthor ">Norma E.  Roncal</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Lee</span>, <span class="hlFld-ContribAuthor ">Susan E.  Leed</span>, <span class="hlFld-ContribAuthor ">Jessey  Erath</span>, <span class="hlFld-ContribAuthor ">Ana  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Richard J.  Sciotti</span>, <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2014,</strong> <em>5 </em>
                                    (5)
                                     , 655-658. <a href="https://doi.org/10.1039/C4MD00045E" title="DOI URL">https://doi.org/10.1039/C4MD00045E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00045E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00045E%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DRepurposing%252Bhuman%252BAurora%252Bkinase%252Binhibitors%252Bas%252Bleads%252Bfor%252Banti-protozoan%252Bdrug%252Bdiscovery%26aulast%3DPatel%26aufirst%3DGautam%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D5%26spage%3D655%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lori  Ferrins</span>, <span class="hlFld-ContribAuthor ">Raphaël  Rahmani</span>, <span class="hlFld-ContribAuthor ">Jonathan B  Baell</span>. </span><span class="cited-content_cbyCitation_article-title">Drug discovery and human African trypanosomiasis: a disease less neglected?. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2013,</strong> <em>5 </em>
                                    (15)
                                     , 1801-1841. <a href="https://doi.org/10.4155/fmc.13.162" title="DOI URL">https://doi.org/10.4155/fmc.13.162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.162%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDrug%252Bdiscovery%252Band%252Bhuman%252BAfrican%252Btrypanosomiasis%25253A%252Ba%252Bdisease%252Bless%252Bneglected%25253F%26aulast%3DFerrins%26aufirst%3DLori%26date%3D2013%26volume%3D5%26issue%3D15%26spage%3D1801%26epage%3D1841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer  Dent</span>, <span class="hlFld-ContribAuthor ">Roopa  Ramamoorthi</span>, <span class="hlFld-ContribAuthor ">Katy  Graef</span>, <span class="hlFld-ContribAuthor ">Lisa Marie  Nelson</span>, <span class="hlFld-ContribAuthor ">Johannes Christian  Wichard</span>. </span><span class="cited-content_cbyCitation_article-title">WIPO Re:Search: a consortium catalyzing research and product development for neglected tropical diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2013,</strong> <em>2 </em>
                                    (5)
                                     , 591-596. <a href="https://doi.org/10.4155/ppa.13.49" title="DOI URL">https://doi.org/10.4155/ppa.13.49</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.13.49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.13.49%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DWIPO%252BRe%25253ASearch%25253A%252Ba%252Bconsortium%252Bcatalyzing%252Bresearch%252Band%252Bproduct%252Bdevelopment%252Bfor%252Bneglected%252Btropical%252Bdiseases%26aulast%3DDent%26aufirst%3DJennifer%26date%3D2013%26volume%3D2%26issue%3D5%26spage%3D591%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Analogues <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) formamide, 170 °C, 4 h, 70%; (b) thionyl chloride, DMF, 80 °C, 12 h, 85%; (c) 3-chloro-4-((3-fluorobenzyl)oxy)aniline, 2-propanol, 80 °C, 12 h, 85%; (d) Ar-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, DME, EtOH, 80 °C, 12 h.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Requisite Aniline Intermediates <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) alkyl halide, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, 50 °C, 12 h; (b) Zn, NH<sub>4</sub>Cl, MeOH, H<sub>2</sub>O, 25–50 °C, 6 h.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Headgroup Expansion Set <b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (4-(morpholinosulfonyl)phenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, DME, EtOH, 80 °C, 30 h, 85%; (b) thionyl chloride, DMF, 80 °C, 36 h, 66%; (c) Ar-NH<sub>2</sub>, 2-propanol, 80 °C, 12 h.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Analogues <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) bis(pinacolato)diboron, PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub>, KOAc, 1,4-dioxane, 80 °C, 12 h, 33–72%; (b) <b>14</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, DME, EtOH, 80 °C, 12 h.</p></p></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Assessment of <b>23a</b> in a mouse model of human African trypanosomiasis. Parasitemia was measured each day in untreated (U, red) and treated (T, blue) mice (20 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/medium/jm-2013-00349k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of <b>23a</b> on the cell cycle of the trypanosome. (A) <b>23a</b>-treated or control trypanosomes were analyzed by flow cytometry (10000 events analyzed; see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). Propidium iodide (PI) fluorescence is plotted against cell populations. (B) Quantitation of DNA content per cell (calculated with FloJo software). (C) Microscopic analysis of <b>23a</b>-treated or untreated trypanosomes after staining with DNA-binding dye DAPI. N, nucleus; K, kinetoplast; DIC, differential interference contrast image. (D) Quantitation of organelle (nucleus (N) or kinetoplast (K)) distribution after <b>23a</b> treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400349k/production/images/large/jm-2013-00349k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400349k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04521" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04521" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 51 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>Uniting to Combat NTDs Homepage; <a href="http://www.unitingtocombatntds.org" class="extLink">www.unitingtocombatntds.org</a>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><div class="note"><p class="first last">(accessed 12 April 2013)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Uniting+to+Combat+NTDs+Homepage%3B+www.unitingtocombatntds.org%2C+2013%3B+%28accessed+12+April+2013%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DUniting%2520to%2520Combat%2520NTDs%2520Homepage%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Pollastri, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. K.</span><span> </span><span class="NLM_article-title">Target repurposing for neglected diseases</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">1315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.4155%2Ffmc.11.92" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=21859304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKjtrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1307-1315&author=M.+P.+Pollastriauthor=R.+K.+Campbell&title=Target+repurposing+for+neglected+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Target repurposing for neglected diseases</span></div><div class="casAuthors">Pollastri, Michael P.; Campbell, Robert K.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1307-1315</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Infectious diseases are an enormous burden to global health and ,since drug discovery is costly, those infectious diseases that affect the developing world are often not pursued by com. drug-discovery efforts.  Therefore, pragmatic means by which new therapeutics can be discovered are needed.  One such approach is target repurposing, where pathogen targets are matched with homologous human targets that have been pursued for drug discovery for other indications.  In many cases, the medicinal chem., structural biol. and biochem. knowledge around these human targets can be directly repurposed to launch and accelerate new drug-discovery efforts against the pathogen targets.  This article describes the overarching strategy of target repurposing as a tool for initiating and prosecuting neglected disease drug-discovery programs, highlighting this approach with three case studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyF0eLS_dzUrVg90H21EOLACvtfcHk0ljGmwIJrkwlTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKjtrzK&md5=886d8cc9e04cbbc4a0b139c78f0d3df7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.92%26sid%3Dliteratum%253Aachs%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26aulast%3DCampbell%26aufirst%3DR.%2BK.%26atitle%3DTarget%2520repurposing%2520for%2520neglected%2520diseases%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D1307%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gould, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Koning, H. P.</span><span> </span><span class="NLM_article-title">Cyclic-nucleotide signalling in protozoa</span> <span class="citation_source-journal">FEMS Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=515-541&author=M.+K.+Gouldauthor=H.+P.+de+Koning&title=Cyclic-nucleotide+signalling+in+protozoa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DM.%2BK.%26aulast%3Dde%2BKoning%26aufirst%3DH.%2BP.%26atitle%3DCyclic-nucleotide%2520signalling%2520in%2520protozoa%26jtitle%3DFEMS%2520Microbiol.%2520Rev.%26date%3D2011%26volume%3D35%26spage%3D515%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Parsons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthey, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mottram, J. C.</span><span> </span><span class="NLM_article-title">Comparative analysis of the kinomes of three pathogenic trypanosomatids: <i>Leishmania major</i>, <i>Trypanosoma brucei</i> and <i>Trypanosoma cruzi</i></span> <span class="citation_source-journal">BMC Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1186%2F1471-2164-6-127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=16164760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A280%3ADC%252BD2MrmvVKrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=127&author=M.+Parsonsauthor=E.+A.+Wortheyauthor=P.+N.+Wardauthor=J.+C.+Mottram&title=Comparative+analysis+of+the+kinomes+of+three+pathogenic+trypanosomatids%3A+Leishmania+major%2C+Trypanosoma+brucei+and+Trypanosoma+cruzi"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi</span></div><div class="casAuthors">Parsons Marilyn; Worthey Elizabeth A; Ward Pauline N; Mottram Jeremy C</div><div class="citationInfo"><span class="NLM_cas:title">BMC genomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The trypanosomatids Leishmania major, Trypanosoma brucei and Trypanosoma cruzi cause some of the most debilitating diseases of humankind: cutaneous leishmaniasis, African sleeping sickness, and Chagas disease.  These protozoa possess complex life cycles that involve development in mammalian and insect hosts, and a tightly coordinated cell cycle ensures propagation of the highly polarized cells.  However, the ways in which the parasites respond to their environment and coordinate intracellular processes are poorly understood.  As a part of an effort to understand parasite signaling functions, we report the results of a genome-wide analysis of protein kinases (PKs) of these three trypanosomatids.  RESULTS:  Bioinformatic searches of the trypanosomatid genomes for eukaryotic PKs (ePKs) and atypical PKs (aPKs) revealed a total of 176 PKs in T. brucei, 190 in T. cruzi and 199 in L. major, most of which are orthologous across the three species.  This is approximately 30% of the number in the human host and double that of the malaria parasite, Plasmodium falciparum.  The representation of various groups of ePKs differs significantly as compared to humans: trypanosomatids lack receptor-linked tyrosine and tyrosine kinase-like kinases, although they do possess dual-specificity kinases.  A relative expansion of the CMGC, STE and NEK groups has occurred.  A large number of unique ePKs show no strong affinity to any known group.  The trypanosomatids possess few ePKs with predicted transmembrane domains, suggesting that receptor ePKs are rare.  Accessory Pfam domains, which are frequently present in human ePKs, are uncommon in trypanosomatid ePKs.  CONCLUSION:  Trypanosomatids possess a large set of PKs, comprising approximately 2% of each genome, suggesting a key role for phosphorylation in parasite biology.  Whilst it was possible to place most of the trypanosomatid ePKs into the seven established groups using bioinformatic analyses, it has not been possible to ascribe function based solely on sequence similarity.  Hence the connection of stimuli to protein phosphorylation networks remains enigmatic.  The presence of numerous PKs with significant sequence similarity to known drug targets, as well as a large number of unusual kinases that might represent novel targets, strongly argue for functional analysis of these molecules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT76DpkTfbK3P9pSBfyDvp7fW6udTcc2eZAINFnyrSWYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrmvVKrtA%253D%253D&md5=85170d5fb5d963fbf768a31b4cebff4c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2F1471-2164-6-127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2164-6-127%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DWorthey%26aufirst%3DE.%2BA.%26aulast%3DWard%26aufirst%3DP.%2BN.%26aulast%3DMottram%26aufirst%3DJ.%2BC.%26atitle%3DComparative%2520analysis%2520of%2520the%2520kinomes%2520of%2520three%2520pathogenic%2520trypanosomatids%253A%2520Leishmania%2520major%252C%2520Trypanosoma%2520brucei%2520and%2520Trypanosoma%2520cruzi%26jtitle%3DBMC%2520Genomics%26date%3D2005%26volume%3D6%26spage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bland, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashton, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiana, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gechijian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garceau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangurde, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortenberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ondrechen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Pharmacological validation of <i>Trypanosoma brucei</i> phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8188</span><span class="NLM_x">–</span> <span class="NLM_lpage">8194</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201148s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8188-8194&author=N.+D.+Blandauthor=C.+Wangauthor=C.+Tallmanauthor=A.+E.+Gustafsonauthor=Z.+Wangauthor=T.+D.+Ashtonauthor=S.+O.+Ochianaauthor=G.+McAllisterauthor=K.+Cotterauthor=A.+P.+Fangauthor=L.+Gechijianauthor=N.+Garceauauthor=R.+Gangurdeauthor=R.+Ortenbergauthor=M.+J.+Ondrechenauthor=R.+K.+Campbellauthor=M.+P.+Pollastri&title=Pharmacological+validation+of+Trypanosoma+brucei+phosphodiesterases+B1+and+B2+as+druggable+targets+for+African+sleeping+sickness"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm201148s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201148s%26sid%3Dliteratum%253Aachs%26aulast%3DBland%26aufirst%3DN.%2BD.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DTallman%26aufirst%3DC.%26aulast%3DGustafson%26aufirst%3DA.%2BE.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DAshton%26aufirst%3DT.%2BD.%26aulast%3DOchiana%26aufirst%3DS.%2BO.%26aulast%3DMcAllister%26aufirst%3DG.%26aulast%3DCotter%26aufirst%3DK.%26aulast%3DFang%26aufirst%3DA.%2BP.%26aulast%3DGechijian%26aufirst%3DL.%26aulast%3DGarceau%26aufirst%3DN.%26aulast%3DGangurde%26aufirst%3DR.%26aulast%3DOrtenberg%26aufirst%3DR.%26aulast%3DOndrechen%26aufirst%3DM.%2BJ.%26aulast%3DCampbell%26aufirst%3DR.%2BK.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DPharmacological%2520validation%2520of%2520Trypanosoma%2520brucei%2520phosphodiesterases%2520B1%2520and%2520B2%2520as%2520druggable%2520targets%2520for%2520African%2520sleeping%2520sickness%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8188%26epage%3D8194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ochiana, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandarinath, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ondrechen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruben, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">The human Aurora kinase inhibitor danusertib is a lead compound for anti-trypanosomal drug discovery via target repurposing</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=777-784&author=S.+O.+Ochianaauthor=V.+Pandarinathauthor=Z.+Wangauthor=R.+Kapoorauthor=M.+J.+Ondrechenauthor=L.+Rubenauthor=M.+P.+Pollastri&title=The+human+Aurora+kinase+inhibitor+danusertib+is+a+lead+compound+for+anti-trypanosomal+drug+discovery+via+target+repurposing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOchiana%26aufirst%3DS.%2BO.%26aulast%3DPandarinath%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DKapoor%26aufirst%3DR.%26aulast%3DOndrechen%26aufirst%3DM.%2BJ.%26aulast%3DRuben%26aufirst%3DL.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DThe%2520human%2520Aurora%2520kinase%2520inhibitor%2520danusertib%2520is%2520a%2520lead%2520compound%2520for%2520anti-trypanosomal%2520drug%2520discovery%2520via%2520target%2520repurposing%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D62%26spage%3D777%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Diaz-Gonzalez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhlmann, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galan-Rodriguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira da Silva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saldivia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karver, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beverley, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing</span> <span class="citation_source-journal">PLoS Negl. Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=e1297&author=R.+Diaz-Gonzalezauthor=F.+M.+Kuhlmannauthor=C.+Galan-Rodriguezauthor=L.+Madeira+da+Silvaauthor=M.+Saldiviaauthor=C.+E.+Karverauthor=A.+Rodriguezauthor=S.+M.+Beverleyauthor=M.+Navarroauthor=M.+P.+Pollastri&title=The+susceptibility+of+trypanosomatid+pathogens+to+PI3%2FmTOR+kinase+inhibitors+affords+a+new+opportunity+for+drug+repurposing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz-Gonzalez%26aufirst%3DR.%26aulast%3DKuhlmann%26aufirst%3DF.%2BM.%26aulast%3DGalan-Rodriguez%26aufirst%3DC.%26aulast%3DMadeira%2Bda%2BSilva%26aufirst%3DL.%26aulast%3DSaldivia%26aufirst%3DM.%26aulast%3DKarver%26aufirst%3DC.%2BE.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DBeverley%26aufirst%3DS.%2BM.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DThe%2520susceptibility%2520of%2520trypanosomatid%2520pathogens%2520to%2520PI3%252FmTOR%2520kinase%2520inhibitors%2520affords%2520a%2520new%2520opportunity%2520for%2520drug%2520repurposing%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2011%26volume%3D5%26spage%3De1297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">de Koning, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterk, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenor, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luginbuehl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seebeck, T.</span><span> </span><span class="NLM_article-title">Pharmacological validation of <i>Trypanosoma brucei</i> phosphodiesterases as novel drug targets</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1093%2Finfdis%2Fjir857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=22291195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVaiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2012&pages=229-237&author=H.+P.+de+Koningauthor=M.+K.+Gouldauthor=G.+J.+Sterkauthor=H.+Tenorauthor=S.+Kunzauthor=E.+Luginbuehlauthor=T.+Seebeck&title=Pharmacological+validation+of+Trypanosoma+brucei+phosphodiesterases+as+novel+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Validation of Trypanosoma brucei Phosphodiesterases as Novel Drug Targets</span></div><div class="casAuthors">de Koning, Harry P.; Gould, Matthew K.; Sterk, Geert Jan; Tenor, Hermann; Kunz, Stefan; Luginbuehl, Edith; Seebeck, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-237</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The development of drugs for neglected infectious diseases often uses parasite-specific enzymes as targets.  We here demonstrate that parasite enzymes with highly conserved human homologs may represent a promising reservoir of new potential drug targets.  The cyclic nucleotide-specific phosphodiesterases (PDEs) of Trypanosoma brucei, causative agent of the fatal human sleeping sickness, are essential for the parasite.  The highly conserved human homologs are well-established drug targets.  We here describe what is to our knowledge the first pharmacol. validation of trypanosomal PDEs as drug targets.  High-throughput screening of a proprietary compd. library identified a no. of potent hits.  One compd., the tetrahydrophthalazinone compd. A (Cpd A), was further characterized.  It causes a dramatic increase of intracellular cyclic adenosine monophosphate (cAMP).  Short-term cell viability is not affected, but cell proliferation is inhibited immediately, and cell death occurs within 3 days.  Cpd A prevents cytokinesis, resulting in multinucleated, multiflagellated cells that eventually lyse.  These observations pharmacol. validate the highly conserved trypanosomal PDEs as potential drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7qBOV9RqH9LVg90H21EOLACvtfcHk0lgzgtUtmAYPhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVaiurg%253D&md5=541bc0e9cf3f9a30c102d873abeb7181</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjir857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjir857%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BKoning%26aufirst%3DH.%2BP.%26aulast%3DGould%26aufirst%3DM.%2BK.%26aulast%3DSterk%26aufirst%3DG.%2BJ.%26aulast%3DTenor%26aufirst%3DH.%26aulast%3DKunz%26aufirst%3DS.%26aulast%3DLuginbuehl%26aufirst%3DE.%26aulast%3DSeebeck%26aufirst%3DT.%26atitle%3DPharmacological%2520validation%2520of%2520Trypanosoma%2520brucei%2520phosphodiesterases%2520as%2520novel%2520drug%2520targets%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D206%26spage%3D229%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Beghyn, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laconde, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span> </span><span class="NLM_article-title">Drug to genome to drug: discovery of new antiplasmodial compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3222</span><span class="NLM_x">–</span> <span class="NLM_lpage">3240</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1014617" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3222-3240&author=T.+B.+Beghynauthor=J.+Chartonauthor=F.+Lerouxauthor=G.+Lacondeauthor=A.+Bourinauthor=P.+Cosauthor=L.+Maesauthor=B.+Deprez&title=Drug+to+genome+to+drug%3A+discovery+of+new+antiplasmodial+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Drug to Genome to Drug: Discovery of New Antiplasmodial Compounds</span></div><div class="casAuthors">Beghyn, Terence B.; Charton, Julie; Leroux, Florence; Laconde, Guillaume; Bourin, Arnaud; Cos, Paul; Maes, Louis; Deprez, Benoit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3222-3240</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dominant strategy for discovery of new antimalarial drugs relies on cell-free assays on specific biochem. pathways of Plasmodium falciparum.  However, it appears that screening directly on the parasite is a more rewarding approach.  The "drug to genome to drug" approach consists of testing a small set of structural analogs of a drug acting on human proteins that have plasmodial orthologues.  Both man and plasmodium possess cyclic nucleotide phosphodiesterases (PDEs) that are key players of cell homeostasis.  We synthesized and tested 40 analogs of tadalafil, a human PDE5 inhibitor, on P. falciparum in culture and obtained potent inhibitors of parasite growth.  We discuss the structure-activity relationships, which support the hypothesis that our compds. kill the parasite via inhibition of plasmodial PDE activity.  We also prove that antiplasmodial derivs. inhibit the hydrolysis of cyclic nucleotides of the parasite, validating the cAMP/cGMP pathways as therapeutic targets against Plasmodium falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYOJ83XRZb3bVg90H21EOLACvtfcHk0lgzgtUtmAYPhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVCmu7Y%253D&md5=970cf7f4d8dbd6d9fbd597bc9bf13a35</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm1014617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1014617%26sid%3Dliteratum%253Aachs%26aulast%3DBeghyn%26aufirst%3DT.%2BB.%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DLaconde%26aufirst%3DG.%26aulast%3DBourin%26aufirst%3DA.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DDeprez%26aufirst%3DB.%26atitle%3DDrug%2520to%2520genome%2520to%2520drug%253A%2520discovery%2520of%2520new%2520antiplasmodial%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3222%26epage%3D3240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Nwaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, A.</span><span> </span><span class="NLM_article-title">Innovative lead discovery strategies for tropical diseases</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=941-955&author=S.+Nwakaauthor=A.+Hudson&title=Innovative+lead+discovery+strategies+for+tropical+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNwaka%26aufirst%3DS.%26aulast%3DHudson%26aufirst%3DA.%26atitle%3DInnovative%2520lead%2520discovery%2520strategies%2520for%2520tropical%2520diseases%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D941%26epage%3D955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Chahrour, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omran, Z.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitors as anti-cancer therapeutics</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=399-411&author=O.+Chahrourauthor=D.+Cairnsauthor=Z.+Omran&title=Small+molecule+kinase+inhibitors+as+anti-cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChahrour%26aufirst%3DO.%26aulast%3DCairns%26aufirst%3DD.%26aulast%3DOmran%26aufirst%3DZ.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitors%2520as%2520anti-cancer%2520therapeutics%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D399%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Page, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smolinska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbaniak, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foxwell, B. M.</span><span> </span><span class="NLM_article-title">Tyrosine kinases and inflammatory signalling</span> <span class="citation_source-journal">Curr. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.2174%2F156652409787314507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=19199943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=69-85&author=T.+H.+Pageauthor=M.+Smolinskaauthor=J.+Gillespieauthor=A.+M.+Urbaniakauthor=B.+M.+Foxwell&title=Tyrosine+kinases+and+inflammatory+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinases and inflammatory signalling</span></div><div class="casAuthors">Page, Theresa H.; Smolinska, Maria; Gillespie, Justin; Urbaniak, Anna M.; Foxwell, Brian M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Molecular Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-85</span>CODEN:
                <span class="NLM_cas:coden">CMMUBP</span>;
        ISSN:<span class="NLM_cas:issn">1566-5240</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The activity of tyrosine kinases is central to many cellular processes, and accumulating evidence suggests that their role in inflammation is no less profound.  Three main tyrosine kinase families, the Src, Tec and Syk kinase families are intimately involved in TLR signalling, the crit. first step in cellular recognition of invading pathogens and tissue damage.  Their activity results in changes in gene expression in affected cells.  Key amongst these genes are the cytokines, which orchestrate both the duration and extent of inflammation.  Tyrosine kinases also play important roles in cytokine function, and are implicated in signalling through both pro- and anti-inflammatory cytokines such as TNF, IL-6 and IL-10.  Thus, strategies to modulate tyrosine kinase activity have significant therapeutic potential in combating the chronic inflammatory state that is typical of many major health issues that face us today, including Rheumatoid Arthritis, Cardiovascular disease and cancer.  Here we review current knowledge of the role of tyrosine kinases in inflammation with particular emphasis on their role in TLR signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP5SfZlsc1LrVg90H21EOLACvtfcHk0ljK8nx4r-rAGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSgsb8%253D&md5=921639d539c31fe42df8a56236bd13c9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F156652409787314507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156652409787314507%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DT.%2BH.%26aulast%3DSmolinska%26aufirst%3DM.%26aulast%3DGillespie%26aufirst%3DJ.%26aulast%3DUrbaniak%26aufirst%3DA.%2BM.%26aulast%3DFoxwell%26aufirst%3DB.%2BM.%26atitle%3DTyrosine%2520kinases%2520and%2520inflammatory%2520signalling%26jtitle%3DCurr.%2520Mol.%2520Med.%26date%3D2009%26volume%3D9%26spage%3D69%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caramori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adcock, I. M.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Phosphatidylinositol 3-Kinase Inhibitors in Inflammatory Respiratory Disease</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1124%2Fjpet.106.111674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=17021257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVSks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=1-8&author=K.+Itoauthor=G.+Caramoriauthor=I.+M.+Adcock&title=Therapeutic+Potential+of+Phosphatidylinositol+3-Kinase+Inhibitors+in+Inflammatory+Respiratory+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease</span></div><div class="casAuthors">Ito, Kazuhiro; Caramori, Gaetano; Adcock, Ian M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase(s) (PI3K) are a family of proteins that catalyze the phosphorylation of the 3-OH position of phosphoinositides and generate lipids that control a wide variety of intracellular signaling pathways.  They are classified into three families according to their structure and substrate specificity and are thought to have distinct biol. roles.  Recent studies suggested that numerous components of the PI3K pathway play a crucial role in the expression and activation of inflammatory mediators, inflammatory cell recruitment, immune cell function, airway remodeling, and corticosteroid insensitivity in chronic inflammatory respiratory disease.  Selective PI3K inhibitors have been developed that reduce inflammation and some characteristics of disease in exptl. animal models.  Targeting specific PI3K isoforms that may be overexpressed or overactive in disease should allow for selective treatment of respiratory diseases.  Encouraging data from animal models, primary cells and clin. studies in other diseases suggest that inhibitors of PI3K/Akt may prove to be useful novel therapies in the treatment of asthma and chronic obstructive pulmonary disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGragTLs5kLAG7Vg90H21EOLACvtfcHk0ljK8nx4r-rAGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVSks70%253D&md5=560fb10d63224617939f976512dd06c2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.111674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.111674%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DK.%26aulast%3DCaramori%26aufirst%3DG.%26aulast%3DAdcock%26aufirst%3DI.%2BM.%26atitle%3DTherapeutic%2520Potential%2520of%2520Phosphatidylinositol%25203-Kinase%2520Inhibitors%2520in%2520Inflammatory%2520Respiratory%2520Disease%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Louvet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szot, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bluestone, J. A.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">18895</span><span class="NLM_x">–</span> <span class="NLM_lpage">18900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=18895-18900&author=C.+Louvetauthor=G.+L.+Szotauthor=J.+Langauthor=M.+R.+Leeauthor=N.+Martinierauthor=G.+Bollagauthor=S.+Zhuauthor=A.+Weissauthor=J.+A.+Bluestone&title=Tyrosine+kinase+inhibitors+reverse+type+1+diabetes+in+nonobese+diabetic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLouvet%26aufirst%3DC.%26aulast%3DSzot%26aufirst%3DG.%2BL.%26aulast%3DLang%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DMartinier%26aufirst%3DN.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DBluestone%26aufirst%3DJ.%2BA.%26atitle%3DTyrosine%2520kinase%2520inhibitors%2520reverse%2520type%25201%2520diabetes%2520in%2520nonobese%2520diabetic%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D18895%26epage%3D18900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wagman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, D. E.</span><span> </span><span class="NLM_article-title">Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1105</span><span class="NLM_x">–</span> <span class="NLM_lpage">1137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.2174%2F1381612043452668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=15078145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivF2iu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1105-1137&author=A.+S.+Wagmanauthor=K.+W.+Johnsonauthor=D.+E.+Bussiere&title=Discovery+and+development+of+GSK3+inhibitors+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes</span></div><div class="casAuthors">Wagman, Allan S.; Johnson, Kirk W.; Bussiere, Dirksen E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1105-1137</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Originally identified as a modulator of glycogen metab., glycogen synthase kinase-3 (GSK3) is now understood to play an important regulatory role in a variety of pathways including initiation of protein synthesis, cell proliferation, cell differentiation, apoptosis, and is essential for embryonic development as a component of the Wnt signaling cascade.  GSK3 can be considered as a target for both metabolic and neurol. disorders.  GSK3's assocn. with neuronal apoptosis and hyper-phosphorylation of tau make this kinase an attractive therapeutic target for neurodegenerative conditions such as head trauma, stroke, and Alzheimer's disease.  While noting GSK3's many assocd. functions, this review will focus on GSK3 as a central neg. regulator in the insulin signaling pathway, its role in insulin resistance, and the utility of GSK3 inhibitors for intervention and control of metabolic diseases including type 2 diabetes.  Recent crystal structures, including the active (phosphorylated Tyr-216) form of GSK3β, provide a wealth of structural information and greater understanding of GSK3's unique regulation and substrate specificity.  Many potent and selective small mol. inhibitors of GSK3 have now been identified, and used in vitro to modulate glycogen metab. and gene transcription, increase glycogen synthase activity and enhance insulin-stimulated glucose transport.  The pharmacol. of potent and selective GSK3 inhibitors (CT 99021 and CT 20026) is described in a no. of in vitro and in vivo models following acute or chronic exposure.  The efficacy of clin. candidates in diabetic primates and the implications for clin. development are discussed.  The profile of activity is consistent with a unique form of insulin sensitization which is well suited for indications such as metabolic syndrome X and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqncX-9ISkjCLVg90H21EOLACvtfcHk0liE9Ws0nqPkIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivF2iu74%253D&md5=9f4663cd4bf90fc0916fe49e0ed8076c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1381612043452668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043452668%26sid%3Dliteratum%253Aachs%26aulast%3DWagman%26aufirst%3DA.%2BS.%26aulast%3DJohnson%26aufirst%3DK.%2BW.%26aulast%3DBussiere%26aufirst%3DD.%2BE.%26atitle%3DDiscovery%2520and%2520development%2520of%2520GSK3%2520inhibitors%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D1105%26epage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Chico, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, D. M.</span><span> </span><span class="NLM_article-title">Targeting protein kinases in central nervous system disorders</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=892-909&author=L.+K.+Chicoauthor=L.+J.+Van+Eldikauthor=D.+M.+Watterson&title=Targeting+protein+kinases+in+central+nervous+system+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChico%26aufirst%3DL.%2BK.%26aulast%3DVan%2BEldik%26aufirst%3DL.%2BJ.%26aulast%3DWatterson%26aufirst%3DD.%2BM.%26atitle%3DTargeting%2520protein%2520kinases%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D892%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Natoli, C.</span><span> </span><span class="NLM_article-title">Tyrosine Kinase Inhibitors</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.2174%2F156800910791517208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=20384577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWlsLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=462&author=C.+Natoli&title=Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinase inhibitors</span></div><div class="casAuthors">Natoli, C.; Perrucci, B.; Perrotti, F.; Falchi, L.; Iacobelli, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">462-483</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the last ten years, several new and therapeutically relevant cancer drugs targeting tyrosine kinase signaling pathways have been developed.  Tyrosine kinase inhibitors (TKIs) are a pharmaceutical class of small mols., orally available, well-tolerated, worldwide approved drugs for the treatment of several neoplasms, including lung, breast, kidney and pancreatic cancer as well as gastro-intestinal stromal tumors and chronic myeloid leukemia.  This comprehensive review focuses on the most relevant members of the first and the second generation TKIs designed to interact with receptor and nonreceptor TKs.  Attention is mainly focused on mol. mechanisms in in vitro and in vivo models related to the clin. activity of the drugs and to the development of resistance to treatment, still the major challenge in cancer research and care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLC0hSF4ig7rVg90H21EOLACvtfcHk0liE9Ws0nqPkIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWlsLnE&md5=eefddbc808fc8075376e1cc06fc92566</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F156800910791517208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800910791517208%26sid%3Dliteratum%253Aachs%26aulast%3DNatoli%26aufirst%3DC.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2010%26volume%3D10%26spage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lackey, K. E.</span><span> </span><span class="NLM_article-title">Lessons from the drug discovery of lapatinib, a dual ErbB1/2 tyrosine kinase inhibitor</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.2174%2F156802606776743156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=16719802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtV2juro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=435-460&author=K.+E.+Lackey&title=Lessons+from+the+drug+discovery+of+lapatinib%2C+a+dual+ErbB1%2F2+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from the drug discovery of Lapatinib, a dual ErbB1/2 tyrosine Kinase inhibitor</span></div><div class="casAuthors">Lackey, Karen E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">435-460</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein Kinases offer many opportunities for drug intervention points since phosphorylation is the most common post-translational modification.  Phosphorylation regulates activity, location, degrdn., and conformation and the aberrant activity is implicated in many diseases, including cancer, inflammation, cardiovascular, and central nervous system diseases.  The focus of this review will be on the generation of highly effective signaling inhibitors targeting members of the erbB family of receptor tyrosine kinases, EGFR and ErbB-2, also known as transmembrane Type 1 receptor tyrosine kinases of the HER family of receptors.  Ligand binding to the receptor causes a conformational change which activates the tyrosine kinase domain leading to autophosphorylation.  This autophosphorylation activates the RAS/mitogen-activated protein (MAP) kinase and phosphoinositol-3-kinase (PI3K) pathways leading to a myriad of signaling and cellular activities.  Type 1 receptors are overexpressed in a variety of cancers and generally correlate with poor prognosis.  For this reason, scientists at GlaxoSmithKline and many others in the scientific community target the ATP binding site of the intracellular portion of the protein to block the aberrant signaling event.  This review intends to cover the lessons learned in the discovery of Lapatinib (GW572016, GW2016) by pulling together the various different publications that have been generated in distinct disciplines on aspects of the drug discovery program.  Data analyses and correlation of assay data to help with the design of drug-like mols. are included and demonstrate a break from the traditional focus on abs. potency as a guiding factor in lead compd. selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnKhQE45WWsbVg90H21EOLACvtfcHk0liE9Ws0nqPkIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtV2juro%253D&md5=5bb70c03abc1fb8c301cac0f5f713fbe</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F156802606776743156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776743156%26sid%3Dliteratum%253Aachs%26aulast%3DLackey%26aufirst%3DK.%2BE.%26atitle%3DLessons%2520from%2520the%2520drug%2520discovery%2520of%2520lapatinib%252C%2520a%2520dual%2520ErbB1%252F2%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D435%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Johannessen, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringerike, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madshus, I. H.</span><span> </span><span class="NLM_article-title">Epidermal growth factor receptor efficiently activates mitogen-activated protein kinase in HeLa cells and Hep2 cells conditionally defective in clathrin-dependent endocytosis</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1006%2Fexcr.2000.5004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=11010818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVeitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=2000&pages=136-145&author=L.+E.+Johannessenauthor=T.+Ringerikeauthor=J.+Molnesauthor=I.+H.+Madshus&title=Epidermal+growth+factor+receptor+efficiently+activates+mitogen-activated+protein+kinase+in+HeLa+cells+and+Hep2+cells+conditionally+defective+in+clathrin-dependent+endocytosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal growth factor receptor efficiently activates mitogen-activated protein kinase in HeLa cells and Hep2 cells conditionally defective in clathrin-dependent endocytosis</span></div><div class="casAuthors">Johannessen, Lene Elisabeth; Ringerike, Tove; Molnes, Janne; Madshus, Inger Helene</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">136-145</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Epidermal growth factor (EGF)-induced signaling was investigated in cells conditionally defective in clathrin-dependent endocytosis by overexpression of K44A dynamin in HeLa cells and potassium depletion in Hep2 cells.  Overexpression of mutant dynamin disrupts high-affinity EGF-EGF receptor (EGFR) interaction.  However, the EGFR substrates Shc and c-Cbl were as efficiently tyrosine phosphorylated in endocytosis-deficient HeLa cells exhibiting only low-affinity EGFRs as in HeLa cells with intact endocytosis and with both high- and low-affinity EGFRs.  Both Raf and mitogen-activated protein kinase (MAPK) were activated to the same extent and with the same kinetics.  HeLa cells distributed equally in the cell cycle regardless of EGFR internalization.  Upon potassium depletion of Hep2 cells, EGF-induced EGFR endocytosis was inhibited.  However, the EGFR and MAPK were efficiently activated by EGF in both the absence and the presence of clathrin-dependent endocytosis.  The EGFR was weakly tyrosine phosphorylated by potassium depletion even in the absence of EGF, and this activation resulted in detectable activation of MAPK.  The authors' results demonstrate that internalization of EGFR by clathrin-dependent endocytosis is not required for activation of MAPK.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWJNrMDja0crVg90H21EOLACvtfcHk0liW-AwEqewBDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVeitbY%253D&md5=48a9cb8198da4909bf9982096eb44886</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1006%2Fexcr.2000.5004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.2000.5004%26sid%3Dliteratum%253Aachs%26aulast%3DJohannessen%26aufirst%3DL.%2BE.%26aulast%3DRingerike%26aufirst%3DT.%26aulast%3DMolnes%26aufirst%3DJ.%26aulast%3DMadshus%26aufirst%3DI.%2BH.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520efficiently%2520activates%2520mitogen-activated%2520protein%2520kinase%2520in%2520HeLa%2520cells%2520and%2520Hep2%2520cells%2520conditionally%2520defective%2520in%2520clathrin-dependent%2520endocytosis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2000%26volume%3D260%26spage%3D136%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Naula, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mottram, J. C.</span><span> </span><span class="NLM_article-title">Protein kinases as drug targets in trypanosomes and <i>Leishmania</i></span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1754</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1754&publication_year=2005&pages=151-159&author=C.+Naulaauthor=M.+Parsonsauthor=J.+C.+Mottram&title=Protein+kinases+as+drug+targets+in+trypanosomes+and+Leishmania"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaula%26aufirst%3DC.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DMottram%26aufirst%3DJ.%2BC.%26atitle%3DProtein%2520kinases%2520as%2520drug%2520targets%2520in%2520trypanosomes%2520and%2520Leishmania%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1754%26spage%3D151%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Oduor, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkinson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holler, T. P.</span><span> </span><span class="NLM_article-title"><i>Trypanosoma brucei</i> Glycogen Synthase Kinase-3, A Target for Anti-Trypanosomal Drug Development: A Public–Private Partnership to Identify Novel Leads</span> <span class="citation_source-journal">PLoS Negl. Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1017</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=e1017&author=R.+O.+Oduorauthor=K.+K.+Ojoauthor=G.+P.+Williamsauthor=F.+Bertelliauthor=J.+Millsauthor=L.+Maesauthor=D.+C.+Prydeauthor=T.+Parkinsonauthor=W.+C.+Van+Voorhisauthor=T.+P.+Holler&title=Trypanosoma+brucei+Glycogen+Synthase+Kinase-3%2C+A+Target+for+Anti-Trypanosomal+Drug+Development%3A+A+Public%E2%80%93Private+Partnership+to+Identify+Novel+Leads"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOduor%26aufirst%3DR.%2BO.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DWilliams%26aufirst%3DG.%2BP.%26aulast%3DBertelli%26aufirst%3DF.%26aulast%3DMills%26aufirst%3DJ.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DParkinson%26aufirst%3DT.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DHoller%26aufirst%3DT.%2BP.%26atitle%3DTrypanosoma%2520brucei%2520Glycogen%2520Synthase%2520Kinase-3%252C%2520A%2520Target%2520for%2520Anti-Trypanosomal%2520Drug%2520Development%253A%2520A%2520Public%25E2%2580%2593Private%2520Partnership%2520to%2520Identify%2520Novel%2520Leads%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2011%26volume%3D5%26spage%3De1017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Nett, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda-Saavedra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamont, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehlert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, M. A.</span><span> </span><span class="NLM_article-title">The phosphoproteome of bloodstream form <i>Trypanonosoma brucei</i>, causative agent of African sleeping sickness</span> <span class="citation_source-journal">Mol. Cell Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1527</span><span class="NLM_x">–</span> <span class="NLM_lpage">1538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1074%2Fmcp.M800556-MCP200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=19346560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1Gjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1527-1538&author=I.+R.+Nettauthor=D.+M.+Martinauthor=D.+Miranda-Saavedraauthor=D.+Lamontauthor=J.+D.+Barberauthor=A.+Mehlertauthor=M.+A.+Ferguson&title=The+phosphoproteome+of+bloodstream+form+Trypanonosoma+brucei%2C+causative+agent+of+African+sleeping+sickness"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphoproteome of bloodstream form Trypanosoma brucei, causative agent of African sleeping sickness</span></div><div class="casAuthors">Nett, Isabelle R. E.; Martin, David M. A.; Miranda-Saavedra, Diego; Lamont, Douglas; Barber, Jonathan D.; Mehlert, Angela; Ferguson, Michael A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Proteomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1527-1538</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9476</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The protozoan parasite Trypanosoma brucei is the causative agent of human African sleeping sickness and related animal diseases, and it has over 170 predicted protein kinases.  Protein phosphorylation is a key regulatory mechanism for cellular function that, thus far, has been studied in T. brucei principally through putative kinase mRNA knockdown and observation of the resulting phenotype.  However, despite the relatively large kinome of this organism and the demonstrated essentiality of several T. brucei kinases, very few specific phosphorylation sites have been detd. in this organism.  Using a gel-free, phosphopeptide enrichment-based proteomics approach the authors performed the first large scale phosphorylation site analyses for T. brucei.  Serine, threonine, and tyrosine phosphorylation sites were detd. for a cytosolic protein fraction of the bloodstream form of the parasite, resulting in the identification of 491 phosphoproteins based on the identification of 852 unique phosphopeptides and 1204 phosphorylation sites.  The phosphoproteins detected in this study are predicted from their genome annotations to participate in a wide variety of biol. processes, including signal transduction, processing of DNA and RNA, protein synthesis, and degrdn. and to a minor extent in metabolic pathways.  The anal. of phosphopeptides and phosphorylation sites was facilitated by inhouse developed software, and this automated approach was validated by manual annotation of spectra of the kinase subset of proteins.  Anal. of the cytosolic bloodstream form T. brucei kinome revealed the presence of 44 phosphorylated protein kinases in the authors' data set that could be classified into the major eukaryotic protein kinase groups by applying a multilevel hidden Markov model library of the kinase catalytic domain.  Identification of the kinase phosphorylation sites showed conserved phosphorylation sequence motifs in several kinase activation segments, supporting the view that phosphorylation-based signaling is a general and fundamental regulatory process that extends to this highly divergent lower eukaryote.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJpegvn6bdjLVg90H21EOLACvtfcHk0liW-AwEqewBDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1Gjtbo%253D&md5=2df640c6ffcfbba8998d38c40decd9fc</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M800556-MCP200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M800556-MCP200%26sid%3Dliteratum%253Aachs%26aulast%3DNett%26aufirst%3DI.%2BR.%26aulast%3DMartin%26aufirst%3DD.%2BM.%26aulast%3DMiranda-Saavedra%26aufirst%3DD.%26aulast%3DLamont%26aufirst%3DD.%26aulast%3DBarber%26aufirst%3DJ.%2BD.%26aulast%3DMehlert%26aufirst%3DA.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%26atitle%3DThe%2520phosphoproteome%2520of%2520bloodstream%2520form%2520Trypanonosoma%2520brucei%252C%2520causative%2520agent%2520of%2520African%2520sleeping%2520sickness%26jtitle%3DMol.%2520Cell%2520Proteomics%26date%3D2009%26volume%3D8%26spage%3D1527%26epage%3D1538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Nett, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamont, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, M. A.</span><span> </span><span class="NLM_article-title">Identification and specific localization of tyrosine-phosphorylated proteins in <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">Eukaryotic Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=617-626&author=I.+R.+Nettauthor=L.+Davidsonauthor=D.+Lamontauthor=M.+A.+Ferguson&title=Identification+and+specific+localization+of+tyrosine-phosphorylated+proteins+in+Trypanosoma+brucei"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNett%26aufirst%3DI.%2BR.%26aulast%3DDavidson%26aufirst%3DL.%26aulast%3DLamont%26aufirst%3DD.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520and%2520specific%2520localization%2520of%2520tyrosine-phosphorylated%2520proteins%2520in%2520Trypanosoma%2520brucei%26jtitle%3DEukaryotic%2520Cell%26date%3D2009%26volume%3D8%26spage%3D617%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Katiyar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span> </span><span class="NLM_article-title">Lapatinib-Binding Protein Kinases in the African Trypanosome: A General Method for Identification of Targets for Kinase-Directed Drugs in a Cell</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e56150</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e56150&author=S.+Katiyarauthor=I.+Kufarevaauthor=R.+Beheraauthor=Y.+Ogataauthor=M.+P.+Pollastriauthor=R.+Abagyanauthor=K.+Mensa-Wilmot&title=Lapatinib-Binding+Protein+Kinases+in+the+African+Trypanosome%3A+A+General+Method+for+Identification+of+Targets+for+Kinase-Directed+Drugs+in+a+Cell"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatiyar%26aufirst%3DS.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DBehera%26aufirst%3DR.%26aulast%3DOgata%26aufirst%3DY.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26atitle%3DLapatinib-Binding%2520Protein%2520Kinases%2520in%2520the%2520African%2520Trypanosome%253A%2520A%2520General%2520Method%2520for%2520Identification%2520of%2520Targets%2520for%2520Kinase-Directed%2520Drugs%2520in%2520a%2520Cell%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De56150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Slichenmyer, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">CI-1033, a pan-erbB tyrosine kinase inhibitor</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2FS0093-7754%2801%2990285-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=11706399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1Wgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=80-85&author=W.+J.+Slichenmyerauthor=W.+L.+Elliottauthor=D.+W.+Fry&title=CI-1033%2C+a+pan-erbB+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">CI-1033, a pan-erbB tyrosine kinase inhibitor</span></div><div class="casAuthors">Slichenmyer, William J.; Elliott, William L.; Fry, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5, Suppl. 16</span>),
    <span class="NLM_cas:pages">80-85</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">A review.  Overexpression of the erbB family of receptor tyrosine kinases has been implicated in a variety of tumors including breast, lung, prostate, and brain.  Most solid tumors express one or more of these receptors, which can often be related to tumor aggressiveness and poor patient prognosis.  CI-1033, a pan-erbB tyrosine kinase inhibitor, is a clin. promising agent that is active against all four members of the erbB receptor tyrosine kinase family.  In vitro studies of human cancer cell lines indicate that CI-1033 results in prompt, potent, and sustained inhibition of tyrosine kinase activity.  This inhibition is highly selective for erbBI (epidermal growth factor receptor), erbB2, erbB3, and erbB4 without inhibiting tyrosine kinase activity of receptors such as platelet-derived growth factor receptor, fibroblast growth factor receptor, and insulin receptor, even at high concns.  Treatment of athymic nude mice bearing xenografts of human A431 epidermoid carcinoma, H125 non-small cell lung carcinoma, and SF-767 glioblastoma results in highly significant suppression of tumor growth.  The major toxicity in animals is diarrhea, which is more severe at higher doses.  In animal models, all side effects are reversible on cessation of treatment.  Thus, CI-1033, which is currently undergoing phase I clin. trials, holds significant potential for use in a broad range of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWblWCZGMLQLVg90H21EOLACvtfcHk0lhnxP-4wAJm2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1Wgu7c%253D&md5=cc0507480a4182c3e52314750347b4c2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0093-7754%2801%2990285-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0093-7754%252801%252990285-4%26sid%3Dliteratum%253Aachs%26aulast%3DSlichenmyer%26aufirst%3DW.%2BJ.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DCI-1033%252C%2520a%2520pan-erbB%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DSemin.%2520Oncol.%26date%3D2001%26volume%3D28%26spage%3D80%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, N. L.</span><span> </span><span class="NLM_article-title">Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6255</span><span class="NLM_x">–</span> <span class="NLM_lpage">6263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1038%2Fsj.onc.1205794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=12214266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1yrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=6255-6263&author=W.+Xiaauthor=R.+J.+Mullinauthor=B.+R.+Keithauthor=L.+H.+Liuauthor=H.+Maauthor=D.+W.+Rusnakauthor=G.+Owensauthor=K.+J.+Alligoodauthor=N.+L.+Spector&title=Anti-tumor+activity+of+GW572016%3A+a+dual+tyrosine+kinase+inhibitor+blocks+EGF+activation+of+EGFR%2FerbB2+and+downstream+Erk1%2F2+and+AKT+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways</span></div><div class="casAuthors">Xia, Wenle; Mullin, Robert J.; Keith, Barry R.; Liu, Lei-Hua; Ma, Hong; Rusnak, David W.; Owens, Gary; Alligood, Krystal J.; Spector, Neil L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">6255-6263</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Dual EGFR/erbB2 inhibition is an attractive therapeutic strategy for epithelial tumors, as ligand-induced erbB2/EGFR heterodimerization triggers potent proliferative and survival signals.  Here we show that a small mol., GW572016, potently inhibits both EGFR and erbB2 tyrosine kinases leading to growth arrest and/or apoptosis in EGFR and erbB2-dependent tumor cell lines.  GW572016 markedly reduced tyrosine phosphorylation of EGFR and erbB2, and inhibited activation of Erk1/2 and AKT, downstream effectors of proliferation and cell survival, resp.  Complete inhibition of activated AKT in erbB2 overexpressing cells correlated with a 23-fold increase in apoptosis compared with vehicle controls.  EGF, often elevated in cancer patients, did not reverse the inhibitory effects of GW572016.  These observations were reproduced in vivo, where GW572016 treatment inhibited activation of EGFR, erbB2, Erk1/2 and AKT in human tumor xenografts.  Erk1/2 and AKT represent potential biomarkers to assess the clin. activity of GW572016.  Inhibition of activated AKT in EGFR or erbB2-dependent tumors by GW572016 may lead to tumor regressions when used as a monotherapy, or may enhance the anti-tumor activity of chemotherapeutics, since constitutive activation of AKT has been linked to chemo-resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYPkZ4sa88irVg90H21EOLACvtfcHk0lhnxP-4wAJm2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1yrs7w%253D&md5=38d6e25a7cfa1fdfe77fa2fea2c0aa0c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1205794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1205794%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DW.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DKeith%26aufirst%3DB.%2BR.%26aulast%3DLiu%26aufirst%3DL.%2BH.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DOwens%26aufirst%3DG.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DSpector%26aufirst%3DN.%2BL.%26atitle%3DAnti-tumor%2520activity%2520of%2520GW572016%253A%2520a%2520dual%2520tyrosine%2520kinase%2520inhibitor%2520blocks%2520EGF%2520activation%2520of%2520EGFR%252FerbB2%2520and%2520downstream%2520Erk1%252F2%2520and%2520AKT%2520pathways%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D6255%26epage%3D6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Traxler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegrini, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosios, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McSheehy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wartmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caravatti, G.</span><span> </span><span class="NLM_article-title">AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">4931</span><span class="NLM_x">–</span> <span class="NLM_lpage">4941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4931-4941&author=P.+Traxlerauthor=P.+R.+Allegriniauthor=R.+Brandtauthor=J.+Brueggenauthor=R.+Cozensauthor=D.+Fabbroauthor=K.+Grosiosauthor=H.+A.+Laneauthor=P.+McSheehyauthor=J.+Mestanauthor=T.+Meyerauthor=C.+Tangauthor=M.+Wartmannauthor=J.+Woodauthor=G.+Caravatti&title=AEE788%3A+a+dual+family+epidermal+growth+factor+receptor%2FErbB2+and+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitor+with+antitumor+and+antiangiogenic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26aulast%3DAllegrini%26aufirst%3DP.%2BR.%26aulast%3DBrandt%26aufirst%3DR.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DCozens%26aufirst%3DR.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGrosios%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DH.%2BA.%26aulast%3DMcSheehy%26aufirst%3DP.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DJ.%26aulast%3DCaravatti%26aufirst%3DG.%26atitle%3DAEE788%253A%2520a%2520dual%2520family%2520epidermal%2520growth%2520factor%2520receptor%252FErbB2%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%2520with%2520antitumor%2520and%2520antiangiogenic%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D4931%26epage%3D4941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Steverding, D.</span><span> </span><span class="NLM_article-title">The transferrin receptor of <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">Parasitol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2FS1383-5769%2899%2900018-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=11227758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADyaK1MXnvFelurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2000&pages=191-198&author=D.+Steverding&title=The+transferrin+receptor+of+Trypanosoma+brucei"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The transferrin receptor of Trypanosoma brucei</span></div><div class="casAuthors">Steverding, D.</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology International</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">191-198</span>CODEN:
                <span class="NLM_cas:coden">PAINFD</span>;
        ISSN:<span class="NLM_cas:issn">1383-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 48 refs.  Bloodstream forms of Trypanosoma brucei, the causative agent of sleeping sickness in humans, require transferrin for growth.  Uptake of host transferrin is mediated by a heterodimeric glycosylphosphatidylinositol-anchored receptor.  The trypanosomal transferrin receptor is homologous to the N-terminal domain of the variant surface glycoprotein (VSG) and bears no structural similarity with the human transferrin receptor.  In this review, the structure, biochem. properties and function of the transferrin receptor of T. brucei are summarized and compared to the transferrin receptor of mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX6PmydLq4M7Vg90H21EOLACvtfcHk0lijo6EFbAHYRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvFelurY%253D&md5=908454a736df5585098660d048e7b2ca</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS1383-5769%2899%2900018-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1383-5769%252899%252900018-5%26sid%3Dliteratum%253Aachs%26aulast%3DSteverding%26aufirst%3DD.%26atitle%3DThe%2520transferrin%2520receptor%2520of%2520Trypanosoma%2520brucei%26jtitle%3DParasitol.%2520Int.%26date%3D2000%26volume%3D48%26spage%3D191%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Subramanya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardin, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steverding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span> </span><span class="NLM_article-title">Glycosylphosphatidylinositol-specific phospholipase C regulates transferrin endocytosis in the African trypanosome</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">417</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2009&pages=685-694&author=S.+Subramanyaauthor=C.+F.+Hardinauthor=D.+Steverdingauthor=K.+Mensa-Wilmot&title=Glycosylphosphatidylinositol-specific+phospholipase+C+regulates+transferrin+endocytosis+in+the+African+trypanosome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanya%26aufirst%3DS.%26aulast%3DHardin%26aufirst%3DC.%2BF.%26aulast%3DSteverding%26aufirst%3DD.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26atitle%3DGlycosylphosphatidylinositol-specific%2520phospholipase%2520C%2520regulates%2520transferrin%2520endocytosis%2520in%2520the%2520African%2520trypanosome%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D417%26spage%3D685%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Subramanya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span> </span><span class="NLM_article-title">Diacylglycerol-stimulated endocytosis of transferrin in trypanosomatids is dependent on tyrosine kinase activity</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e8538</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e8538&author=S.+Subramanyaauthor=K.+Mensa-Wilmot&title=Diacylglycerol-stimulated+endocytosis+of+transferrin+in+trypanosomatids+is+dependent+on+tyrosine+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanya%26aufirst%3DS.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26atitle%3DDiacylglycerol-stimulated%2520endocytosis%2520of%2520transferrin%2520in%2520trypanosomatids%2520is%2520dependent%2520on%2520tyrosine%2520kinase%2520activity%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De8538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Behera, R.; Guyett, P.; Thomas, S.; Katiyar, S.; Ogata, Y.; Mensa-Wilmot, K.</span>,unpublished results</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Behera%2C+R.%3B+Guyett%2C+P.%3B+Thomas%2C+S.%3B+Katiyar%2C+S.%3B+Ogata%2C+Y.%3B+Mensa-Wilmot%2C+K.%2Cunpublished+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBehera%26aufirst%3DR." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Affleck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span> </span><span class="NLM_article-title">The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=12467226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=85-94&author=D.+W.+Rusnakauthor=K.+Lackeyauthor=K.+Affleckauthor=E.+R.+Woodauthor=K.+J.+Alligoodauthor=N.+Rhodesauthor=B.+R.+Keithauthor=D.+M.+Murrayauthor=W.+B.+Knightauthor=R.+J.+Mullinauthor=T.+M.+Gilmer&title=The+effects+of+the+novel%2C+reversible+epidermal+growth+factor+receptor%2FErbB-2+tyrosine+kinase+inhibitor%2C+GW2016%2C+on+the+growth+of+human+normal+and+tumor-derived+cell+lines+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo</span></div><div class="casAuthors">Rusnak, David W.; Lackey, Karen; Affleck, Karen; Wood, Edgar R.; Alligood, Krystal J.; Rhodes, Nelson; Keith, Barry R.; Murray, Doris M.; Knight, W. Blaine; Mullin, Robert J.; Gilmer, Tona M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-94</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) and ErbB-2 transmembrane tyrosine kinases are currently being targeted by various mechanisms in the treatment of cancer.  GW2016 is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, resp.  This report describes the efficacy in cell growth assays of GW2016 on human tumor cell lines overexpressing either EGFR or ErbB-2: HN5 (head and neck), A-431 (vulva), BT474 (breast), CaLu-3 (lung), and N87 (gastric).  Normal human foreskin fibroblasts, nontumorigenic epithelial cells (HB4a), and nonoverexpressing tumor cells (MCF-7 and T47D) were tested as neg. controls.  After 3 days of compd. exposure, av. IC50 values for growth inhibition in the EGFR- and ErbB-2-overexpressing tumor cell lines were <0.16 μM.  The av. selectivity for the tumor cells vs. the human foreskin fibroblast cell line was 100-fold.  Inhibition of EGFR and ErbB-2 receptor autophosphorylation and phosphorylation of the downstream modulator, AKT, was verified by Western blot anal. in the BT474 and HN5 cell lines.  As a measure of cytotoxicity vs. growth arrest, the HN5 and BT474 cells were assessed in an outgrowth assay after a transient exposure to GW2016.  The cells were treated for 3 days in five concns. of GW2016, and cell growth was monitored for an addnl. 12 days after removal of the compd.  In each of these tumor cell lines, concns. of GW2016 were reached where outgrowth did not occur.  Furthermore, growth arrest and cell death were obsd. in parallel expts., as detd. by bromodeoxyuridine incorporation and propidium iodide staining.  GW2016 treatment inhibited tumor xenograft growth of the HN5 and BT474 cells in a dose-responsive manner at 30 and 100 mg/kg orally, twice daily, with complete inhibition of tumor growth at the higher dose.  Together, these results indicate that GW2016 achieves excellent potency on tumor cells with selectivity for tumor vs. normal cells and suggest that GW2016 has value as a therapy for patients with tumors overexpressing either EGFR or ErbB-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5OJ41zsWu6rVg90H21EOLACvtfcHk0lijo6EFbAHYRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmtbs%253D&md5=64fd8cadce83eda3b9b82ab50f1e57b0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DLackey%26aufirst%3DK.%26aulast%3DAffleck%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DRhodes%26aufirst%3DN.%26aulast%3DKeith%26aufirst%3DB.%2BR.%26aulast%3DMurray%26aufirst%3DD.%2BM.%26aulast%3DKnight%26aufirst%3DW.%2BB.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26atitle%3DThe%2520effects%2520of%2520the%2520novel%252C%2520reversible%2520epidermal%2520growth%2520factor%2520receptor%252FErbB-2%2520tyrosine%2520kinase%2520inhibitor%252C%2520GW2016%252C%2520on%2520the%2520growth%2520of%2520human%2520normal%2520and%2520tumor-derived%2520cell%2520lines%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2001%26volume%3D1%26spage%3D85%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Petrov, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook, R. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K. E.</span><span> </span><span class="NLM_article-title">Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4686</span><span class="NLM_x">–</span> <span class="NLM_lpage">4691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2Fj.bmcl.2006.05.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=16777410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFOlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4686-4691&author=K.+G.+Petrovauthor=Y.+M.+Zhangauthor=M.+Carterauthor=G.+S.+Cockerillauthor=S.+Dickersonauthor=C.+A.+Gauthierauthor=Y.+Guoauthor=R.+A.+Mookauthor=D.+W.+Rusnakauthor=A.+L.+Walkerauthor=E.+R.+Woodauthor=K.+E.+Lackey&title=Optimization+and+SAR+for+dual+ErbB-1%2FErbB-2+tyrosine+kinase+inhibition+in+the+6-furanylquinazoline+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series</span></div><div class="casAuthors">Petrov, Kimberly G.; Zhang, Yue-Mei; Carter, Malcolm; Cockerill, G. Stuart; Dickerson, Scott; Gauthier, Cassandra A.; Guo, Yu; Mook, Robert A.; Rusnak, David W.; Walker, Ann L.; Wood, Edgar R.; Lackey, Karen E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4686-4691</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthetic modifications on a 6-furanylquinazoline scaffold to optimize the dual ErbB-1/ErbB-2 tyrosine kinase inhibition afforded consistent SAR whereby a 4-(3-fluorobenzyloxy)-3-haloanilino structure provided the best enzyme potency and cellular selectivity.  Changes made to the 6-furanyl group had little impact on the enzyme activity, but appeared to dramatically affect the cellular efficacy.  The discovery of lapatinib emerged from this work.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtejUjyH9in7Vg90H21EOLACvtfcHk0ljLuA6uV7Dk5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFOlu7o%253D&md5=946712927ab1a7940ea3ef2fea7574b5</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.05.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.05.090%26sid%3Dliteratum%253Aachs%26aulast%3DPetrov%26aufirst%3DK.%2BG.%26aulast%3DZhang%26aufirst%3DY.%2BM.%26aulast%3DCarter%26aufirst%3DM.%26aulast%3DCockerill%26aufirst%3DG.%2BS.%26aulast%3DDickerson%26aufirst%3DS.%26aulast%3DGauthier%26aufirst%3DC.%2BA.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DLackey%26aufirst%3DK.%2BE.%26atitle%3DOptimization%2520and%2520SAR%2520for%2520dual%2520ErbB-1%252FErbB-2%2520tyrosine%2520kinase%2520inhibition%2520in%2520the%25206-furanylquinazoline%2520series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4686%26epage%3D4691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Affleck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubberfield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guntrip, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jowett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stables, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignola, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadwell, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reep, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span> </span><span class="NLM_article-title">The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">7196</span><span class="NLM_x">–</span> <span class="NLM_lpage">7203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=11585755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsVeht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=7196-7203&author=D.+W.+Rusnakauthor=K.+Affleckauthor=S.+G.+Cockerillauthor=C.+Stubberfieldauthor=R.+Harrisauthor=M.+Pageauthor=K.+J.+Smithauthor=S.+B.+Guntripauthor=M.+C.+Carterauthor=R.+J.+Shawauthor=A.+Jowettauthor=J.+Stablesauthor=P.+Topleyauthor=E.+R.+Woodauthor=P.+S.+Brignolaauthor=S.+H.+Kadwellauthor=B.+R.+Reepauthor=R.+J.+Mullinauthor=K.+J.+Alligoodauthor=B.+R.+Keithauthor=R.+M.+Crosbyauthor=D.+M.+Murrayauthor=W.+B.+Knightauthor=T.+M.+Gilmerauthor=K.+Lackey&title=The+characterization+of+novel%2C+dual+ErbB-2%2FEGFR%2C+tyrosine+kinase+inhibitors%3A+potential+therapy+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer</span></div><div class="casAuthors">Rusnak, David W.; Affleck, Karen; Cockerill, Stuart G.; Stubberfield, Colin; Harris, Robert; Page, Martin; Smith, Kathryn J.; Guntrip, Stephen B.; Carter, Malcolm C.; Shaw, Robert J.; Jowett, Amanda; Stables, Jeremy; Topley, Peter; Wood, Edgar R.; Brignola, Perry S.; Kadwell, Sue H.; Reep, Bryan R.; Mullin, Robert J.; Alligood, Krystal J.; Keith, Barry R.; Crosby, Renae M.; Murray, Doris M.; Knight, W. Blaine; Gilmer, Tona M.; Lackey, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7196-7203</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The type 1 receptor tyrosine kinases constitute a family of transmembrane proteins involved in various aspects of cell growth and survival and have been implicated in the initiation and progression of several types of human malignancies.  The best characterized of these proteins are the epidermal growth factor receptor (EGFR) and ErbB-2 (HER-2/neu).  We have developed potent quinazoline and pyrido-[3,4-d]-pyrimidine small mols. that are dual inhibitors of ErbB-2 and EGFR.  The compds. demonstrate potent in vitro inhibition of the ErbB-2 and EGFR kinase domains with IC50s <80 nM.  Growth of ErbB-2- and EGFR-expressing tumor cell lines is inhibited at concns. <0.5 μM.  Selectivity for tumor cell growth inhibition vs. normal human fibroblast growth inhibition ranges from 10- to >75-fold.  Tumor growth in mouse s.c. xenograft models of the BT474 and HN5 cell lines is inhibited in a dose-responsive manner using oral doses of 10 and 30 mg/kg twice per day.  In addn., the tested compds. caused a redn. of ErbB-2 and EGFR autophosphorylation in tumor fragments from these xenograft models.  These data indicate that these compds. have potential use as therapy in the broad population of cancer patients overexpressing ErbB-2 and/or EGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoifUxgOrEfMLVg90H21EOLACvtfcHk0ljLuA6uV7Dk5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsVeht70%253D&md5=374cb1b4451356866a5060c5ff39a1d1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DAffleck%26aufirst%3DK.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DStubberfield%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DPage%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DGuntrip%26aufirst%3DS.%2BB.%26aulast%3DCarter%26aufirst%3DM.%2BC.%26aulast%3DShaw%26aufirst%3DR.%2BJ.%26aulast%3DJowett%26aufirst%3DA.%26aulast%3DStables%26aufirst%3DJ.%26aulast%3DTopley%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DBrignola%26aufirst%3DP.%2BS.%26aulast%3DKadwell%26aufirst%3DS.%2BH.%26aulast%3DReep%26aufirst%3DB.%2BR.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DKeith%26aufirst%3DB.%2BR.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DMurray%26aufirst%3DD.%2BM.%26aulast%3DKnight%26aufirst%3DW.%2BB.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DLackey%26aufirst%3DK.%26atitle%3DThe%2520characterization%2520of%2520novel%252C%2520dual%2520ErbB-2%252FEGFR%252C%2520tyrosine%2520kinase%2520inhibitors%253A%2520potential%2520therapy%2520for%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D7196%26epage%3D7203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, H.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C.</span><span> </span><span class="NLM_article-title">Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-<i>N</i>-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2000</span><span class="NLM_x">–</span> <span class="NLM_lpage">2009</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901453q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2000-2009&author=X.+Caiauthor=H.-X.+Zhaiauthor=J.+Wangauthor=J.+Forresterauthor=H.+Quauthor=L.+Yinauthor=C.-J.+Laiauthor=R.+Baoauthor=C.+Qian&title=Discovery+of+7-%284-%283-Ethynylphenylamino%29-7-methoxyquinazolin-6-yloxy%29-N-hydroxyheptanamide+%28CUDC-101%29+as+a+Potent+Multi-Acting+HDAC%2C+EGFR%2C+and+HER2+Inhibitor+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm901453q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901453q%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26aulast%3DZhai%26aufirst%3DH.-X.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DForrester%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DLai%26aufirst%3DC.-J.%26aulast%3DBao%26aufirst%3DR.%26aulast%3DQian%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25207-%25284-%25283-Ethynylphenylamino%2529-7-methoxyquinazolin-6-yloxy%2529-N-hydroxyheptanamide%2520%2528CUDC-101%2529%2520as%2520a%2520Potent%2520Multi-Acting%2520HDAC%252C%2520EGFR%252C%2520and%2520HER2%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2000%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eamyWgad5AjTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Webster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, W. R.</span><span> </span><span class="NLM_article-title">Endocytosis by African trypanosomes. II. Occurrence in different life-cycle stages and intracellular sorting</span> <span class="citation_source-journal">Eur. J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=2776776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A280%3ADyaL1Mznsl2htg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1989&pages=303-310&author=P.+Websterauthor=W.+R.+Fish&title=Endocytosis+by+African+trypanosomes.+II.+Occurrence+in+different+life-cycle+stages+and+intracellular+sorting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Endocytosis by African trypanosomes. II. Occurrence in different life-cycle stages and intracellular sorting</span></div><div class="casAuthors">Webster P; Fish W R</div><div class="citationInfo"><span class="NLM_cas:title">European journal of cell biology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-10</span>
        ISSN:<span class="NLM_cas:issn">0171-9335</span>.
    </div><div class="casAbstract">Horseradish peroxidase (HRP) and colloidal gold-labeled proteins enter many of the endocytic organelles of bloodstream forms of Trypanosoma brucei and T. congolense.  However, the colloidal gold markers were excluded from substantial parts of the pathway that contained HRP.  Morphometric studies revealed that HRP entered organelles that accounted for approximately 5% of the total cell volume while transferrin-gold entered organelles that comprised approximately 2% of the total cell volume.  In addition, large colloidal gold particles were excluded from organelles that contained smaller gold particles.  Antibodies, raised against the variable surface glycoprotein, when applied to thawed cryosections were found to label structures from which endocytosed colloidal gold coupled to bovine serum albumin (BSA) was excluded.  Endocytosis was shown to occur in two in vitro propagated forms of trypanosomes, similar to those found in the insect vector (Glossina spp.).  The mammal-infective metacyclic forms were similar to bloodstream forms in that they endocytosed HRP and colloidal gold markers but excluded colloidal gold from approximately 3% of the endocytic organelles.  Estimation of the flagellar pocket volumes of bloodstream form T. brucei showed that this organelle occupied 0.5% to 1.4% of the total cell volume.  The flagellar pocket volume of T. congolense varied between life-cycle stages, with a fractional volume of 4.4% for bloodstream forms, 2.3% for metacyclic forms and 1.4% for procyclic forms.  Endocytosis of HRP, but not of protein-gold markers, occurred in procyclic (uncoated) forms.  Endocytosis by procyclic forms has heretofore not been reported.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTJRIcIfUNTGlSCSgBhwJFfW6udTcc2eamyWgad5AjTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1Mznsl2htg%253D%253D&md5=a90995c0c5ebcf04068d1ce34f6c5b7b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWebster%26aufirst%3DP.%26aulast%3DFish%26aufirst%3DW.%2BR.%26atitle%3DEndocytosis%2520by%2520African%2520trypanosomes.%2520II.%2520Occurrence%2520in%2520different%2520life-cycle%2520stages%2520and%2520intracellular%2520sorting%26jtitle%3DEur.%2520J.%2520Cell%2520Biol.%26date%3D1989%26volume%3D49%26spage%3D303%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Hall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, M. C.</span><span> </span><span class="NLM_article-title">Both of the Rab5 subfamily small GTPases of <i>Trypanosoma brucei</i> are essential and required for endocytosis</span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2Fj.molbiopara.2004.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=15500917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovV2iu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2004&pages=67-77&author=B.+Hallauthor=C.+L.+Allenauthor=D.+Gouldingauthor=M.+C.+Field&title=Both+of+the+Rab5+subfamily+small+GTPases+of+Trypanosoma+brucei+are+essential+and+required+for+endocytosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Both of the Rab5 subfamily small GTPases of Trypanosoma brucei are essential and required for endocytosis</span></div><div class="casAuthors">Hall, Belinda; Allen, Clare L.; Goulding, David; Field, Mark C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-77</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Endocytosis is an essential process in Trypanosoma brucei, and all evidence suggests it is exclusively clathrin-mediated.  The trypanosome genome encodes two Rab5 proteins, small GTPases that play a role in very early stages of endocytosis.  In the mammalian bloodstream stage, TbRAB5A localizes to compartments contg. internalized antibody, variant surface glycoprotein (VSG) and transferrin, while TbRAB5B localizes to compartments contg. the transmembrane protein ISG100.  Dominant-active forms of TbRAB5A stimulate endocytosis in procyclic forms and alter the kinetics of anti-VSG antibody and transferrin turnover in bloodstream stages.  Similar mutants of TbRAB5B increase fluid phase uptake in procyclic cells but do not significantly affect endocytosis in bloodstream forms.  Here, the authors use RNA interference to evaluate the relative importance of TbRAB5A and TbRAB5B and show that both GTPases are essential in the bloodstream form.  Depletion of either TbRAB5A or TbRAB5B results in morphol. abnormalities, including enlargement of the flagellar pocket, consistent with a potent block to endocytosis.  Also, RNAi compromises transferrin accumulation in both cases but induces distinct patterns of mislocalization of endosomal markers.  Finally, RNAi of either TbRAB5A or TbRAB5B results in a decrease in levels of clathrin.  These data indicate that both TbRAB5A and TbRAB5B are required for endocytosis in trypanosomes and demonstrate that there are multiple essential endocytic routes in this organism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooc53lbbDSB7Vg90H21EOLACvtfcHk0lhLwZ4zaD5eog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovV2iu7o%253D&md5=700e2296f179bb8e9421c12c4fbef86f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2004.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2004.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DB.%26aulast%3DAllen%26aufirst%3DC.%2BL.%26aulast%3DGoulding%26aufirst%3DD.%26aulast%3DField%26aufirst%3DM.%2BC.%26atitle%3DBoth%2520of%2520the%2520Rab5%2520subfamily%2520small%2520GTPases%2520of%2520Trypanosoma%2520brucei%2520are%2520essential%2520and%2520required%2520for%2520endocytosis%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2004%26volume%3D138%26spage%3D67%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Hammarton, T. C.</span><span> </span><span class="NLM_article-title">Cell cycle regulation in <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2Fj.molbiopara.2007.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=17335918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFaltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2007&pages=1-8&author=T.+C.+Hammarton&title=Cell+cycle+regulation+in+Trypanosoma+brucei"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle regulation in Trypanosoma brucei</span></div><div class="casAuthors">Hammarton, Tansy C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cell division is regulated by intricate and interconnected signal transduction pathways that precisely coordinate, in time and space, the complex series of events involved in replicating and segregating the component parts of the cell.  In Trypanosoma brucei, considerable progress has been made over recent years in identifying mol. regulators of the cell cycle and elucidating their functions, although many regulators undoubtedly remain to be identified, and there is still a long way to go with respect to detg. signal transduction pathways.  However, it is clear that cell cycle regulation in T. brucei is unusual in many respects.  Analyses of trypanosome orthologs of conserved eukaryotic cell cycle regulators have demonstrated divergence of their function in the parasite, and a no. of other key regulators are missing from T. brucei.  Cell cycle regulation differs in different parasite life cycle stages, and T. brucei appears to use different checkpoint control strategies compared to model eukaryotes.  It is therefore probable that T. brucei has evolved novel pathways to control its cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiOO78xMMvWrVg90H21EOLACvtfcHk0lhLwZ4zaD5eog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFaltLk%253D&md5=c0c5a4804d3d60e2d2c7ec12279045b8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2007.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2007.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DHammarton%26aufirst%3DT.%2BC.%26atitle%3DCell%2520cycle%2520regulation%2520in%2520Trypanosoma%2520brucei%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2007%26volume%3D153%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Siegel, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hekstra, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, G. A.</span><span> </span><span class="NLM_article-title">Analysis of the <i>Trypanosoma brucei</i> cell cycle by quantitative DAPI imaging</span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2Fj.molbiopara.2008.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=18501977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Sntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2008&pages=171-174&author=T.+N.+Siegelauthor=D.+R.+Hekstraauthor=G.+A.+Cross&title=Analysis+of+the+Trypanosoma+brucei+cell+cycle+by+quantitative+DAPI+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the Trypanosoma brucei cell cycle by quantitative DAPI imaging</span></div><div class="casAuthors">Siegel, T. Nicolai; Hekstra, Doeke R.; Cross, George A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-174</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Trypanosoma brucei has two DNA compartments: the nucleus and the kinetoplast.  DNA replication of these two compartments only partially coincides.  Woodward and Gull comprehensively studied the relative timing of the replication and segregation of nuclear DNA (nDNA) and kinetoplast DNA (kDNA).  Others have since assumed the consistency of morphol. indicators of cell-cycle stage among strains and conditions.  We report the use of quant. DAPI imaging to det. the cell-cycle stage of individual procyclic cells.  Using this approach, we found that kinetoplast elongation occurs mainly during nuclear S phase and not during G2, as previously assumed.  We confirmed this finding by sorting cells by DNA content, followed by fluorescence microscopy.  In addn., simultaneous quant. imaging at two wavelengths can be used to det. the abundance of cell-cycle-regulated proteins during the cell cycle.  We demonstrate this technique by co-staining for the non-acetylated state of lysine 4 of histone H4 (H4K4), which is enriched during nuclear S phase.  The imaging program imageJ is available at http://rsb.info.nih.gov/ij/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWKvCmTEJRLVg90H21EOLACvtfcHk0lhLwZ4zaD5eog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1Sntbw%253D&md5=72f28e288bb773ed9ec20b5f9097b669</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2008.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2008.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DT.%2BN.%26aulast%3DHekstra%26aufirst%3DD.%2BR.%26aulast%3DCross%26aufirst%3DG.%2BA.%26atitle%3DAnalysis%2520of%2520the%2520Trypanosoma%2520brucei%2520cell%2520cycle%2520by%2520quantitative%2520DAPI%2520imaging%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2008%26volume%3D160%26spage%3D171%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hammarton, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnerat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mottram, J. C.</span><span> </span><span class="NLM_article-title">Cytokinesis in trypanosomatids</span> <span class="citation_source-journal">Curr. Opin. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2Fj.mib.2007.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=18023244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlyksrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=520-527&author=T.+C.+Hammartonauthor=S.+Monneratauthor=J.+C.+Mottram&title=Cytokinesis+in+trypanosomatids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokinesis in trypanosomatids</span></div><div class="casAuthors">Hammarton, Tansy C.; Monnerat, Severine; Mottram, Jeremy C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">520-527</span>CODEN:
                <span class="NLM_cas:coden">COMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1369-5274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The process of cytokinesis, where the cytoplasm of one cell is divided to produce two daughter cells, is intricate in trypanosomatids because of the requirement to replicate and segregate a no. of single copy organelles, including the nucleus, kinetoplast, Golgi app., and flagellum.  Identifying regulators of the three stages of cytokinesis, initiation, furrow ingression, and abscission is complicated by the fact that cell division in trypanosomatids is easily perturbed and aberrant cells are readily produced during functional characterization of gene products.  In this review, we discuss direct and indirect effects on cytokinesis, using Trypanosoma brucei as a model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAMwdXHP2rl7Vg90H21EOLACvtfcHk0lgI54h8C-Ifyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlyksrbF&md5=0411333499cfc5ecb8d79ea30c552213</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.mib.2007.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mib.2007.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DHammarton%26aufirst%3DT.%2BC.%26aulast%3DMonnerat%26aufirst%3DS.%26aulast%3DMottram%26aufirst%3DJ.%2BC.%26atitle%3DCytokinesis%2520in%2520trypanosomatids%26jtitle%3DCurr.%2520Opin.%2520Microbiol.%26date%3D2007%26volume%3D10%26spage%3D520%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Mackey, Z. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baca, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallari, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansell, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span> </span><span class="NLM_article-title">Discovery of trypanocidal compounds by whole cell HTS of <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1111%2Fj.1747-0285.2006.00389.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=16784460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVeqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=355-363&author=Z.+B.+Mackeyauthor=A.+M.+Bacaauthor=J.+P.+Mallariauthor=B.+Apselauthor=A.+Shelatauthor=E.+J.+Hansellauthor=P.+K.+Chiangauthor=B.+Wolffauthor=K.+R.+Guyauthor=J.+Williamsauthor=J.+H.+McKerrow&title=Discovery+of+trypanocidal+compounds+by+whole+cell+HTS+of+Trypanosoma+brucei"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei</span></div><div class="casAuthors">Mackey, Zachary B.; Baca, Arthur M.; Mallari, Jeremy P.; Apsel, Beth; Shelat, Anang; Hansell, Elizabeth J.; Chiang, Peter K.; Wolff, Brian; Guy, Kiplin R.; Williams, Janice; McKerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">355-363</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Chemotherapy against human African trypanosomiasis relies on four drugs that cause frequent and occasionally severe side-effects.  Because human African trypanosomiasis is a disease of poor people in Africa, the traditional market-driven pathways to drug development are not available.  One potentially rapid and cost-effective approach to identifying and developing new trypanocidal drugs would be high throughput-screening of existing drugs already approved for other uses, as well as clin. candidates in late development.  The authors have developed an ATP-bioluminescence assay that could be used to rapidly and efficiently screen compd. libraries against trypanosomes in a high throughput-screening format to validate this notion.  They screened a collection of 2160 FDA-approved drugs, bioactive compds. and natural products to identify hits that were cytotoxic to cultured Trypanosoma brucei at a concn. of 1 μM or less.  This meant that any hit identified would be effective at a concn. readily achievable by std. drug dosing in humans.  From the screen, 35 hits from seven different drug categories were identified.  These included the two approved trypanocidal drugs, suramin and pentamidine, several other drugs suspected but never validated as trypanocidal, and 17 novel trypanocidal drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe74ryTulvdrVg90H21EOLACvtfcHk0lgI54h8C-Ifyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVeqsbo%253D&md5=5b61478d2b9c3e22924e42af51ffb31f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2006.00389.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2006.00389.x%26sid%3Dliteratum%253Aachs%26aulast%3DMackey%26aufirst%3DZ.%2BB.%26aulast%3DBaca%26aufirst%3DA.%2BM.%26aulast%3DMallari%26aufirst%3DJ.%2BP.%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DShelat%26aufirst%3DA.%26aulast%3DHansell%26aufirst%3DE.%2BJ.%26aulast%3DChiang%26aufirst%3DP.%2BK.%26aulast%3DWolff%26aufirst%3DB.%26aulast%3DGuy%26aufirst%3DK.%2BR.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DDiscovery%2520of%2520trypanocidal%2520compounds%2520by%2520whole%2520cell%2520HTS%2520of%2520Trypanosoma%2520brucei%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D355%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+Desirable+Central+Nervous+System+Drug+Space+through+the+Alignment+of+Molecular+Properties%2C+in+Vitro+ADME%2C+and+Safety+Attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lgI54h8C-Ifyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520Desirable%2520Central%2520Nervous%2520System%2520Drug%2520Space%2520through%2520the%2520Alignment%2520of%2520Molecular%2520Properties%252C%2520in%2520Vitro%2520ADME%252C%2520and%2520Safety%2520Attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+To+Enable+Alignment+of+Druglike+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgI54h8C-Ifyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520To%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Iino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiki, J.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span> </span><span class="NLM_article-title">Discovery and structure–activity relationships of a novel class of quinazoline glucokinase activators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5531</span><span class="NLM_x">–</span> <span class="NLM_lpage">5538</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5531-5538&author=T.+Iinoauthor=Y.+Sasakiauthor=M.+Bambaauthor=M.+Mitsuyaauthor=A.+Ohnoauthor=K.+Kamataauthor=H.+Hosakaauthor=H.+Marukiauthor=M.+Futamuraauthor=R.+Yoshimotoauthor=S.+Ohyamaauthor=K.+Sasakiauthor=M.+Chibaauthor=N.+Ohtakeauthor=Y.+Nagataauthor=J.-i.+Eikiauthor=T.+Nishimura&title=Discovery+and+structure%E2%80%93activity+relationships+of+a+novel+class+of+quinazoline+glucokinase+activators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIino%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DBamba%26aufirst%3DM.%26aulast%3DMitsuya%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DA.%26aulast%3DKamata%26aufirst%3DK.%26aulast%3DHosaka%26aufirst%3DH.%26aulast%3DMaruki%26aufirst%3DH.%26aulast%3DFutamura%26aufirst%3DM.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DOhyama%26aufirst%3DS.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DOhtake%26aufirst%3DN.%26aulast%3DNagata%26aufirst%3DY.%26aulast%3DEiki%26aufirst%3DJ.-i.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520a%2520novel%2520class%2520of%2520quinazoline%2520glucokinase%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5531%26epage%3D5538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Mahboobi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichhorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongratz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span> </span><span class="NLM_article-title">Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrids as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8546</span><span class="NLM_x">–</span> <span class="NLM_lpage">8555</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100665z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8546-8555&author=S.+Mahboobiauthor=A.+Sellmerauthor=M.+Winklerauthor=E.+Eichhornauthor=H.+Pongratzauthor=T.+Ciossekauthor=T.+Baerauthor=T.+Maierauthor=T.+Beckers&title=Novel+Chimeric+Histone+Deacetylase+Inhibitors%3A+A+Series+of+Lapatinib+Hybrids+as+Potent+Inhibitors+of+Epidermal+Growth+Factor+Receptor+%28EGFR%29%2C+Human+Epidermal+Growth+Factor+Receptor+2+%28HER2%29%2C+and+Histone+Deacetylase+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm100665z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100665z%26sid%3Dliteratum%253Aachs%26aulast%3DMahboobi%26aufirst%3DS.%26aulast%3DSellmer%26aufirst%3DA.%26aulast%3DWinkler%26aufirst%3DM.%26aulast%3DEichhorn%26aufirst%3DE.%26aulast%3DPongratz%26aufirst%3DH.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DBaer%26aufirst%3DT.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DBeckers%26aufirst%3DT.%26atitle%3DNovel%2520Chimeric%2520Histone%2520Deacetylase%2520Inhibitors%253A%2520A%2520Series%2520of%2520Lapatinib%2520Hybrids%2520as%2520Potent%2520Inhibitors%2520of%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528EGFR%2529%252C%2520Human%2520Epidermal%2520Growth%2520Factor%2520Receptor%25202%2520%2528HER2%2529%252C%2520and%2520Histone%2520Deacetylase%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8546%26epage%3D8555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Hirumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirumi, K.</span><span> </span><span class="NLM_article-title">Axenic culture of African trypanosome bloodstream forms</span> <span class="citation_source-journal">Parasitol. Today.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2F0169-4758%2894%2990402-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=15275508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A280%3ADC%252BD2cznsVKktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1994&pages=80-84&author=H.+Hirumiauthor=K.+Hirumi&title=Axenic+culture+of+African+trypanosome+bloodstream+forms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Axenic culture of African trypanosome bloodstream forms</span></div><div class="casAuthors">Hirumi H; Hirumi K</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology today (Personal ed.)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">80-4</span>
        ISSN:<span class="NLM_cas:issn">0169-4758</span>.
    </div><div class="casAbstract">In this article, Hiroyuki Hirumi and Kazuko Hirumi review recent technical developments of in vitro systems that support the growth of bloodstream forms of African trypanosomes in the absence of mammalian feeder layer cells, which were required in earlier methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTTzbk2bNA7hFwe7cAcrfPfW6udTcc2eaAujWNNBkpG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cznsVKktQ%253D%253D&md5=0df2e001948ddaa4f2c114d9beef19e8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0169-4758%2894%2990402-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0169-4758%252894%252990402-2%26sid%3Dliteratum%253Aachs%26aulast%3DHirumi%26aufirst%3DH.%26aulast%3DHirumi%26aufirst%3DK.%26atitle%3DAxenic%2520culture%2520of%2520African%2520trypanosome%2520bloodstream%2520forms%26jtitle%3DParasitol.%2520Today.%26date%3D1994%26volume%3D10%26spage%3D80%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Ferrari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornasiero, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isetta, A. M.</span><span> </span><span class="NLM_article-title">MTT colorimetric assay for testing macrophage cytotoxic activity in vitro</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1016%2F0022-1759%2890%2990187-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=2391427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADyaK3cXmtV2nsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=1990&pages=165-172&author=M.+Ferrariauthor=M.+C.+Fornasieroauthor=A.+M.+Isetta&title=MTT+colorimetric+assay+for+testing+macrophage+cytotoxic+activity+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">MTT colorimetric assay for testing macrophage cytotoxic activity in vitro</span></div><div class="casAuthors">Ferrari, Mario; Fornasiero, Maria Chiara; Isetta, Anna Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-72</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">The MTT [3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide] cleavage assay, originally described by T. Mosmann (1983) for measuring cell survival/proliferation, was used successfully to quantitate macrophage-mediated cytotoxicity.  Peritoneal macrophages, from control or pyran copolymer MVE2-treated mice and from TU5 and L929 murine cell lines, were used as effectors and targets resp. in a 48 h cytotoxicity test, at 3 effector: target ratios (10:1, 5:1, 2:1).  The amt. of MTT reduced by cells to its blue formazan deriv. during an addnl. 4 h of culture was quantified spectrophotometrically at 570 nm using an ELISA reader.  A linear relationship between the formazan generated and the no. of viable TU5 and L929 cells was demonstrated, together with time-dependent growth characteristics for these cells.  The formazan produced by macrophages was independent of their functional state and did not interfere with the target cell signal.  MVE2-activated macrophages strongly inhibited the survival/growth of target cells in a dose-related way, whereas the cytotoxic activity of control macrophages was very low.  Finally, the MTT method compared favorably with the 3H-TdR uptake method in evaluating macrophage cytotoxicity, and both of them were more sensitive than the 3H-TdR release assay.  The MTT cleavage method is a useful alternative to radioisotopic methods for quantitating macrophage cytotoxicity for actively growing in vitro targets.  Its main advantages are: (a) sensitivity and reproducibility; (b) elimination of the need for radioactive compds.; (c) ease with which it can be performed and quantified; and (d) rapidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrezxA3w4p2ebVg90H21EOLACvtfcHk0lgDWIY6AZPgjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtV2nsLo%253D&md5=e0b83e032dccb6f10faa9fc8a8ca16ce</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2890%2990187-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252890%252990187-Z%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DM.%26aulast%3DFornasiero%26aufirst%3DM.%2BC.%26aulast%3DIsetta%26aufirst%3DA.%2BM.%26atitle%3DMTT%2520colorimetric%2520assay%2520for%2520testing%2520macrophage%2520cytotoxic%2520activity%2520in%2520vitro%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1990%26volume%3D131%26spage%3D165%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Sykes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moawad, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganame, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioset, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span> </span><span class="NLM_article-title">Identification of Compounds with Anti-Proliferative Activity against <i>Trypanosoma brucei brucei</i> Strain 427 by a Whole Cell Viability Based HTS Campaign</span> <span class="citation_source-journal">PLoS Negl. Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1896</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=e1896&author=M.+L.+Sykesauthor=J.+B.+Baellauthor=M.+Kaiserauthor=E.+Chatelainauthor=S.+R.+Moawadauthor=D.+Ganameauthor=J.-R.+Iosetauthor=V.+M.+Avery&title=Identification+of+Compounds+with+Anti-Proliferative+Activity+against+Trypanosoma+brucei+brucei+Strain+427+by+a+Whole+Cell+Viability+Based+HTS+Campaign"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DMoawad%26aufirst%3DS.%2BR.%26aulast%3DGaname%26aufirst%3DD.%26aulast%3DIoset%26aufirst%3DJ.-R.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26atitle%3DIdentification%2520of%2520Compounds%2520with%2520Anti-Proliferative%2520Activity%2520against%2520Trypanosoma%2520brucei%2520brucei%2520Strain%2520427%2520by%2520a%2520Whole%2520Cell%2520Viability%2520Based%2520HTS%2520Campaign%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2012%26volume%3D6%26spage%3De1896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Sokolova, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyllie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oza, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlamb, A. H.</span><span> </span><span class="NLM_article-title">Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2893</span><span class="NLM_x">–</span> <span class="NLM_lpage">2900</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm400349k&amp;key=10.1128%2FAAC.00332-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm400349k&amp;key=20439607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm400349k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVeltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=2893-2900&author=A.+Y.+Sokolovaauthor=S.+Wyllieauthor=S.+Pattersonauthor=S.+L.+Ozaauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=Cross-resistance+to+nitro+drugs+and+implications+for+treatment+of+human+African+trypanosomiasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis</span></div><div class="casAuthors">Sokolova, Antoaneta Y.; Wyllie, Susan; Patterson, Stephen; Oza, Sandra L.; Read, Kevin D.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2893-2900</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The success of nifurtimox-eflornithine combination therapy (NECT) for the treatment of human African trypanosomiasis (HAT) has renewed interest in the potential of nitro drugs as chemotherapeutics.  In order to study the implications of the more widespread use of nitro drugs against these parasites, we examd. the in vivo and in vitro resistance potentials of nifurtimox and fexinidazole and its metabolites.  Following selection in vitro by exposure to increasing concns. of nifurtimox, Trypanosoma brucei brucei nifurtimox-resistant clones designated NfxR1 and NfxR2 were generated.  Both cell lines were found to be 8-fold less sensitive to nifurtimox than parental cells and demonstrated cross-resistance to a no. of other nitro drugs, most notably the clin. trial candidate fexinidazole (∼27-fold more resistant than parental cells).  Studies of mice confirmed that the generation of nifurtimox resistance in these parasites did not compromise virulence, and NfxR1 remained resistant to both nifurtimox and fexinidazole in vivo.  In the case of fexinidazole, drug metab. and pharmacokinetic studies indicate that the parent drug is rapidly metabolized to the sulfoxide and sulfone form of this compd.  These metabolites retained trypanocidal activity but were less effective in nifurtimox-resistant lines.  Significantly, trypanosomes selected for resistance to fexinidazole were 10-fold more resistant to nifurtimox than parental cells.  This reciprocal cross-resistance has important implications for the therapeutic use of nifurtimox in a clin. setting and highlights a potential danger in the use of fexinidazole as a monotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpwMvjfLmRaLVg90H21EOLACvtfcHk0lh2X_Jv0Ki3mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVeltrY%253D&md5=3e34cfad24c02c4f41f5289b30fd9ad5</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1128%2FAAC.00332-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00332-10%26sid%3Dliteratum%253Aachs%26aulast%3DSokolova%26aufirst%3DA.%2BY.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DOza%26aufirst%3DS.%2BL.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DCross-resistance%2520to%2520nitro%2520drugs%2520and%2520implications%2520for%2520treatment%2520of%2520human%2520African%2520trypanosomiasis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D2893%26epage%3D2900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Jacobs, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nare, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sligar, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenks, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noe, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowling, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewerts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaukel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randolph, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacchi, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarlett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Don, R.</span><span> </span><span class="NLM_article-title">SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis</span> <span class="citation_source-journal">PLoS Negl. Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=e1151&author=R.+T.+Jacobsauthor=B.+Nareauthor=S.+A.+Wringauthor=M.+D.+Orrauthor=D.+Chenauthor=J.+M.+Sligarauthor=M.+X.+Jenksauthor=R.+A.+Noeauthor=T.+S.+Bowlingauthor=L.+T.+Mercerauthor=C.+Rewertsauthor=E.+Gaukelauthor=J.+Owensauthor=R.+Parhamauthor=R.+Randolphauthor=B.+Beaudetauthor=C.+J.+Bacchiauthor=N.+Yarlettauthor=J.+J.+Plattnerauthor=Y.+Freundauthor=C.+Dingauthor=T.+Akamaauthor=Y.+K.+Zhangauthor=R.+Brunauthor=M.+Kaiserauthor=I.+Scandaleauthor=R.+Don&title=SCYX-7158%2C+an+Orally-Active+Benzoxaborole+for+the+Treatment+of+Stage+2+Human+African+Trypanosomiasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DOrr%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DSligar%26aufirst%3DJ.%2BM.%26aulast%3DJenks%26aufirst%3DM.%2BX.%26aulast%3DNoe%26aufirst%3DR.%2BA.%26aulast%3DBowling%26aufirst%3DT.%2BS.%26aulast%3DMercer%26aufirst%3DL.%2BT.%26aulast%3DRewerts%26aufirst%3DC.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DOwens%26aufirst%3DJ.%26aulast%3DParham%26aufirst%3DR.%26aulast%3DRandolph%26aufirst%3DR.%26aulast%3DBeaudet%26aufirst%3DB.%26aulast%3DBacchi%26aufirst%3DC.%2BJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DDon%26aufirst%3DR.%26atitle%3DSCYX-7158%252C%2520an%2520Orally-Active%2520Benzoxaborole%2520for%2520the%2520Treatment%2520of%2520Stage%25202%2520Human%2520African%2520Trypanosomiasis%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2011%26volume%3D5%26spage%3De1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i88"><a href="/doi/suppl/10.1021/jm400349k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_05143"></div></div></div></div></div><hr /></hr><p class="last">Synthesis of selected boronates and a tabulation of all the inhibitors, with their Northeastern registry numbers and screening data. Also included are biological assay details, data from pharmacokinetic, and in vivo efficacy studies, plasma protein binding, and results from cell cycle analysis following inhibitor treatment. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400349k/suppl_file/jm400349k_si_001.pdf">jm400349k_si_001.pdf (603.58 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400349k&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm400349k%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-10%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400349k" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ac533e8bd22f0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
